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Abstract 
Haemonchus contortus is a blood-feeding Strongylid parasite that is economically 
significant worldwide. Due to the increasing problem of anthelmintic resistance, 
alternative approaches are urgently required for parasitic nematode control. H. 
contortus cathepsin B gut cysteine proteases have received attention as 
potential vaccine candidates because of their proposed role in blood feeding. 
The increasing amount of H. contortus genome information has now enabled 
detailed identification and annotation of cathepsin B protease gene families. In 
this study H. contortus BAC 18f22 was annotated and found to encode eight 
tandemly arranged cysteine proteases related to the previously identified AC 
family, but with six novel genes identified. Annotation of supercontig and 
scaffold sequence identified many more members of the HmCP and GCP-7 
cathepsin B families. In total this work has shown that the H. contortus genome 
encodes at least 41 cathepsin B protease genes, more than in other nematodes, 
to date. In contrast, Hc-cpr-6 is present as a single copy gene that is highly 
conserved in a number of species, suggesting an important conserved function.  
Further work examined regulation of gut gene expression in H. contortus, in 
particular the H. contortus ELT-2 GATA transcription factor (TF), as it has been 
shown to be the major TF in C. elegans controlling gut gene expression. A high 
throughput assay was developed and used to screen an integrated C. elegans 
worm strain expressing GFP in the gut and hypodermis (Ce-cpl-1::gfp) against 
594 chemical compounds. Compounds were identified that specifically cause a 
decrease in gut GFP expression, affect larval development and show a degree of 
lethality. Further work on two of the compounds identified an embryonic effect, 
with a significant decrease in number of progeny. To conclude, this thesis 
identified a number of novel cathepsin B genes as well as two compounds 
potentially interfering with TF activity and gut gene expression which may be of 
use as novel anthelmintics.  
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1.1 Parasitic nematode infections 
1.1.1 Haemonchus contortus 
Many helminths are responsible for parasitic infection in plants, animals and 
humans. It is estimated that over one billion people are infected worldwide with 
the majority of these individuals being in the developing countries of the world 
(Hotez et al., 2008). In the UK alone, endemic parasite infections cost the 
livestock industry millions of pounds every year 
(http://www.knowledgescotland.org/briefings.php?id=75). 
Haemonchus contortus is a Strongylid parasite and is one of the most pathogenic 
nematodes in sheep and goats. It is a blood sucking abomasal parasite that can 
cause anaemia, weakness, oedema, loss of appetite, diarrhoea and subsequently 
death. Economically, H. contortus is one of the most important parasites of 
ruminants worldwide, with weight loss resulting in decreased production and in 
many cases mortality (Githigia et al., 2001). Development of the H. contortus 
free-living stage is enhanced by the presence of warm and wet climatic 
conditions, indicating why this parasite was traditionally found in more tropical 
climates (Waller et al., 2006). H. contortus is becoming more widespread, an 
occurrence that may be due to changes in sheep management and the farming 
industry, climate change and from the overuse/incorrect use of anthelmintic 
drugs (Coles, 2002). Primary infection comes from the ingestion of infective L3 
larvae on the pasture, therefore an increase in the intensity of sheep farming 
resulting in higher stocking densities can lead to an increase in larval numbers 
consumed from the pasture (Thamsborg et al., 1996). Global warming resulting 
in warmer, wetter conditions favouring parasite survival may be a contributing 
factor to the increase in parasitaemia. As such conditions are favourable for 
larval development, this can result in a rapid increase in infective larvae on 
pastures (Kenyon et al., 2009). Compounding the increased exposure of livestock 
to parasitic nematodes is the problem of anthelmintic resistance. Surveys 
suggest that 80% of UK sheep farms have resistance to at least one class of 
anthelmintic drug (Taylor, 2009).  
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Nematode species can be categorised into clades (Blaxter, 1998) based on small 
subunit ribosomal RNA gene sequence and other genes. Each clade contains a 
mixture of free-living and parasitic species except for clade III which contains 
only animal parasites (Figure 1.1). This phylogenetic analysis has helped group 
the free-living nematode Caenorhabditis elegans in the same clade as H. 
contortus. This indicates that the two species are closely related and suggests C. 
elegans is suitable for the study of H. contortus (Gilleard, 2004).  
 
Figure 1.1  Phylogenetic tree depicting the nematode clades  
The five nematode clades are indicated, with examples of species contained within them. H. 
contortus and C. elegans are both found in clade V. (Image courtesy of Gilleard, 2004) 
1.1.2 H. contortus life cycle 
Knowledge of the H. contortus life cycle (Figure 1.2) is important for the 
understanding of possible control methods and the correct use of anthelmintic 
drugs. H. contortus has a direct life cycle, and is an obligate parasite, with 
sheep and goats being the definitive host (Angulo-Cubillan et al., 2010). Initially 
eggs are passed in faeces onto the pasture. These eggs hatch on the pasture to 
the L1 stage. Moulting occurs, producing the L2 stage, after the second moult 
the cuticle is not shed resulting in ensheathed L3 larvae that cannot feed. L3 
move from the faeces onto the pasture and are ingested by the host, with the 
Chapter 1  18 
host required for the completion of the life cycle. After ingestion, L3 larvae 
exsheath and moult, resulting in L4s in the abomasum. These larvae latch on to 
the stomach lining and begin to feed, causing bleeding and clot formation 
around the individual larva. Each worm results in the loss of about 0.05 ml of 
blood per day through ingestion and from lesions. Thus a sheep with a burden of 
5,000 worms could lose up to 250 ml per day, an indication of why anaemia is 
one of the symptoms of infection (Abbott et al., 2009). After approximately 3 
days the mature L4 larvae emerges from the clot and moults to the final adult 
stage. It is at this point that the adult worm attaches to the mucosa of the 
abomasum, mates and begins producing eggs. When mature, worms can be up to 
2 cm in length and a mature female can produce thousands of eggs per day. H. 
contortus eggs can first be detected in the faeces approximately 14 days after 
initial larval ingestion (these time periods are important for the use of strategic 
anthelmintic dosing). Larvae can also undergo arrested development, thus they 
can survive in vivo through periods where pasture survival would not be possible 
(Waller et al., 2004). Bad pasture management and the pattern of sheep grazing 
(for example, exposing clean pasture to resistant worms and/or not rotating 
pasture) (http://www.fwi.co.uk/academy/article/126167/worms-in-sheep.html) 
can lead to a large ingestion of infective larvae. At certain times of the year 
(e.g. spring) many larvae restart their development at the same time, resulting 
in a noticeable detrimental effect on the health of the flock (Whittier et al., 
2009). 
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Figure 1.2 H. contortus life cycle  
Image courtesy of Virginia Cooperative Extension http://pubs.ext.vt.edu/410/410-027/410-
027.html. 
1.1.3  The use of anthelmintic drugs to treat parasitic infection 
The predominant method of control for H. contortus is the use of broad 
spectrum anthelmintic drugs of which there are three major classes; 
Benzimidazoles (BZ, group 1), Imidazothiazoles and Tetrahydropyrimidines 
(group 2) and Avermectins and Milbemycins (group 3). Drugs contained within 
families have the same mode of action, with many of these drugs targeting the 
parasite nervous system (Sleigh, 2010). Anthelmintic drugs are generally 
administered by oral drench however other methods such as slow release bolus, 
injection or in-feed methods are also available. There are both advantages and 
disadvantages to each delivery method (Taylor, 1999).  
Group 1 anthelmintics inhibit microtubule formation by binding to the tubulin 
precursors and preventing polymerisation through a process known as ‘capping’ 
(Oxberry et al., 2001). Microtubules are intracellular organelles composed of α-
tubulin and β-tubulin proteins. They have a wide range of functions including 
formation of the mitotic spindle, maintenance of cell shape and intracellular 
transport, thus are essential for normal growth and development. Tubulin 
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contains three binding domains and it is the colchine binding domain at which 
benzimidazoles bind, forming a tubulin-benzimidazole complex (Lacey, 1988). 
Evidence suggests that benzimidazoles bind to the β-tubulin gene, as mutations 
in this sequence confer resistance (Drogemuller et al., 2004). Other proposed 
ideas include benzimidazoles binding to the α-subunit but still being regulated 
by β-tubulin (Banerjee and Luduena, 1992).  
Group 2 anthelmintics are nicotinic agonists which target the nicotinic 
acetycholine receptors (nAChRs) at nematode neuromuscular junctions. These 
anthelmintics have more potent activity than acetylcholine at the receptors and 
cause the opening of ligand-gated receptors on the muscle cell. Anthelmintic 
drugs are not rapidly degraded resulting in a prolonged channel opening and 
continued Ca2+ entry (Sleigh, 2010). The resulting contraction of the muscle 
fibres causes a rigid paralysis of the worm (Harrow and Gration, 1985). 
Group 3 anthelmintics are a group of Macrocyclic lactones that are produced 
from the fermentation of Streptomyces species (Taylor, 1999). This group is able 
to target the GABA receptors in both vertebrates and invertebrates, and the 
glutamate-gated chloride channels in invertebrates. Macrocyclic lactones target 
these ligand-gated ion receptors which function in neuronal and muscular 
systems, and paralyse the parasite by increasing permeability of the muscle to 
Cl- (Cully et al., 1996).  
It has been over 25 years since the last anthelmintic was released on to the 
market. Within this period two classes, cyclodepsipeptides and paraherquamides 
have emerged but as yet neither have produced a marketable product (Ducray et 
al., 2008). More recently however a new class, the amino-acetonitrile 
derivatives (AADs), has been shown to provide anthelmintic activity (Kaminsky et 
al., 2008a;Kaminsky et al., 2008b). This is a synthetic class of drug that has 
provided activity against nematodes. Work has been carried out in C. elegans to 
determine the mode of action of the AADs and an acr-23 gene was identified as a 
major target. In H. contortus the monepantel-1 (Hco-mptl-1) gene is thought to 
be a potential target. Both these genes are part of the ligand-gated ion channel 
superfamily and are nAChR subunits (Rufener et al., 2010). These drugs work by 
a novel mode of action and are effective against those isolates already resistant 
to conventional drug classes, a necessity for any new anthelmintic. The main 
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drug used in studies is Monepantel (AAD 1566) as it targets resistant isolates, has 
a high efficacy and is well tolerated in vivo. It causes contraction of the body 
wall muscles leading to parasite paralysis and death (Kaminsky et al., 2009). 
This drug has been developed by Novartis Animal Health and was released under 
the trade name Zolvix in 2010. In addition to the AADs was the discovery of the 
spiroindoles (SI) another new class (Lee et al., 2002). The SIs work as cholinergic 
neuromuscular blockers to cause flaccid paralysis and as the target binding sites 
are different from other classes it is effective against worms resistant to other 
classes (Little et al., 2010). 2-deoxy-paraquamide (derquantel) was the first 
studied and when used solely was a mid-spectrum anthelmintic, for this reason it 
was combined with abamectin and trialled in field (Little et al., 2011). 
STARTECT (Pfizer Animal Health) was subsequently released into the market in 
2011. As these are the first new anthelmintics in 25 years, care must be taken to 
preserve their efficacy for as long as possible as there is now widespread 
resistance to the other three classes of anthelmintic drug.  
1.1.4 Anthelmintic resistance 
Drug resistance is defined by the change in the pharmacodynamics of a drug 
(Lacey, 1990). There is now nematode resistance to the three main classes of 
anthelmintic currently available. The resulting decrease in production and 
increase in mortality is an increasing economic threat to the livestock industry, 
thus alternative control approaches are required. Development of the new drugs 
Monepantel and STARTECT are two attempts to combat this problem. There are 
many factors contributing to anthelmintic resistance, examples include; overuse, 
incorrect dosage and unnecessary dosing (Prichard, 1990). Once resistance has 
developed to a compound within a group, the efficacy of other members within 
the group is also decreased due to the conservation of mode of action between 
members within a group.  
H. contortus was one of the first parasites to demonstrate anthelmintic 
resistance in the early 1960s (Conway, 1964), to the drug Phenothiazine a 
member of the Benzimidazole family. Thiabendazole was then introduced to the 
market, but subsequent overuse resulted in its inefficacy within just a few 
years. Widespread resistance to the Benzimidazole family had become apparent 
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by the 1970s. This pattern of resistance was also followed by the newer 
anthelmintic classes; Imidazothiazoles and Tetrahydropyrimidines and 
Avermectins and Milbemycins (Table 1.1). By the early 1980s there were reports 
of multiple drug resistant (MDR) worms demonstrating resistance to drugs in 
different classes. Of these, resistance to the Benzimidazole class of drug is the 
most understood (Kaplan, 2004). There are two isotypes of β-tubulin that have 
been identified in parasitic nematode species. Using C. elegans Kwa et al., 
(1995) showed that mutation of the β-tubulin isotype-1 gene resulted in 
resistance to Benzimidazoles and that this could be reversed by introduction of 
H. contortus β-tubulin. Resistance to group 2 anthelmintics can occur in several 
ways, either by a decrease in number or sequence mutation of the nAChRs in 
muscle, or by inefficacy after long periods of exposure to the drug, resulting in 
either complete recovery or partial paralysis (Lewis et al., 1980). 
Drug Year of drug approval First report of resistance 
published 
Benzimidazoles 
Thiabendazole 1961 1964 
Imidazothiazoles-Tetrahydropyrimidines 
Levamisole 1970 1979 
Avermectins-Milbemycins 
Ivermectin 1981 1988 
Moxidectin 1991 1995 
 
Table 1.1 Major anthelmintic classes used in the control of H. contortus 
The period of time between drug approval into the market and resistance being reported in sheep 
is indicated. (Adapted from Kaplan, 2004) 
As yet there is no recorded resistance to Monepantel but, as indicated for the 
other classes, conversion to resistance is so rapid that money spent on the 
formation of new drugs may be considered economically unviable. The 
increasing information on parasite gene sequence, function and regulation can 
be exploited to understand mechanisms of drug resistance and to develop novel 
ways to interfere with parasite development and survival. 
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1.1.5 Alternative approaches for H. contortus control 
In view of the problem of drug resistance, alternative control measures are 
required. There is only one successful and commercially available vaccine used 
for the treatment of parasitic nematodes to date, the Bovilis Husk vaccine. This 
vaccine contains attenuated larvae and is used against the bovine lungworm 
Dictyocaulus viviparus (Sharma et al., 1988). 
Development of a potential vaccine against gastrointestinal parasites will require 
in depth knowledge of the target proteins of interest. The gut of parasitic blood-
feeding nematodes contains a number of proteins that are able to confer 
protective immunity during the blood-feeding process (Jasmer and McGuire, 
1991). Work carried out by Munn et al., (1987) showed that young animals 
immunized with native H. contortus gut membrane proteins showed a significant 
decrease in worm burden after challenge infection.  
There are a number of potential protective antigens that are considered possible 
vaccine targets, including the H11 aminopeptidase family, the H-gal-GP complex 
(a complex of metallo and aspartate proteases) and the HmCP family (Knox et 
al., 2003). These antigens are all hidden, meaning they are not recognised by 
the host even after exposure to infection (Smith et al., 1997). As H. contortus is 
a blood feeder, the surface of the parasite intestine will be exposed to host 
immunoglobulin and thus to potential antibodies induced by vaccination. 
Significant effort has been made to target and potentially interfere with their 
proposed digestive function. Immunity provided by hidden antigens is different 
to that from natural infection. In natural infection, if an animal is exposed to 
the parasite for a number of weeks it will subsequently be able to prevent most 
larvae establishing due to naturally generated antibodies (Schallig et al., 1997). 
This is in contrast to animals immunised with hidden antigens in which there 
would be no or little boosting of the immune system by natural infection, thus 
booster vaccinations would be required. In order for vaccination to be 
successful, the formulation, cost effectiveness and route of administration are 
all important considerations (Emery and Wagland, 1991). 
Although H11 and H-gal-GP can induce high levels of protection in native form, 
attempts to vaccinate sheep with recombinant proteins have proved far less 
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successful (Cachate et al., 2010;Munn et al., 1997). This is thought to be due to 
differences in conformation and/or glycosylation and has led to work using C. 
elegans as a suitable expression system for H. contortus and T. circumcincta 
vaccine candidates (Murray et al., 2007) (Roberts and Britton, unpublished data; 
Longhi, Nisbet, Britton and McNeilly, unpublished data). In the meantime, 
attention has re-focussed on vaccination with native H. contortus gut antigens, 
through improvements to the extraction process. While this still requires a 
supply of parasites for antigen preparation, recent field trials have proved very 
successful (Smith et al., 2000;Smith et al., 2003). 
Screening using antibody to a ‘protein enriched’ gut membrane extract resulted 
in the identification of three cDNAs encoding cathepsin B cysteine proteases, 
HmCP1, 4 and 6. These HmCP genes are developmentally regulated and are only 
expressed in blood feeding stages (Skuce et al., 1999). A number of cysteine 
protease genes were previously identified in a US strain of H. contortus, namely 
the AC protease gene family (Pratt et al., 1990) and gcp-7 (Rehman and Jasmer, 
1999). Work has shown that the HmCP genes are distinct from those previously 
isolated, as at best they only share a 60% amino acid identity (Skuce et al., 
1999). 
Protective antigens have also been isolated from excretory-secretory (ES) 
components obtained through in vitro incubation of worms. These antigens are 
considered to be excreted from the parasite and thus available to the host 
mucosal lymphoid cells and lymph nodes via the circulatory system. These 
naturally occurring antigens elicit both a cellular and antibody response (Bakker 
et al., 2004). Schallig et al., (1997) examined two ES proteins of 15 and 24 kDa 
from H. contortus adult worms and subsequent analysis indicated that a strong 
antibody response was generated against these antigens, with over 70% 
protection rates recorded.  
The identification of a single protein that provides protection would be ideal for 
commercial vaccine development. However this may be very difficult to achieve, 
thus looking for a combination of proteins that together may provide significant 
protection and/or protection against a number of parasites would also be of 
great benefit (Munn et al., 1997). For commercial vaccine production, 
development of a suitable recombinant protein expression system is a priority. 
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1.1.6 Nematode genome sequencing 
Sequencing of the C. elegans genome has sparked great interest in the study of 
the human genome and provided better tools for genome analysis 
(http://www.hgc.jp/english/software.html). This has led to the initiation of 
genome sequencing projects for a wide range of other smaller organisms 
(http://www.sanger.ac.uk/). The free-living nematode C. elegans was the first 
multi-cellular organism to have its genome sequenced and this data has been 
widely used in comparative studies (Sulston et al., 1992). Additionally there was 
a wealth of genetic data available indicating that C. elegans could be used as a 
model system for studying development, neurobiology, signalling and behaviour 
in other multicellular organisms (Brenner, 1974).  
Sequencing work began with the creation of a physical map of the C. elegans 
genome. This was only possible through communication of a number of labs 
working with the C. elegans nematode. The aim was to have access to any 
segment of the genome and provide a start point for large scale sequencing 
(Coulson et al., 1986). After assembly of the sequenced cosmids, gaps were still 
present, largely due to the size constraints in the cloning system, with a 50 kb 
fragment the maximum length of an individually sequenced region. It was not 
until the development of yeast artificial chromosome (YAC) clones that the 
majority of the gaps could be filled. Unlike original cloning vectors, YACs can 
contain fragments of up to several hundred kb (Burke et al., 1987). The C. 
elegans genome was completed in 1998 (The C.elegans Sequencing Consortium, 
1998), is ~97 Mb in size and encodes over 19,000 genes. The importance of this 
data not only to C. elegans but to other organisms is indicated by the fact that 
more than 40% of the predicted protein products were found to be homologous 
to those identified in other organisms. Therefore, information from C. elegans 
genetic mutants and gene knockouts can provide a first indication of the 
potential role of conserved genes. 
The C. briggsae genome sequence is also available (98% complete) allowing a 
direct comparison between the two Caenorhabditis species. These nematodes 
diverged approximately 100 million years ago, but have similar genome sizes. 
Gene arrangement on chromosomes is also well conserved with 96% of genes 
Chapter 1  26 
showing synteny (Stein et al., 2003). The information provided by the C. 
briggsae genome has enabled improved gene annotation in C. elegans. In 
addition, analysis of sequence conservation and divergence has helped identify 
functional domains within coding and non-coding regions, such as motifs in 
promoter and 3’ UTR sequences.  
A draft genome assembly and annotation was published for the filarial nematode 
Brugia malayi in 2007. It is an estimated 90-95 Mb in size, similar to that of C. 
elegans and C. briggsae and was obtained through whole-genome shotgun (WGS) 
sequencing (Ghedin et al., 2007), involving the piecing together of overlapping 
reads to give one continuous sequence. WGS is used for larger fragments by 
sequencing from opposite ends on different strands. It was identified that there 
is very little synteny between B. malayi and C. elegans and that B. malayi has a 
far fewer number of estimated genes than those found in C. elegans, however 
sequencing is still only 80% complete. Having access to a number of nematode 
genomes enables large-scale comparative studies which, in time, will provide 
information about nematode developmental pathways and molecules that can be 
used as possible control targets (Ghedin et al., 2007).  
The genome of H. contortus is currently being sequenced. This work is being 
carried out at the Wellcome Trust Sanger Institute and is just one of the many 
helminth sequencing projects currently underway 
(http://www.sanger.ac.uk/cgi-bin/blast/submitblast/h_contortus). Current 
work suggests the H. contortus genome may be over four times the size of 
original estimates (200-300 Mb) (Gilleard lab, unpublished work). The initial 
estimate of 50 Mb was based on flow cytometry (Leroy et al., 2003) and is 
thought to be an underestimate. As mentioned previously, both H. contortus and 
C. elegans are clade V nematodes and phylogenetic analysis suggests they 
diverged approximately 400 million years ago (Laing et al., 2011). Thus there are 
likely to be similarities in gene sequence. The complete sequencing of the H. 
contortus genome would enable all genes to be identified. As this would be the 
first clade V parasitic nematode for which complete genome data is available it 
would allow a full genomic comparison between H. contortus and Caenorhabditis 
species. 
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1.1.7 Caenorhabditis elegans as a model for parasitic nematodes 
Parasitic nematodes such as H. contortus are not ideal for in vitro studies; they 
have complex lifestyles and are difficult to culture and maintain. It is for this 
reason that research on H. contortus and other parasitic nematodes has made 
use of the free-living nematode C. elegans (Bürglin et al., 1998). C. elegans is a 
soil living nematode and its growth requirements are relatively basic; warm 
humid temperature, oxygen and bacteria as food. The C. elegans life-cycle is 
very rapid and takes just 3.5 days at 20OC with each worm producing up to 300 
progeny in just 4 days, thus providing a very useful resource for large-scale 
studies (Byerly et al., 1976). Sequence as well as functional information on C. 
elegans genes (http://www.wormbase.org) also provides an important resource 
for studies on parasitic nematodes, particularly for clade V nematodes such as H. 
contortus and hookworms.   
C. elegans worms are amenable to transformation making it possible to identify 
the expression pattern of genes spatially and temporally. More recently the roles 
of genes within specific tissues have been studied using gene-specific promoters 
to drive expression, for example Hc-cpr-1 (Britton et al., 1998) Hc-elt-2 
(Couthier et al., 2004). These types of studies have been possible due to work 
carried out by Fire et al., (1990) which saw the creation of a number of vectors, 
containing various promoters and marker genes and which have been improved 
over time. Parasitic gene promoter regions and functional genes can also be 
introduced into these vectors and then into C. elegans worms creating 
transgenic lines that can be easily cultured and studied in vitro. This has helped 
demonstrate the expression pattern of genes and show that similar gene 
regulatory mechanisms exist in C. elegans and parasitic nematodes (Britton et 
al., 1999). In addition, rescue of C. elegans mutant phenotypes can be used to 
demonstrate conserved gene function (Britton and Murray, 2002;Gillan et al., 
2009). 
Analysis of gene function in C. elegans and in other organisms has been 
revolutionised by the development of RNA interference (RNAi). This is a 
mechanism used to silence genes in a sequence specific manor and is achieved 
by introducing dsRNA into the worm (Fire et al., 1998). Work has been 
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successfully carried out using C. elegans due to its ease of culture in vitro. In C. 
elegans RNAi is effective not only when the dsRNA is injected but also by soaking 
the worms (Tabara et al., 1998) and by feeding the worms on Escherichia coli 
expressing dsRNA (Fire et al., 1998). However C. elegans seems to be an 
exception in the ease with which genes can be silenced. In C. briggsae, RNAi can 
be induced only by injection of dsRNA, a difference that is speculated to be due 
to different SID-2 transporter proteins (Winston et al., 2007). In parasitic 
nematodes in vitro culture alone is difficult, and thus RNAi approaches which 
effectively deliver dsRNA to worms and allow analysis of any resulting phenotype 
have proved difficult (Geldhof et al., 2007). Soaking is the main method used, 
but achieving sufficient uptake has proved difficult. Alternative approaches such 
as microinjection of the small larval stages in not easy due to poor survival, and 
electoporation did not improve gene knockdown (Geldhof et al., 2006). 
Differences in transport may also explain RNAi deficiencies in parasitic 
nematodes (Winston et al., 2007). Future work such as the introduction of the 
sid-2 gene or other C. elegans transporters into parasitic nematodes may lead to 
better RNAi effects. Transgenic methods have been developed for Strongyloides 
species and B. malayi thus making such studies potentially feasible (Li et al., 
2006;Xu et al., 2011). 
1.2 Gene regulation 
1.2.1 Gene regulation in nematodes 
Gene regulation in nematodes can occur via many mechanisms. Currently the 
most well-studied include direct regulation by transcription factors (TFs) and 
microRNAs (miRNAs) (Carthew, 2006;Hobert, 2008). TFs are proteins that bind to 
specific regions of DNA, termed cis-regulatory DNA elements, and cause either a 
positive or negative effect on gene transcription. They contain at least one DNA 
binding domain which targets the upstream region of the genes to which they 
bind (Reece-Hoyes et al., 2005). Identification of gene regulatory elements has 
traditionally relied on the “promoter bashing” approach. This involved deletion 
and mutation of regions thought to be important for regulation. The sequence 
information that is now available for a number of Caenorhabditis species has 
enabled the prediction of putative protein coding genes in C. elegans, and has 
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made identification of conserved regulatory elements within the promoter 
regions of these genes possible (Gaudet and McGhee, 2010).  
Haerty et al., (2008) carried out an extensive study looking at putative TF 
activity in C. elegans. 998 genes were identified as being under the control of 
TFs. TF networks have been created to help understand differences in gene 
expression. These networks identified the relationships between gene targets 
and their TF proteins, and enabled functionally important TFs to be highlighted 
(Reece-Hoyes et al., 2005). One TF which has been well studied in C. elegans is 
HSF-1, a heat-shock factor that responds to heat and stress. When HSF-1 is over-
expressed there is an increase in lifespan, however if HSF-1 is decreased the 
opposite is true (Hsu et al., 2003). One major advantage of using C. elegans for 
the study of TFs is the ability to knock-out TFs in the genome to identify their 
function (Gaudet and McGhee, 2010). Given the importance of TFs in gene 
regulation, loss of activity often results in phenotypic effects. 
In addition to transcriptional regulation by TFs, many genes can also be subject 
to post-transcriptional regulation by microRNAs (miRNAs). TFs themselves can be 
regulated by miRNAs, establishing feedback control loops (Martinez et al., 2008). 
miRNAs are single stranded RNAs that are approximately 22 nucleotides in length 
and regulate gene expression in protein-coding genes. miRNAs were first 
identified in C. elegans and their mechanism of action demonstrates similarities 
to the RNAi pathway. Unlike RNAi in which the target mRNA is always degraded, 
many miRNAs work by repressing the translation of their target RNAs with only 
some causing the degradation of the target RNAs (Bartel, 2004). The first miRNA 
identified was lin-4 which targeted the LIN-14 protein (Lee et al., 1993). In this 
mechanism of gene regulation, the lin-4 gene binds to sites present at the 3’ 
UTR of lin-14. Subsequent inhibition of the LIN-14 protein occurs, which affects 
early larval development. let-7 was the second miRNA gene to be discovered and 
results in the inhibition of LIN-41 expression which is responsible for late larval 
development. Subsequently let-7 was identified in a number of other species 
and to date hundreds of miRNA genes have been identified in plants and animals 
(Bagga et al., 2005). More recently, miRNAs have been identified as having a 
role in drug resistance, with a large focus in tumour cell biology (Zhang et al., 
2007). If miRNAs play a part in tumour drug efficacy they may also affect other 
drugs. One proposal is that the changes in gene expression levels, associated 
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with miRNAs could have a role in drug resistance in parasitic nematodes 
(Devaney et al., 2010). 
1.2.2 Regulation of gut expressed genes in nematodes 
The nematode intestine is a remarkable structure and has been shown to be 
involved in lifespan and ageing (Libina et al., 2003). Labina et al., (2003) 
identified that activity of the TF DAF-16 in the intestine increases worm lifespan 
by both positive and negative regulation of gene expression. Thus detailed 
knowledge of the C. elegans intestinal composition is an invaluable resource.  
Due to the importance of the C. elegans intestine in survival and development, 
regulation of a number of gut genes has been studied experimentally. Work 
carried out to date has identified the presence of GATA transcription factors 
involved in the control of C. elegans gut gene promoters. GATA factors are 
transcriptional activators that bind to GATA sequences in DNA. There are six 
classes of mammalian GATA factor, named GATA 1-6, all of which contain a 
distinct pair of zinc finger domains. In C. elegans a GATA-1 like gene termed elt-
1, was initially identified and found to be responsible for control of C. elegans 
gut genes, for example ges-1(Kennedy et al., 1993). Probing of C. elegans cDNA 
expression libraries identified a second GATA factor termed elt-2. ELT-2 appears 
to be most closely related to GATA-5 and unlike the other GATA factors only 
contains one zinc finger (Hawkins and McGhee, 1995). A recent study looking at 
putative TFs in C. elegans identified 9 GATA-type TFs which are highly conserved 
in other nematode species C. briggsae and Caenorhabditis remanei (Haerty et 
al., 2008). 
There are three GATA-type TFs expressed in the intestine of the adult C. elegans 
worm; ELT-2, ELT-4 and ELT-7. Experimentally, ELT-2 has been shown to be the 
major transcription factor (McGhee et al., 2007). Evidence that the ELT-2 GATA 
TF is essential for gut gene regulation and gut development was determined by 
studies on the gut specific ges-1 esterase gene (Fukushige et al., 1998). elt-2 
also plays a role in the activation of endodermal differentiation and specific 
gene expression. end-1 and end-3 (Stainier, 2002) are involved in the initiation 
phase of gut development and elt-2 is required for progression of development. 
Work by McGhee et al., (2007) additionally identified 108 non-GATA TFs that 
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were expressed in the C. elegans adult intestine. RNAi has been applied to 
determine the roles of these TFs; to date, elt-2 RNAi has been found to have a 
significant effect on gene function. 
The intestine has been identified as an important source of protective antigens 
in H. contortus, with some of the enzymes found being similar to those found in 
C. elegans. Some of these enzymes are under the control of GATA-type TFs in C. 
elegans, thus using C. elegans as a model to study H. contortus promoters and 
TFs can help identify regulatory elements and TFs controlling expression of H. 
contortus gut genes. A better understanding of gut gene regulation in H. 
contortus and other nematodes has important relevance to interfering with gut 
activity in general and may lead to new approaches to parasite control. 
1.3 Aims and Objectives 
The overall objective of this project was to study H. contortus gut gene 
regulation and function, and to determine whether ELT-2 is a master regulator 
of gut gene expression in this parasitic nematode.  
The main aims of this work were to; 
• Identify and characterise potential gut expressed genes from H. contortus 
by annotation of the available genome data. 
• Carry out bioinformatic promoter region analysis to identify potential 
regulatory motifs controlling gut gene expression. 
• Identify small molecule compounds that interfere with gut gene 
expression and potentially target the ELT-2 GATA TF in C. elegans worms, 
using transgenic C. elegans as a screening tool (collaboration with Pfizer 
Veterinary Medicine, Kalamazoo, USA). 
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2.1 C. elegans methods 
2.1.1 Culture and maintenance  
C. elegans worm strains used in this thesis were obtained from the 
Caenorhabditis Genetics Centre (CGC) (http://www.cbs.umn.edu/CGC/strains/) 
unless otherwise stated. For optimum development, C. elegans worms were 
maintained on NGM agar plates (Appendix 1) seeded with an E. coli OP50 strain 
at 20OC. In some instances plates became contaminated with either an 
overgrowth of bacteria or with fungi, bleaching was used to clean cultures. The 
plate to be cleaned should contain a sufficient number of gravid 
hermaphrodites. The plate was washed with 1 ml of sterile water and the 
worm/water mixture transferred to a 1.5 ml eppendorf. 0.5 M NaOH and 1% 
bleach (Sodium Hypochlorite) were added and the solution vortexed for a few 
seconds every 2 min for 10 min. The solution was centrifuged at 13,000 g for 30 
sec to pellet eggs. The pellet was washed with water and this was repeated until 
the water appeared clean. An end volume of approximately 100 µl of embryos 
was transferred onto a seeded OP50 plate and cultured under standard 
procedures.  
C. elegans worm strains can be maintained for long periods of time. Once a plate 
has cleared of bacteria it can be sealed with parafilm and stored at 15OC. At this 
temperature and with no food the worms become arrested and can be kept in 
this state for months. Alternatively, worm strains can be frozen and stored at -
80OC. Worm plates just cleared of bacteria were washed with equal volumes of 
M9 buffer (Appendix 1) and freezing solution (Appendix 1). This solution was split 
between two 1.5 ml screw top eppendorf tubes and placed in a polystyrene box 
at -80OC overnight to freeze slowly and prevent damage to the worms, and was 
subsequently transferred to a freezer box for storage. Worms were available for 
use as required by thawing and transferring the contents onto seeded NGM 
plates. 
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2.1.2 Transformation of C. elegans by microinjection 
The microinjection procedure was as described in WormBook 
(http://www.wormbook.org/chapters/www_transformationmicroinjection/trans
formationmicroinjection.html). DNA was injected along with a marker gene into 
the gonads of adult hermaphrodites. pRF4 (rol-6) (Kramer et al., 1990) and p76-
16B (unc-rescue) (Bloom and Horvitz, 1997) marker gene plasmids were used in 
this study. Introduction of rol-6 to wild-type worms has a visible rolling effect 
and unc-76 rescue was achieved by injecting the rescue plasmid into the DR96 
strain.  
DNA for injection was purified using the QIAGEN Plasmid mini kit. The injection 
mix contained 10-50 ng/µl of DNA (concentrations dependent on plasmid) and 
100 ng/µl of the marker gene in distilled water. The mix was centrifuged at 
13,000 g for 15 min and the supernatant transferred to a clean tube to eliminate 
any substrates that may block the needles. 
Needles were prepared from borosilicate glass capillaries (1.2 mm diameter, 
Harvard Apparatus) using a 773 APP Micropipette Puller (Campden Instruments 
Ltd). They can either be loaded using a standard bench pipette or a mouth 
pipette and a volume of approximately 1 µl is sufficient for injection of tens of 
worms. Needles were placed into a needle holder attached to a Zeiss Axiovert 
S100 Inverted Differential Interference Contrast (DIC) microscope and a pressure 
of 40 psi applied to the needle using a foot pedal.  
For injection, healthy young adult worms were placed onto a agarose injection 
pad containing a drop of mineral oil, to prevent dehydration, and then 
positioned so that the gonad was visible. Agarose injection pads were made by 
pipetting a small volume of warm 2% UltraPure Agarose (Invitrogen) solution 
onto a glass cover slip and then using another to flatten it, giving a flat circular 
pad. Pads were then baked at 40OC for 2 hours before use. Once the needle tip 
was inserted into the worm, filling of the gonad was observed when DNA solution 
was injected. Worms were placed onto OP50 seeded NGM agar plates, with a 
small volume of M9 for recovery. After 3 days the F1 generation were of an age 
at which phenotypic markers could be observed. F1 transfromants were 
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transferred onto fresh OP50 seeded NGM agar plates and allowed to egg lay. 
Stable F2 transformants were then selected.   
2.1.3 Staining and viewing C. elegans worms 
In this study, work carried out with transgenic lines had either Green 
Fluorescent Protein (GFP) or Lac-Z as a marker. GFP can be viewed using a 
bench microscope with a UV light and requires no staining for visualisation. 
Conversely, Lac-Z is only visible after staining with an X-gal stain (Appendix 1) 
for β–galactosidase activity. Worms for Lac-Z staining were washed off plates 
using an M9/0.001% Triton solution (Appendix 1) into a 1.5 ml eppendorf. The 
tubes were centrifuged at 13,000 g for 1 min to pellet worms and the excess 
supernatant removed leaving approximately 100 µl. 1.25% gluteraldehyde (Sigma 
Aldrich) was added and left for 15 min. The worms were subsequently washed in 
the M9/Triton solution three times to remove all gluteraldehyde. An 
approximate volume of 50 µl was left after the last wash and transferred onto a 
glass slide. Slides were left to air dry and then placed in acetone at -20OC for 3-5 
min for fixation of worms. Once dry, approximately 100-200 µl of X-gal stain was 
added to the slides and left to develop in a humid chamber for a minimum of 1 
hour, with overnight incubations giving stronger results. Worms were examined 
using an Axioscop 2 plus miscroscope (Zeiss) under bright field light. 
2.1.4 Transgene integration 
The method used is based on John Kim’s adaptation of the Greenwald and 
Hobert Labs’ integration protocol 
(http://www.elegansfusion.org/index.php?option=com_content&task=view&id=2
2&Itemid=43). Integration is used to achieve 100% transmission of a transgenic 
line with an original transmission rate of <100%. The Ce-cpl-1::gfp+unc-76 
rescued transgenic line used in this study had a transmission rate of ~70% and 
was selected for integration based on its potential use in elt-2 RNAi studies. 5 
transgenic L4 hermaphrodites were picked onto an OP50 seeded NGM agar plate, 
and this procedure repeated to give 30 plates in total. The plates were placed in 
a Stratagene UV crosslinker (Stratalinker) with the lids removed and irradiated 
using 350 µJ x100. The plates were left to starve for approximately 10-14 days at 
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20OC. Each plate was numbered 1-30 and from each starved plate 4 small areas 
were removed and placed onto fresh OP50 seeded NGM agar plates. These plates 
were numbered according to the plate from which they came, e.g. 1.1, 1.2, 1.3, 
1.4, giving a total of 120 plates. These plates were left for 1-2 days and 5 
transgenic hermaphrodites were picked from each plate. The adults were put 
onto smaller 3 cm seeded plates and left to egg lay. Approximately 60 eggs per 
plate is ideal and the adults were subsequently removed. Each plate was given a 
letter and a number corresponding to the plate of origin, e.g. 1.1a, 1.1b, 1.1c, 
1.1d, 1.1e, giving a total of 600 small plates containing eggs. These plates were 
left for a few days and then observed and any plates with 100% transgenic 
animals are fully integrated. 
Because irradiation results in chromosome disruption, mutations can arise and 
for this reason integrated lines were out-crossed by mating with wild-type 
males. C. elegans males occur at a very low percentage within a population. 
Male wild-type worms were picked onto seeded NGM agar plates along with a 
number of young hermaphrodites to obtain a supply of males for use. The out-
cross protocol used was; one integrated hermaphrodite was initially crossed with 
male wild-type worms and male transgenic progeny picked for cross two with 
wild-type hermaphrodites. The third cross is between a transgenic 
hermaphrodites and wild-type males and male transgenic progeny picked for 
cross four. The final cross is between transgenic males and a single wild-type 
hermaphrodite, this should give a fully integrated line (Figure 2.1). 
Approximately 20 transgenic hermaphrodites were picked from the last cross 
onto individual seeded NGM plates, and 100% of the progeny were transgenic 
worms. 
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Cross 1 
(Looking for GFP +ve 
male) 
 
GFP +ve 
 
single hermaphrodite 
wild-type 
 
4-5 males 
 
 
Cross 2 
(Looking for GFP +ve 
hermaphrodite) 
 
GFP +ve progeny 
 
4-5 males 
wild-type 
 
2-3 hermaphrodites 
 
 
Cross 3 
(Looking for GFP +ve 
male) 
GFP +ve progeny 
 
single hermaphrodite 
wild-type 
 
4-5 males 
 
 
Cross 4 
(Looking for GFP +ve 
hermaphrodite) 
GFP +ve progeny 
 
4-5 males 
wild-type 
 
single hermaphrodite 
 
 
Figure 2.1 Diagrammatic representation of the C. elegans transgenic out-cross protocol 
2.1.5 C. elegans RNA interference (RNAi) 
The RNAi method used in C. elegans has been adapted from WormBook 
(http://www.wormbook.org/chapters/www_introreversegenetics/introreversege
netics.html). For this study RNAi was carried out using the feeding method. IPTG 
agar plates (Appendix 1) were seeded with a bacterial strain containing a 
plasmid expressing dsRNA from two T7 promoters, and incubated at room 
temperature overnight to enable dsRNA production. Two different methods were 
used; the first involved ~20 adult females being picked onto an un-seeded NGM 
agar plate and left for approximately 5 min, allowing time for the gut to clear of 
bacteria. These adults were then transferred onto one RNAi plate and allowed to 
egg lay for approximately 2 hours. 50-70 eggs per plate was a sufficient number 
and the adults were subsequently removed. It takes approximately three days 
for the worms to reach a suitable age for analysis. The second method involved 
transferring L3/L4 stage larvae onto the RNAi plates, after a 5 min period on an 
un-seeded OP50 plate to clear the gut. This method is favoured if the RNAi 
effect is likely to affect development, as the RNAi effects on development are 
likely to be less detrimental in the already developed larvae.  
X 
X 
X 
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The RNAi feeding method was also carried out in liquid culture and on NGM agar 
plates at a laboratory at Pfizer. In the previously mentioned RNAi feeding 
method, worms were maintained on IPTG agar plates, with the IPTG enabling 
the production of dsRNA, thus an alternative method for dsRNA production in 
culture was required. One colony of the plasmid in E. coli bacteria was cultured 
overnight in a shaker at 37OC in 50 ml of L. Broth (Appendix 1). 0.4 mM IPTG was 
added to L. Broth (Ongvarrasoponea et al., 2007) and was incubated for an 
additional 4 hours at 37OC before being used to feed mixed stage worms. 
Alternatively, the bacteria, L. broth and IPTG solution were used to seed NGM 
agar plates which were incubated at 37OC for 4 hours before mixed stage worms 
were added. The latter method proved more effective.  
2.1.6 Antibody localisation methods 
2.1.6.1 Generation of an anti-peptide antibody 
Anti-peptide antibodies were generated at CovalAb in France against the C. 
elegans CPR-6 protein. Two C. elegans peptide regions that were highly 
conserved in H. contortus CPR-6 were identified. A BLAST search was carried out 
against the C. elegans and H. contortus genome sequences to ensure that these 
regions were unique. Approximately 26 mg of the Peptide regions 
SFDSRDNWPKCDSIKV and PHDLYPTPKCEKKCV were synthesised and conjugated 
at Covalab. These were then used to immunise two rabbits with both peptides. 
0.5 ml of antigen and 0.5 ml of Freund’s adjuvant were injected on days 0, 21, 
42 and 63. An initial pre-immune bleed was taken on day 0 and post-
immunisation bleeds on days 53 and 74. At each test bleed an Enzyme-linked 
immunosorbent assay (ELISA) was carried out to monitor the immunoreactivity of 
the antisera. A final bleed was taken on day 88 from which anti-peptide IgG was 
subsequently immunopurified using an affinity column. The final antibody 
concentration obtained was 9.2 µg/ml. 
2.1.6.2  Preparation of protein extracts 
Approximately 1,000 H. contortus ex-sheathed (Section 2.2.1) L3 larvae were 
centrifuged and washed in M9 buffer with the supernatant removed to leave a 
final volume of approximately 30 µl. C. elegans wild-type worms from a plate 
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that had just cleared of bacteria were washed off in M9 buffer, centrifuged and 
the supernatant removed to leave a final volume of approximately 30 µl. 30 µl of 
SDS loading buffer were added to this and heated at 95OC for 10 min. This buffer 
is 2x SDS-PAGE buffer (Appendix 1) and 0.7 M 2-mercaptoethanol (Sigma-
Aldrich). The mixture was stable enough to be stored at -20OC until required.  
2.1.6.3  Protein separation by polyacrylamide gel electrophoresis 
Protein extracts were separated using sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE). Approximately 20 µl of previously prepared 
sample (section 2.1.6.2) was heated to 95OC for a few min before use. Samples 
were loaded onto a 4-15% Tris-HCl Gel (BioRad) and run in 1x Tris/Glycine/SDS 
running buffer (BioRad) (Appendix 1) at 200 V for 1 hour using a BioRad Power 
Pac 200. A pre-stained protein marker was included to allow sample 
visualisation. 
2.1.6.4  Western Blotting of Ce-CPR-6 
The separated protein samples were then transferred onto an activated Hybond-
P membrane (Amersham). A sandwich consisting of (from back to front); a pre-
soaked sponge, filter paper, gel, membrane, filter paper and sponge was set-up 
for the transfer. The transfer was carried out in a chamber filled with chilled 1x 
Tris/Glycine blotting buffer (BioRad) (Appendix 1) and an ice box and was run at 
100 V for 1 hour. The membrane was removed from the sandwich and rinsed in 
1x PBST (Appendix 1) and then left to shake for 20 min in 5% block solution 
(Appendix 1). The block was removed and a 1/2000 dilution of the primary CPR-6 
antibody (CovalAb) in 5% block solution added. This was left to shake at 4OC 
overnight. The sample was washed three times with 5% block solution to remove 
the primary antibody and a 1/10000 dilution of purified goat anti-rabbit IgG HRP 
antibody in 5% block solution added. This was left to shake at room temperature 
for 1 hour. The sample was then washed three times in 1x PBST. The ECL Plus 
Western Blotting Detection System (Amersham) was used for antibody detection 
following the manufacturer’s instruction. The kit produces a fluorescent light 
emission that can be detected by exposure to x-ray. 
Chapter 2                                                                                                                                          40 
2.1.6.5  Freeze-crack method for worm immunofluorescence 
A glass slide was coated with approximately 100 µl of poly-l-lysine (Sigma-
Aldrich) in a square in the centre. Approximately 10 µl of water was added to 
the poly-l-lysine coated slide and a number of worms (20+) picked into this and 
using a scalpel blade the individual worms were cut behind the head to expose 
the gut. A glass cover slip was placed over the worms and the slide put on a 
metal plate within a dry ice filled box, and placed at -80OC for at least 30 min. 
The cover slip was cracked off using the end of a scalpel blade and the worms 
fixed by immersion in methanol at -20OC for 10 min and then in acetone at -20OC 
for 10 min. Slides were stored at -20OC until required. 
2.1.6.6  CPR-6 antibody staining method 
The slides prepared in section 2.1.6.5 were incubated in 1x PBST for a few min 
then 1% block solution (Appendix 1) added. After 20 min, the block was gently 
tipped off and a 1/50 dilution of CPR-6 antibody in 1% block solution added to 
the slide. The slide was placed in a humidifying chamber at 4OC overnight. The 
slide was gently washed three times in 1% block and a 1/200 dilution of a 
purified goat anti-rabbit FITC antibody in 1% block solution added, and placed in 
a humidifying chamber for 1 hour at room temperature. The slide was washed 
twice in 1x PBST and then rinsed with PBS. A 1/1000 dilution of DAPI (Invitrogen) 
was added to the slide and left for 1 min before rinsing with PBS; this was to aid 
identification of the worms under the microscope. A 1/2 dilution of Prolong Gold 
antifade reagent (Invitrogen) in water was added to the slide to prevent 
fluorescence fading during imaging before a cover slip was applied. Worms were 
examined using an Axioscop 2 plus microscope (Zeiss), excitation/emission for 
DAPI ~350/470 nm and for FITC ~485/535 nm. 
2.1.7 C. elegans drug screening 
Screening of transgenic C. elegans CLB01 worms (chapters 2.1.4 and 5.2.1.4) was 
carried out at Pfizer Animal Health. As Pfizer do not routinely use C. elegans 
worms, it was necessary to establish all conditions for drug assays. The specific 
details of how the screen was generated and carried out are found in Chapter 6 
results section 6.2.  
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2.2 H. contortus methods 
2.2.1 H. contortus larval culture 
All the H. contortus used in this study were ISE strain unless otherwise stated.  
H. contortus larvae were kept in water in flasks at 4OC until they were required 
for use. Approximately 1,000 larvae were transferred into a 1.5 ml eppendorf, 
centrifuged pelleted and the majority of the supernatant removed. Larvae were 
exsheathed by adding 200 µl of 1x Phosphate Buffered Saline (PBS) (Sigma-
Aldrich) (Appendix 1) and 5 µl of sodium hypochlorite solution (10-13%, Sigma-
Aldrich) and left for 5 min. The larvae were then washed three times with 1x 
PBS to remove all the sodium hypochlorite. In a sterile hood the larvae were 
washed twice in Earle’s Balanced Salt Solution (EBSS) pH 5.2 (Invitrogen) 
containing Fungizone (1.25 µg/ml), Penicillin (250 units/ml) and Streptomycin 
(50 µg/ml). After the final wash and spin, the pellet was re-suspended in 200 µl 
of EBSS (containing Penicillin/Streptomycin and Fungizone) and incubated at 
37OC for 3-7 days. Cultured H. contortus larvae were used for cDNA synthesis and 
examination of CPR-6 antibody localisation patterns.   
2.2.2 H. contortus drug screening 
A standard plate of 96 or 384 wells requires 8,000 viable larvae per ml. 10 ml of 
H. contortus L3 larvae (USA strain), from water flasks at 4OC, were centrifuged 
for 3 min at 1,000 g and the supernatant removed. The larvae were then washed 
in water and the supernatant removed. The volume was made up to 90 ml with 
Glucose Tyrodes balanced salt solution (Appendix 1). Before screening, larvae 
were ex-sheathed using 10 ml of 2% Sodium Hypochlorite solution. This mix was 
centrifuged for 3 min at 1,000 g and the supernatant removed. 50 ml of Glucose 
Tyrodes balanced salt solution was added and the mixture centrifuged for a 
further 3 min at 1,000 g, following which the supernatant was removed leaving 
an ex-sheathed larval pellet. Glucose Tyrodes balanced salt solution washes 
were repeated three times to ensure all the bleach was removed. The larvae 
were re-suspended in Basal media (Appendix 1) and Penicillin, Streptomycin and 
Gentamicin added. A volume of 100 µl and 25 µl per well were added to 96 and 
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380 well plates, respectively, giving approximately 800 larvae per well in 96 well 
plates and about 200 larvae per well in 380 well plates. 
2.3 Molecular biology methods 
2.3.1 Polymerase Chain Reaction (PCR) 
2.3.1.1  Standard PCR protocol 
Polymerase Chain Reaction (PCR) was carried out using a Techne Flexigene PCR 
machine. GoTaq Flexi DNA polymerase (Promega) was used for standard 
reactions, prepared following the manufacturer’s instructions (1x Green GoTaq 
Flexi Buffer, 1 mM MgCl2, 0.125 mM of each dNTP, 0.5 µM of forward and reverse 
primers, up to 1.25 units of GoTaq Flexi DNA polymerase and 50-100 ng of DNA 
template). Standard PCR conditions were: initial denaturing for 3 min at 95OC, 
25-35 cycles of 30 sec at 95OC to denature, 30 sec at 55-57OC for primer 
annealing and 1 min per kb at 72OC for extension, followed by a final extension 
of 3 min at 72OC.  
2.3.1.2 Proof-reading PCR protocol for gene promoter amplification 
Where PCR products were required for promoter expression studies, the 
proofreading Taq PfuUltra II Fusion HS DNA polymerase (Stratagene) was used. 
Standard protocol was followed using the 10x PfuUltra II Reaction Buffer 
provided. PCR products were blunt ended and thus could not be cloned directly, 
therefore 3’ adenosine overhangs were added by incubation of the PCR reaction 
mix (20 µl) for 5 min at 72OC with 1.25 units of GoTaq Flexi DNA polymerase and 
0.1 mM dATP.    
2.3.1.3  Rapid Amplification of cDNA Ends (RACE) 
Rapid Amplification of cDNA Ends (RACE) was used to obtain the start of the H. 
contortus cysteine proteases present on BAC 18f22 and both the start and end of 
the Hc-cpr-6 gene. RNA was extracted from adult stage H. contortus using the 
Qiagen RNeasy Mini Kit (QIAGEN). H. contortus cDNA was first prepared from 1.6 
µg using the AffinityScript Multi Temperature cDNA Synthesis Kit (Stratagene) 
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and was used in the first round PCR. The FirstChoice RLM-RACE Kit (Ambion) was 
used to prepare the 5’ and 3’ RACE products and a nested PCR protocol was 
followed. The first round PCR protocol: 2 µl cDNA, 1 mM MgCl2, 0.125 mM of 
each dNTP, 0.5 µM of kit outer primer, 0.5 µM of gene specific outer primer, 1x 
Green GoTaq Flexi buffer and up to 1.25 units of GoTaq Flexi DNA polymerase. 
PCR conditions were: denaturing for 3 min at 95OC, 35 cycles of 15 sec at 95OC, 
15 sec at 57OC and 1 min at 72OC, followed by 15 sec at 95OC, 15 sec at 57OC and 
3 min at 72OC.  
The second round PCR used 1 µl of the first round reaction as a template. The 
PCR cycle was the same as the first round and standard PCR reaction as above 
but replacing first round primers with 0.5 µM of the kit inner primer and 0.5 µM 
of the gene specific inner primer. 
3’ RACE was used to obtain the end of the H. contortus cpr-6 gene using the 
same kit. H. contortus RNA, 0.03 µg 3’ RACE Adapter primer and 14.2 µl of 
RNAse free water were incubated at 65OC for 5 min then cooled to room 
temperature for 10 min. Added to this were 1x RT Buffer, 0.02 µM dNTP mix, 20 
units of RNase Inhibitor and 20 units of Reverse Transcriptase. This mixture was 
incubated at 42OC for 60 min and then at 72OC for 10 min, at this point the cDNA 
was stable and could be stored at -20OC. Standard PCR was carried out using 2 µl 
of the generated cDNA, 1x Green GoTaq Buffer, 1 mM MgCl2, 0.125 mM of each 
dNTP, 0.5 µM of 3’ RACE kit outer primer, 0.5 µM of gene specific primer and up 
to 1.25 units of GoTaq Flexi DNA polymerase in a total volume of 30 µl. PCR 
cycles were as for 5’ RACE. 
2.3.1.4  Worm lysis PCR 
Worm lysis PCR was used for confirming the presence of specific genes and 
marker genes in the C. elegans worm. 6-10 C. elegans adult worms were added 
to a standard PCR tube containing 4 µl of a Single Worm Lysis Buffer (SWLB) 
(Appendix 1) and 0.1 mg proteinase K. Tubes were placed at -80OC for at least 
30 min, incubated at 60OC for 1 hour to lyse the worms and then placed at 95OC 
for 15 min. The standard PCR protocol was followed using the 4 µl solution from 
above as the DNA template and gene specific primers.  
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2.3.1.5  Reverse Transcription PCR 
Reverse Transcription PCR was used to check the presence of expressed genes in 
C. elegans and H. contortus (section 2.3.1.3) cDNA. Approximately 80 adult C. 
elegans worms were picked into M9 buffer and re-suspended in 200 µl of lysis 
buffer containing 0.1 mg of Proteinase K and 0.7 M of 2-mercaptoethanol. The 
sample was incubated at -80OC for at least 30 min and heated to 55OC for one 
hour, allowed to cool and incubated at 4OC for 10 min. 500 µl of Total RNA 
Isolation Reagent (ABgene) was added and mixed by vortexing then incubated at 
4OC for 10 min. 100 µl of CHCl3 was added, mixed well, then incubated on ice for 
5 min and then centrifuged at 13,000 g for 15 min. The top phase was collected 
and precipitated in an equal volume of Isopropanol. This was then incubated on 
ice for 10 min and centirfuged at 13,000 g for 10 min, followed by a wash with 
70% ethanol and centrifuged for 5 min at 13,000 g. The supernatant was 
removed and the pellet air dried and re-suspended in 30 µl of RNAse-Free Water 
(QIAGEN). The SuperScript One-step RT-PCR System (Invitrogen) was used to 
produce cDNA from the C. elegans RNA and for the PCR reaction. The PCR 
conditions were: 30 min at 50OC and 2 min at 94OC, then 30 cycles of 30 sec at 
94OC, 30 sec at 58OC and 30 sec at 72OC, then a final extension of 3 min at 72OC. 
2.3.2 Agarose gel electrophoresis 
Standard gels used for viewing PCR products were 1-2% UltraPure Agarose 
(Invitrogen) dissolved in 1x Tris-acetate EDTA (TAE) electrophoresis buffer 
(Appendix 1). Products were visualised using 0.5 µg/ml Ethidium bromide or 0.05 
µl/ml SafeView Nucleic Acid Stain (NBS Biologicals). PCR products were mixed 
with DNA loading buffer (Appendix 1) and loaded onto gels. Electrophoresis was 
performed using Gibco BRL Horizontal Gel Electrophoresis Apparatus at 100-120 
V in 1x TAE. Visualisation was with BioRad Trans UV Illuminator (BioRad). 
Product sizes were identified using 100 bp and 1 kb DNA ladders (Invitrogen) 
(Appendix 1).  
2.3.3 Purification of PCR products 
The PCR product was viewed on the gel using a High Performance UV 
Transilluminator (UVP) which has a lower UV setting and is thus less likely to 
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cause mutations to the DNA. The DNA band was excised using a scalpel and 
placed in a 1.5 ml eppendorf. Gel extraction was then carried out using the 
QIAquick Gel Extraction Kit (QIAGEN). 
2.3.4 Restriction enzyme analysis 
Restriction enzyme digestion was carried out both to confirm the presence of a 
specific sequence and to extract an insert from a vector, e.g. for cloning. 
Restriction endonucleases (New England Biolabs) were used and the standard 
protocol with specific buffers was followed.  
Vectors that were to be used for cloning were treated with Alkaline Phosphatase 
(New England Biolabs) post digestion. 1 unit of Alkaline Phosphatase was added 
to the digest and incubated at 37OC for 30 minutes; this treatment removes the 
5’ phosphate group and prevents the vector from self-ligating. 
Products were viewed using the method described for PCR products in Section 
2.3.2 and purified using the technique described in Section 2.3.3. 
2.3.5 Cloning into pCR 2.1-TOPO 
The TOPO 2.1 TA Cloning Kit (Invitrogen) was used for one step cloning of PCR 
products amplified by Taq. Standard protocol was followed and 2 µl of the 
cloning reaction added to TOP 10 one shot ultracompetent cells (Invitrogen) for 
transformation. 400 µl of SOC medium (Appendix 1) was used, with 120 µl of the 
transformation reaction being spread on an L. Agar plate containing Ampicillin 
(Appendix 1). Blue/white selection of colonies containing PCR products was 
utilised by the addition of 50 µl of IPTG and 50 µl of 2% X-Gal (Appendix 1) to the 
Ampicillin plate and placed at 37OC overnight. 
2.3.6 Cloning into Fire lab vectors 
The Fire lab vectors (Fire et al., 1990) have been used for studying gene 
expression and function of both C. elegans genes and H. contortus expressed 
genes in C. elegans. Initially a ligation between the promoter and vector 
sequence using T4 DNA Ligase (New England Biolabs) was carried out. A 3:1 ratio 
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of insert to vector was desired, aiming for 100 ng of insert per ligation reaction. 
The standard ligation reaction consisted of 1 x ligation buffer, 1 unit ligase, 100 
ng insert and vector in water. This was incubated at 4OC overnight. 
Transformation was carried out using XL10-Gold ultracompetent cells 
(Stratagene). 2 µl of the ligation reaction was added to 40 µl of thawed cells and 
placed on ice for 30-60 min. The reaction was then heat shocked at 42OC for 30 
sec, 400 µl of SOC medium was added and then left to shake for 1 hour at 37OC. 
120 µl of this was then spread onto an Ampicillin L. Agar plate and incubated at 
37OC overnight. 
2.3.7 Identification of positive cultures 
For cloning into the Fire lab vectors no selection is used and any colony may be 
positive. A single colony was lysed in 100 µl of water and heated to 95OC for 10 
min. 5 µl of this lysed colony preparation was used as the DNA template for PCR 
screening. Standard PCR was carried out using either vector or gene specific 
primers. Any positive colonies were cultured in 10 ml of L. Broth with 0.1 µg of 
Ampicillin overnight in a shaker at 37OC. 
2.3.8 DNA purification  
For the purification of TOPO cloned colonies grown in L. Broth and Ampicillin, 
purification of up to 20 µg of DNA was carried out using the Plasmid Mini Kit 
(QIAGEN) as per manufacturer’s instruction. Purification of Fire lab vectors for 
subsequent microinjection into C. elegans worms was carried out using the 
QIAprep Spin Miniprep kit (QIAGEN) as per manufacturer’s instruction. 
2.3.9 Preparation of compounds for drug screening 
Compounds supplied as powders were solubilised in Dimethyl Sulfoxide (DMSO) 
using a Tecan Freedom Evo giving a final volume of about 100-200 µl, depending 
on the molecular weight of the compound. A stock concentration of 30 mM in 
100% DMSO for each compound was achieved. A final working percentage of 
below 0.5% DMSO is required when working with C. elegans, to ensure that there 
is no DMSO interference during drug screening.  
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2.4 Bioinformatic methods 
2.4.1 Software and databases used 
Vector NTI Advance Software (Invitrogen, versions 10 & 11) was used for 
sequence analysis of C. elegans and H. contortus sequences. C. elegans 
sequences are available from wormbase (http://www.wormbase.org/) and H. 
contortus sequences from NCBI (http://www.ncbi.nlm.nih.gov/) and the H. 
contortus BLAST server on the Sanger web page (http://www.sanger.ac.uk/cgi-
bin/blast/submitblast/h_contortus). Alignment and direct sequence comparison 
was carried out using Align X which is part of the Vector NTI software and the 
ClustalW2- Multiple Sequence Alignment tool, available on the European 
Bioinformatics Institute website (http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
Gene sequence analysis was carried out using the Artemis Genome Browser and 
Annotation Tool which is available to download from the Sanger website 
(http://www.sanger.ac.uk/resources/software/artemis/). The MEGA (Molecular 
Evolutionary Genetic Analysis) Tool version 5 (http://www.megasoftware.net/) 
was used for phylogenetic analysis. A number of the figures contained in this 
thesis were generated using Microsoft Office PowerPoint and Microsoft Office 
Excel. Sequence LOGOS within gene promoters were identified using MEME suite, 
which is a motif based sequence analysis tool 
(http://meme.sdsc.edu/meme/cgi-bin/meme.cgi). 
2.4.2 DNA primers for PCR 
Primers were ordered from the Eurofins MWG Operon website 
(http://www.eurofinsdna.com/home.html?gclid=COafvvqyhpcCFQ9hQgodLQnn9g
). 1x TE (Appendix 1) was added to give a stock concentration of 1 µg/µl and 
primers were stored at -20OC. A working stock solution of 50 ng/µl was obtained 
by diluting with water. 
2.4.3 DNA sequencing 
Samples were sent to Eurofins MWG Operon for sequencing. This was carried out 
after insertion of the desired DNA sequence into a vector, most commonly TOPO. 
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Purified plasmid DNA was supplied at a concentration of 50-100 ng/µl in a 
minimum whole volume of 15 µl of double distilled water. Either vector primers 
or gene specific primers were used to carry out sequencing. 
Sequencing results were analysed in Contig Express which is part of the Vector 
NTI software. The results are displayed in both word and chromatogram form. 
The chromatogram is useful as it depicts the ratio of each of the four bases 
found at a specific location during sequencing. Analysis can continue in Align X 
or ClustalW2. 
2.4.4 Signal peptide cleavage identification 
The Signal P programme (http://www.cbs.dtu.dk/services/SignalP/) was used to 
identify the signal peptide region of proteins. This region is usually between 3 
and 60 amino acids in length and is involved in protein transportation from the 
endoplasmic reticulum to the Golgi apparatus for further processing of proteins. 
There are three different scores provided in the output information of this 
programme C, S and Y. The S score is the predicted signal peptide, taking into 
account every amino acid position. High S scores indicate that a particular amino 
acid is part of a signal peptide and a low S score indicative of being part of a 
mature protein. The C score is the cleavage site and is highlighted between two 
amino acids. The second amino acid is the start of the mature protein. The Y 
score is a cleavage site prediction based on a combination of the C score and S 
score. This may give a more accurate identification of the true cleavage site as 
usually there are multiple high scores within a sequence. 
2.4.5 Computational gel analysis for expression levels 
Image J is available to download and was used for the comparison of PCR 
products on agarose gels, e.g. cpr-6 expression in H. contortus 
(http://rsbweb.nih.gov/ij/download.html). Primers for both the gene of interest 
and a control gene e.g. sod-1 were added to the same PCR reaction. On 
observation of the subsequent gel there were two bands in each lane. The gel 
image was used for analysis in Image J, comparing the intensity of the two 
bands.  
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3.1 Introduction 
The genome of H. contortus is currently being sequenced, with completion 
anticipated 2012/2013. Current data suggests that the H. contortus genome may 
be over four times the size of original estimates (300-400 Mb). This size is 
estimated using the N50 statistic which can be applied to contiguous sequence 
databases. N50 is recorded in kb and is widely used in genome size estimation 
and assembly. Initially, contigs are arranged in size from largest to smallest, and 
the lengths added together. The N50 is the size of the last sequence that results 
in the summed length exceeding half of the total length of the database (Miller 
et al., 2010). The predicted size may be larger than original estimates due to 
the increased number and size of introns in the H. contortus genome compared 
to C. elegans (Laing et al., 2011). This genome data is available as contigs, 
supercontigs and as Bacterial Artificial Chromosomes (BACs). Supercontigs are 
individually sequenced regions that have been assembled from overlapping 
sequence reads, whereas BAC reads are more reliable as they have been 
sequenced in full from a single clone. Analysis carried out during this project 
made use of the Sanger databases; H. contortus assembled supercontigs 
(21/08/08)(all reads), H. contortus supercontigs (26/08/2009), H. contortus 
assembled BAC contigs and the most recent assembly available on the Sanger ftp 
site (12062012). From this latest assembly (12062012) the N50 is 83,238 bp 
(James Cotton, personal communication). 
Although a significant amount of sequence information has been generated for 
H. contortus, reliable assembly, which is required for gene annotation, has 
proved a major hurdle. This is thought to be due to heterogeneity of the parasite 
population, with variation in gene sequence making it difficult to identify 
overlapping reads at high stringency. It is hoped that increased depth of 
sequencing combined with sequence from more inbred strains will overcome 
this. 
Due to the blood-feeding activity of H. contortus adult worms, there has been 
great interest in enzymes present within the gut and their putative role in blood 
digestion and anticoagulation. Previous studies have identified a number of 
protease gene sequences from H. contortus that encode cathepsin B cysteine 
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proteases (Rehman and Jasmer, 1999;Skuce et al., 1999). Work by Cox et al. 
(1990) first identified that protein extracts from adult worms can degrade 
fibrinogen and subsequently increase clotting time. One of the major 
components of these extracts was a 35 kDa cysteine protease. This protein was 
termed AC-1 and was identified as being capable of degrading fibrinogen in vitro 
and may be a potential anticoagulant (Cox et al., 1990). AC-1 was shown to have 
significant homology (42% identity) with mammalian cathepsin B when compared 
to sequences available for human, rat and mouse. Other proteases with high 
sequence similarity to AC-1 were subsequently identified, resulting in the 
characterisation of a Cathepsin B-like (CBL) family containing five genes (AC-1, 
AC-2, AC-3, AC-4 and AC-5) (Pratt et al., 1992).  
AC-like proteases were the first to be identified in H. contortus and 
subsequently other cathepsin B proteases have been identified from US strains 
(Cox et al., 1990;Pratt et al., 1990;Pratt et al., 1992). To date, their presence 
has to be confirmed in other strains. In addition it was unclear whether these 
represented distinct genes or population polymorphisms. Most of these are 
distinct from proteases in C. elegans (Pratt et al., 1992), suggesting roles 
specific to the parasite, most likely in anticoagulation and blood digestion (Baig 
et al., 2006). Work has been carried out looking at CBL cysteine proteases in 
other blood feeding parasites, namely hookworms Ancylostoma caninum and 
Necator americanus (Ranjit et al., 2008).  
At the start of this project a H. contortus BAC was identified which contains 
sequence encoding several cathepsin B proteases. 
The main aims of this chapter were to; 
• Identify and annotate the H. contortus cathepsin B protease genes 
present on the BAC. 
• Examine and compare the sequence, structure and expression of the 
cathepsin B cysteine protease genes on the H. contortus BAC. 
• Determine the relationship of the encoded proteases to the previously 
identified cathepsin B enzymes for H. contortus and other nematodes. 
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3.2 Results  
3.2.1 Protease genes on H. contortus BAC 18f22 
3.2.1.1  Annotation of genes on H. contortus BAC 18f22 
Bioinformatic analysis identified eight genes encoding cysteine proteases present 
on H. contortus BAC 18f22. This BAC is 113,944 base pairs in length and the eight 
genes are tandemly arranged, spanning the entire length of the BAC. These 
genes were identified by tBLASTn analysis of H. contortus assembled BAC contig 
sequences (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/h_contortus) 
using the previously identified H. contortus AC-2 protein. The genes are 
therefore related to the H. contortus AC cysteine protease gene family. The 
genes identified were numbered sj01-08, from right to left (due to their location 
on the negative strand) along the BAC. The position on the BAC and size of each 
gene is shown in Figure 3.1. sj01 is incomplete due to its location near the 5’ 
end of the BAC, with only the last three exons present. sj08 is located near the 
3’ end of the BAC, resulting in only the first three exons being present. Further 
work searching for sequences overlapping with BAC 18f22 identified the rest of 
the sj08 gene sequence at a different genomic location, on a supercontig 
(Section 3.2.1.5). The start methionine could not be identified for any of the 
genes so 5’ RACE was performed to attempt to confirm the location of the first 
exon of each gene (Section 3.2.1.2).  
Using both BLAST (with the H. contortus AC-2 sequence) and manual analysis, 
most of the genes could be almost fully annotated using the Artemis Genome 
Browser and Annotation Tool which is available to download from the Sanger 
website (http://www.sanger.ac.uk/resources/software/artemis/). As mentioned 
previously, some parasite genomes are already fully annotated. This however is 
not the case for H. contortus. Annotation of the H. contortus BAC was carried 
out to obtain the location and structure of the genes present on the BAC. Figure 
3.2 is an Artemis screenshot, indicating the location and structure of each gene 
on the BAC. In Artemis, exons are indicated by solid boxes and introns indicated 
by lines joining these boxes. Initial analysis of the structure of each gene showed 
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that while exons are identical in length, intron sizes are more variable. This is 
reflected in the large variations in gene size (4,623-18,353 bp). 
All of the genes which could be fully annotated (sj02-sj05) contained twelve 
exons, however the last exon for sj06 and sj07 could not be identified using the 
AC-2 sequence. This suggested that the last exon of both genes was present, but 
was too divergent to be identified by AC-2 BLAST analysis. These exons were 
subsequently identified by carrying out a tBLASTn search using the C’ terminal 
region of the rat cathepsin B sequence (rcatB, P00787) (Guenette et al., 1994). 
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Figure 3.1 Diagrammatic representation of the size and approximate location of genes on H. contortus BAC 18f22 
The middle line along the length of the diagram indicates the 114 kb BAC 18f22. Genes are present on the negative strand running from right to left. Red 
boxes represent gene locations with the predicted size of their genome coverage indicated below, and the intergenic regions indicated above the boxes. sj01 
and sj08 are incomplete due to their location near the start and end of the BAC, respectively. 
 
 
 
 
Figure 3.2 Artemis screenshot illustrating the gene structure of the annotated protease genes on H. contortus BAC 18f22   
Boxes indicate exons and lines indicate introns. The predicted size of individual genome coverage is indicated below each gene structure.
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3.2.1.2  Identification of the 5’ end of the cysteine protease genes on H. 
contortus BAC 18f22 
tBLASTn analysis failed to identify the start codon for the genes present on the 
BAC. Previous work found that for AC-2 and AC-3 the first exon comprised only 
the start methionine (Pratt et al., 1990). To identify the first exon of the BAC 
genes, 5’ RACE was carried out. This identified the location of the start codon 
for sj03, sj04, sj05, sj06 and sj07 (primer sequences in Appendix 2 Table 3.1). 
Alignment of the 5’ RACE products with the genomic sequence for each gene 
showed that the first exon encoded only the start methionine. 
Although 5’ RACE products for sj03-sj07 could be aligned to the BAC sequence, 
the sequences were not identical. The 5’ RACE products spanned the first three 
exons (150 bp) and within this region there were a number of base pair changes 
compared to the BAC sequence (11 in sj03, 4 in sj04, 6 in sj05, 13 in sj06 and 9 
in sj07). For all of the genes except sj06 the majority of these changes occurred 
in exon 2. sj06 however had 13 bp changes within the third exon. The 5’ UTR 
sequence was well conserved. There were two base pair changes in sj05 and one 
in sj07, but as these regions are non-coding this is not significant. On closer 
examination at the amino acid level, there does not appear to be a pattern as to 
whether base pair changes are silent or result in an amino acid change, with a 
proportion of both being varied across the genes. These differences could be due 
to variation between worms and highlights the heterogeneity in the parasite 
population (Prichard, 2001). Alternatively these differences could be due to 
amplification of closely related but not identical protease genes. The BAC 
represents only one genomic sequence for each AC-related gene and therefore 
variation from this was anticipated. For all sequence analysis carried out, the 
original BAC sequence was used. Few genes of H. contortus have been annotated 
at the genomic level and compared to cDNAs, but similar analysis of the H. 
contortus cathepsin L gene Hc-cpl-1 also found up to eight single nucleotide 
polymorphisms (SNPs), most of which were silent substitutions, over the 1,062 
bp gene (Britton and Murray, 2002). 
Only the last three exons are available on the BAC for sj01 and thus 5’ RACE was 
not attempted for this gene. The start codons for the sj02 and sj08 genes could 
not be confirmed by 5’ RACE despite the more thorough nested 5’ RACE PCR 
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protocol followed. It was thus speculated that the lack of RACE product could be 
due to low expression of these genes, or that the genes were pseudogenes.  
To confirm that sj02 is expressed, RT-PCR was carried out on H. contortus cDNA 
using primers designed across exons 3 to 7 (primer sequences in Appendix 2 
Table 3.2). A product of the desired size (378 bp) was obtained, confirming that 
sj02 is expressed. As 5’ RACE proved unsuccessful after numerous attempts with 
varied conditions, an alternative approach to obtain the start codon was 
attempted. In C. elegans a number of genes have been shown to be trans-
spliced, resulting in the 5’ end of a transcript being replaced by a splice leader 
(SL) sequence, reviewed in Allen et al., (2011). The exact role that trans-splicing 
plays in C. elegans is still unknown, however it may have a role in translation 
initiation (Lall et al., 2004). There are two SL sequences in H. contortus, SL1 
(GGTTTAATTACCCAAGTTTGAG) and SL2 (GGTTTTAACCCAGTTACTCAAG) (Bektesh 
et al., 1988;Blumenthal, 2005). PCRs using either SL1 or SL2 as the forward 
primer were carried out on cDNA with the sj02 reverse primer designed to exon 
7 (primer sequence in Appendix 2 Table 3.2). Neither produced a product, 
indicating that sj02 is not trans-spliced.  
It was however possible to predict the location of the first exon for sj02 and sj08 
by examining the genomic information available for the BAC. For genes sj03-sj07 
the confirmed size of the first intron was in the range of 58 to 96 bp in length. 
Taking this range of intron size into consideration a proposed start codon for 
both the sj02 and sj08 genes was identified. For sj02, PCR was carried out using 
a primer incorporating this sequence (5’ UTR and start codon) together with a 
reverse primer designed to the seventh exon (primer sequences in Appendix 2 
Table 3.3). This produced a product of 465 bp on cDNA (Figure 3.3) and the 
sequence was confirmed by sequencing and mapped to the BAC sequence. 
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Figure 3.3 Confirmation of the 5’ UTR of sj02 by RT-PCR  
Lane A indicates the amplification of a region of sj02 known to give a PCR 
product of 378 bp (exons 3-7) on H. contortus mixed stage cDNA, used as a 
control. Lane B indicates amplification of the sj02 5’ end on H. contortus mixed 
stage cDNA.The 465 bp product indicates the correct start site has been 
identified. 2% Agarose gel stained with 0.05 µl/ml SafeView Nucleic Acid 
stain. 
 
3.2.1.3  Intronic analysis of the H. contortus genes on BAC 18f22 
Previous work in a number of species suggested that in addition to the upstream 
promoter region, the first intron may have an important role in regulating gene 
expression and for this reason may be a valuable region to examine (Bruhat et 
al., 1990;Jeong et al., 2006). Initial analysis of the non-coding regions of the 
BAC protease genes focussed on the first intron. While these were reasonably 
conserved in size (58-96 bp), no obvious long stretches of homology were found 
between the genes. One six base pair motif ATTGAA was identified in a number 
of the first introns and on subsequent analysis of other introns was found to be 
present in these also, which may or may not be significant. The highest identity 
was found between genes located consecutively on the BAC, for example sj03 & 
sj04 and sj04 & sj05 (Table 3.1), with high conservation of base pairs shown in 
Figure 3.4. This reflects their close positioning in the genome and suggests 
recent gene duplication. This is also suggested by conservation of the positions 
of all introns in all of the BAC protease genes (Figure 3.5). Boundary splice site 
sequences appear to be conserved between H. contortus and C. elegans (GU-AG) 
200 bp 
400 bp 
600 bp 
A B 
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(Blumenthal and Steward, 1997). Identification of the conserved sequence 
around the intron/exon boundaries aided gene annotation. 
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Gene sj02 sj03 sj04 sj05 sj06 sj07 sj08 
sj02 100 57 58 55 55 52 56 
sj03  100 72 61 54 48 40 
sj04   100 70 57 59 56 
sj05    100 55 52 61 
sj06     100 57 59 
sj07      100 65 
sj08       100 
 
Table 3.1 DNA comparison of the first intron of the BAC protease genes  
The percentage identity of intronic DNA sequences was calculated from alignments. The 
highest identities, between sj03 & sj04 and between sj04 & sj05, are indicated in red. 
 
 
sj03            ATGGTTAGTTAACTGCCTGACCTACTTTTTAGAATAAATTTTTCTCATTTATATTGAAGTAGTGAGGAATATTGAAAGCATATGTTTCAGATG 90 
      sj04            ATGGTAAGTTACCTCGCTGACCTTCTTTTTACAATAATTTTTTC-CATTTGGATTGAA------CGGCAGATTGAAGATATATG--------- 74 
 
      sj04            ATGGTAAGTTACCTCGCTGACCTTCTTTTTACAATAATTTTTTCCATTTGGATTGAACGGCAGATTGAAGATATATG--------- 74 
      sj05            ATGGTGAGCTGGCTTGTTGACCTTCTTTCTAAGAGGAGTTTTGACATTCAGATTGAACGACAGATCGAGAATAGTCGTTTCAGATG 83 
   
Figure 3.4 DNA alignment of the most conserved first introns of certain BAC genes   
The sequence runs from the start codon on the left (indicated in blue) with intron lengths indicated at the end. Base pair changes between the 
two pairs with highest identity are indicated in red. 
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Figure 3.5 Model indicating the gene structure of the protease genes on BAC 18f22  
The green boxes represent exons and black lines introns. The predicted size of the introns and the 
number of amino acids encoded by each exon are shown. Intron lengths are not shown to scale to 
allow alignment of exons. Only partial sequences available for sj01 and sj08 on BAC 18f22. 
While the majority of corresponding introns are well conserved in length across 
the different genes on BAC 18f22, a few are highly variable (introns 4, 8, 9 and 
11) (Figure 3.5). In particular the size of intron 4 was very variable, ranging from 
301-13,388 bp. The fourth intron for sj02 is 13,388 bp which is almost twice the 
length of any other intron. Overall, introns from the annotated BAC ranged from 
49 bp to 13,388 bp with an average intron size of 710 bp. This is larger than 
reported for C. elegans, 467 bp, (Deutsch and Long, 1999) and B. malayi, 311 
bp, (Ghedin et al., 2007), consistent with the greater size of the H. contortus 
genome. 
The BAC sequence was examined to determine whether repeat elements may 
contribute to the larger size of H. contortus introns. Callaghan and Beh (1994) 
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identified a repeat DNA sequence in H. contortus that was unique to this 
parasite. This sequence (M84609) is 150 bp in length. Hoekstra et al., (1997) 
carried out a study to characterise H. contortus using microsatellites and 
identified a short repeat sequence termed HcREP1 (U86701). Laing et al., (2011) 
identified sequence related to both repeat sequences tandemly arranged on H. 
contortus BAC BH4E20, and preceded by a GTCT repeat. Analysis of BAC 18f22 
identified repeat sequence in the ninth intron of sj04. This intron is 2,634 bp in 
length, which is over 2 kb longer than any other ninth intron on the BAC. The 
Tandem Repeats Finder webpage (http://tandem.bu.edu/trf/trf.html) identified 
an upstream (GTCT)157 repeat sequence 628 bp in length, significantly longer 
than the 56 bp GTCT repeat identified by Laing et al., (2011). Five repeats with 
high sequence identity to the H. contortus repeat sequence identified by 
Callaghan and Beh (1994), were present 571 bp downstream from the end of the 
GTCT repeat (Figure 3.6). No obvious repeat sequences could be identified in 
other large introns.  
 
Figure 3.6 Artemis screenshot indicating the repeat elements on 
BAC 18f22  
The blue boxes indicate sj04 exons and the blue lines sj04 introns. 
The (GTCT)157 repeat is indicated by the green box, the 571 bp gap by 
an arrow and the repeat element by purple boxes, termed A-E.  
To examine whether there was conservation of intronic sequences, MEME suite 
(http://meme.sdsc.edu/meme/cgi-bin/meme.cgi) was used. This is a motif 
based sequence analysis tool. Results are displayed as sequence LOGOS, which 
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depict the motifs as stacks of letters. The higher the height of each letter the 
higher the probability that a letter will appear at that position. MEME was used 
to compare the sequences of corresponding introns across the genes. As shown in 
Table 3.2, two motifs were identified, GGTGAG in intron 5 and GTAGAC in intron 
7, which are highly conserved in four and three of the BAC genes respectively. 
Although interesting, whether these have any functional significance requires 
further analysis.  
Motif Gene and intron 
number 
  
      
 
  
 
Table 3.2 Sequence LOGOS and conserved motifs within intronic 
regions of the BAC genes  
Sequence LOGOS depicting the probability of any letter being present at a 
given site on the left, and the sequence present in each individual gene on 
the right, e.g. sj065 is intron 5 in sj06 (http://meme.sdsc.edu/meme/cgi-
bin/meme.cgi).  
3.2.1.4 Expression patterns of the BAC genes 
To examine the expression profiles of the protease genes encoded by the BAC, a 
number of approaches were taken: analysis of transcriptome data, RT-PCR and 
Expressed Sequence Tag (EST) analysis. Initial expression levels were identified 
from transcriptome data from adult worms. This data was obtained from the 
Sanger Institute (R. Laing, M. Berriman and J.S. Gilleard, unpublished data) and 
the expression profiles observed were consistent with the BAC annotation. Only 
transcripts associated with those regions with cysteine protease annotation were 
identified, thus indicating that no other genes were present on this 114 kb BAC. 
Additionally, a tBLASTn search of the complete H. contortus BAC 18f22 against 
the NCBI BLAST (http://www.ncbi.nlm.nih.gov/) did not identify any other 
related sequences, again confirming that there are no other genes present on 
the BAC. Visual observations of the transcriptome reads using Artemis indicated 
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that all of the genes except for sj08 have associated transcriptome data. 
Subsequent analysis of L3 transcript data also failed to identify reads for sj08. 
This along with the failure to obtain a 5’ RACE product for sj08 and the lack of a 
stop codon in the sequence would indicate that sj08 is a pseudogene. The 
expression profiles for sj05 and sj06 from adult stage worms are indicated in 
Figure 3.7. 
 
Figure 3.7 Artemis screenshot indicating transcriptome data associated with two of the BAC 
genes 
Individual expression profiles shown for sj05 and sj06. Red peaks indicate individual reads 
associated with each exon. 
Expression profiles were examined by semi-quantitative RT-PCR for protease 
genes sj02-sj07 on the BAC. Both H. contortus adult and larval stages were 
examined and compared relative to Hc-sod-1 expression, which has previously 
been reported to be constitutively expressed in H. contortus (Liddell and Knox, 
1998). cDNA from adult male, adult female, early L3 larvae (ex-sheathed and 
cultured for 24 hours) and late L3 larvae (ex-sheathed and cultured for 72 hours) 
(chapter 2.2.1 and 2.3.1.3) was used for PCR analysis (primers in Appendix 2 
Table 3.4). The results for two of the genes, sj03 (expected product size of 249 
bp) and sj04 (expected product size of 221 bp), are indicated in Figure 3.8. 
There was no expression detected in larval stages for any of the genes. This is 
consistent with work previously carried out on H. contortus CBLs for which only 
very low mRNA transcripts were recorded for mixed stage larvae (Pratt et al., 
1990).  
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Figure 3.8 RT-PCR of BAC protease genes relative to Hc-sod-1  
PCR was carried out on cDNA from different stages of H. contortus (chapter 2.2.1). Both gene 
specific and Hc-sod-1 primers were used in each reaction and products were separated by 2% 
agarose gel electrophoresis and stained with 0.05 µg/ml ethidium bromide. PCR was carried out for 
BAC genes sj02-sj07 however repeatable results observed only for sj03 and sj04. 
There is an abundance of Expressed Sequence Tag (EST) data available for a 
number of organisms at varying lifecycle stages. ESTs are obtained from cDNA 
sequence reads and indicate expressed genes. As only one read is obtained for 
each region of the genome there are often errors in the sequence (Parkinson et 
al., 2002). The Nembase webpage (http://www.nematodes.org/nembase4/) has 
22,257 identified ESTs in its database of H. contortus adult worms, and these 
have been grouped into 4,972 clusters. ESTs are clustered to reduce redundancy 
creating one transcript per gene (Nagaraj et al., 2007). Expression data was also 
studied using the information available on the Washington University Basic Local 
Alignment Tool (WU-BLAST) (www.ebi.ac.uk/Tools/sss/wublast/parasites.html). 
BLAST searches were carried out against both databases taking the full cDNA 
sequence of each of the genes. A 95% sequence identity was used as a cut off in 
identification of potential matches. The BLAST searches carried out against Wash 
U identified sequences highly similar to sj03, sj04, sj05 and sj06 using this 
criterion and similarly sj03, sj04 and sj05 were identified using Nembase 4 
(Table 3.3). If the sequence identity was reduced to 94%, sequence representing 
sj06 could be identified in Nembase.  
Geldof et al., (2005) identified that the most abundantly represented genes in 
the Nembase EST dataset are Hc-nim-1 and Hc-nim-2, with these having the 
highest number of associated ESTs. Out of the 39 clusters that were identified as 
being the most abundantly expressed in the H. contortus dataset, one of these 
clusters, HCC00016 with 72 associated ESTs, has high identity to sj04, indicating 
that this is the most abundantly expressed cysteine protease gene present on the 
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BAC. Therefore transcriptome, RT-PCR and EST analysis indicate that, of the BAC 
genes, sj04 is the most highly expressed, then sj05, sj03, sj06, sj07 and sj02, 
with initial transcriptome observations being supported by EST data.  
Gene Nembase 
cluster 
number 
Percentage 
DNA identity 
Nembase 
coverage/gene 
length (bp) 
Number of 
ESTs 
sj01 - - - - 
sj02 - - - - 
sj03 HCC01618_1 95 727/1023 7 
sj04 HCC00016_2 97 100/1026 72 
sj05 HCC00024_1 95 972/1023 7 
sj06 HCC00562_1 94 524/1029 6 
sj07 - - - - 
sj08 - - - - 
 
Table 3.3 EST data for the BAC genes obtained from Nembase 4  
Information obtained from Nembase BLAST searches using the maximum sequence information 
available for each gene. All cluster sequences from adult H. contortus stage 
(www.nematodes.org/nembase4/). 
3.2.1.5  Identification of a complete sj08 sequence 
Previously, the complete sequence for the last gene on the BAC (sj08) was not 
available due to its location near the end of the BAC. A tBLASTn search using the 
amino acid sequence of the three exons from sj08 that were present on the BAC 
against the database of H. contortus assembled supercontigs (21/08/08)(all 
reads) was carried out. Two supercontigs were identified as having high 
sequence identity to sj08. Supercontig_0047752 had the higher percentage 
conservation due to its similarity to the first three exons present on the BAC, 
there were however no additional regions on this supercontig that gave any 
indication that a cysteine protease was present. Subsequent study of 
supercontig_0058857 indicated that the complete sj08 gene was present on this 
supercontig. There are a number of bp differences between the sequence on the 
BAC and this supercontig, however there is high enough conservation to suggest 
that this is the same gene (92% DNA identity in the first 3 exons) (Figure 3.9). 
Further searches using the BAC gene sequences and active cysteine protease 
regions against this supercontig gave no other hits, suggesting that there are no 
other related genes downstream of sj08 on this supercontig. Several attempts to 
confirm linkage of the BAC and supercontig sequence by PCR failed to produce a 
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product. It is possible this could be due to variation in the region used for primer 
design and/or low gene expression or a pseudogene.  
In addition to a BLAST search for the end of sj08, a BLAST search was performed 
to identify the start of sj01. No overlapping supercontigs were identified and 
sj01 is currently incomplete. 
SJ08bac MKYFTLALYVCLCQADIVG--ATRKIPVEAQRLSGEPLVEYLRKNQDLFEVNPDPTPDFE 58 
SJ08sc  MKFFTLALYVCLCQADVVSWSATRKIPVEAQRLSGKPLVEYLRKDQDLFEVNPDPTPDFE 60 
 
SJ08bac LKIMDKKFATKNINYIVKDDNDTGEDIPE------------------------------- 87 
SJ08sc  LKIMDKKFATKNINYIVKDDNDTGEDIPERYDPRTIWTNCTSLFTIRDQANCGSCWAVST 120 
 
SJ08bac ------------------------------------------------------------ 
SJ08sc  AAAISDRICIATKAEKQVNISATDIIACCPYCGAGYCQGGWVLDAWRFFVDDGIVSGGNY 180 
 
SJ08bac ------------------------------------------------------------ 
SJ08sc  NNKEGCRPYPYHPCGHHGNETYYGKCNGTAPNPQCRKTCIAGVRKQYRVDKRYGKTAYKL 240 
 
SJ08bac ------------------------------------------------------------ 
SJ08sc  PPSVKAIQREVLEHGPVVVSFEVYEDFGHYKSGIYKHTAGEIRGHHAVKLIGWGKENGTD 300 
 
SJ08bac ------------------------------------------- 
SJ08sc  YWIIANSWHDDWGEQGFFRIVRGINECGIEEAGTAGLVDIDTL 343 
 
Figure 3.9 SJ08 sequence alignments for the BAC 18f22 and supercontig_0058857  
Alignment includes the first three exons present on the BAC (SJ08bac) and the full protease 
sequence encoded by supercontig_0058857 (SJ08sc). Lines indicate the intron/exon boundaries, 
green shading indicates bp changes. Amino acid colours reflect physicochemical properties; red for 
small, blue for acidic , magenta for basic and green for hydroxyl + sulfhydryl + amine + G.  
 
3.2.2  Analysis of proteases encoded by H. contortus BAC 18f22 
3.2.2.1  Similarity of BAC-encoded proteins to the previously identified H. 
contortus AC family 
The eight cysteine proteases encoded by BAC 18f22 were identified by tBLASTn 
analysis using the AC-2 protease sequence, previously identified by Pratt et al., 
(1990). To examine the similarity of proteases encoded by the BAC to one 
another and to the AC family of which there are five members (AC-1-AC-5), the 
percentage identity and similarity across the proteins was calculated and is 
shown in Table 3.4. This table indicates a 97% sequence conservation between 
AC-1 and AC-2. Additionally, there is a 97% identity between SJ04 & AC-1 and a 
98% identity between SJ04 & AC-2. Analysis at the DNA level indicated a 98% 
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identity between AC-1 and sj04, thus it is proposed that that sj04, AC-1 and AC-
2 are the same gene. Another high percentage DNA identity, 94%, is noted 
between SJ05 and AC-3, which also suggests that these genes are the same. 
There were no other instances of very high conservation between encoded 
proteases. Therefore it is likely that all others represent novel and distinct 
proteins. Thus, given that AC-1, AC-2 & SJ04, and AC-3 & SJ05 appear to be 
encoded by the same genes, this family contains at least 10 members. 
Analysis of the percentage identities between different family members showed 
that in some cases those positioned consecutively on the BAC were more similar 
to one another (Table 3.4). This is true of proteases SJ02 & SJ03, SJ04 & SJ05, 
SJ06 & SJ07 and SJ07 & SJ08, consistent with duplication and sequence 
divergence within this gene region. 
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Protease AC-1 AC-2 AC-3 AC-4 AC-5 SJ02 SJ03 SJ04 SJ05 SJ06 SJ07 SJ08 
AC-1 100 97/98 75/85 75/84 65/77 78/87 73/85 97/98 75/85 68/81 66/79 65/78 
AC-2  100 75/85 74/84 64/76 78/87 73/85 98/98 75/85 69/81 66/79 66/79 
AC-3   100 73/83 62/73 71/80 74/83 72/82 91/93 68/78 63/75 64/75 
AC-4    100 61/72 71/82 71/82 72/82 72/82 62/75 60/73 59/72 
AC-5     100 59/71 59/72 62/74 62/73 63/72 64/75 59/71 
SJ02      100 71/81 79/88 74/84 69/80 67/78 65/78 
SJ03       100 74/86 76/87 65/79 65/76 65/77 
SJ04        100 75/85 69/81 66/79 66/79 
SJ05         100 71/82 66/79 66/78 
SJ06          100 70/81 66/79 
SJ07           100 76/86 
SJ08            100 
 
Table 3.4 Percentage identity/similarity at the amino acid level of proteases encoded by H. contortus BAC 18f22 and the AC protease family  
Percentages highlighted in red are those indicating high amino acid identity and similarity between protein sequences. 
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A similar pattern was depicted using the Molecular Evolutionary Genetic Analysis 
(MEGA) tool (version 5) which is available to download at 
http://www.megasoftware.net/, indicating that proteases encoded by genes 
that are located closer together on the BAC, group closer together 
phylogenetically. This is evident in Figure 3.10, with the proteases encoded by 
the BAC spanning the length of the tree in almost the exact order in which they 
are found on the BAC. This observation is interesting as both AC-4 and AC-5 are 
located on the tree within the region covered by the proteases encoded by the 
BAC and as the rest of the proteases appear in almost perfect chronological 
order this suggests that AC-4 and AC-5 should be located on the BAC. 
Additionally, as expected, the proteases thought to be represented in duplicate 
group together; AC-1, AC-2 & SJ04 and AC-3 & SJ05. Figure 3.10 is a phylogram 
and contains additional information about the divergence of proteases, with 
those furthest away from the node being the most divergent.  
 
Figure 3.10 Phylogenetic tree indicating the BAC and AC protease families  
This is a MEGA phylogram, in which branch length is proportional to divergence. A scale bar is 
included to indicate the degree of change. Bootstrapping has been applied to the tree to confirm 
reliability. Additional proteases are shown from C. elegans, Necator americanus and Ancylostoma 
caninum. 
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A tBLASTn search using the published amino acid sequence for AC-4 and AC-5, 
was carried out against the database of H. contortus supercontigs (28/08/09). 
Sequence encoding AC-4 was identified on supercontig_0005737 however un-
sequenced regions prevented identification of the full protease. Only 244 out of 
the full 343 amino acids were identified, the missing region could not be 
identified in any part of the genome and thus it is likely to be within an un-
sequenced region. This partial sequence is very highly conserved with AC-4 
(Pratt et al., 1992), with only 3 amino acid changes in the 244 identified amino 
acids (Figure 3.11), and a 98% sequence identity at the DNA level. AC-5 could be 
fully annotated on supercontig_0008756. Comparing the published amino acid 
sequence of AC-5 (Pratt et al., 1992) and the AC-5 sequence identified from the 
supercontig indicated that there are 25 amino acid differences between the two 
(Figure 3.12), and a 94% sequence identity at the DNA level. This indicates that 
both proteases are present in UK isolates, but as yet their genomic locations 
have not been linked to the other proteases within the family. 
 
AC-4sc   MYLVLTLCAYLCAASGASINAAQEIPLEAQTLTGEPLVAYLRKNQNLFEVNSEPTPNYEQ 60 
AC-4     MYLVFTLCAYLCAASGASINAAQEIPLEAQTLTGEPLVAYLRKNQNLFEVNSEPTPNFEQ 60 
 
AC-4sc   KIMDIKFKNQKLNFVVKNDPEPNEDIPEEYDPREKFK-CSTFYIRDQANCGSCWAVSTAA 119 
AC-4     KIMDIKFKNQKLNFVVKNDPEPNEDIPEEYDPREKFKNCSTFYIRDQANCGSCWAVSTAA 120 
 
AC-4sc   AISDRICIATNGE----------------------------------------------- 132 
AC-4     AISDRICIATNGEKQVNISSTDILTCCNPQCGFGCGGGWSIRAWEYFVYEGVVSGGEYLT 180 
 
AC-4sc   ---------------------------------------------------GKVAYGVEP 141 
AC-4     KGVCRPYPIHPCGHHGNDTYYGECPREAATPPCKKKCQPGYKKIFRMDKRQGKVAYGVEP 240 
 
AC-4sc   KEEAIQREILRHGPVVASFAVYEDFSLYKTGVYKHTAGALRGYHAVKMMGWGVDSKTKAK 201 
AC-4     KEEAIQREILRHGPVVASFAVYEDFSLYKTGVYKHTAGALRGYHAVKMMGWGVDSKTKAK 300 
 
AC-4sc   YWLIANSWHNDWGENGYFRFIRGINDCEIEDTVAAGIVDVDSL 244 
AC-4     YWLIANSWHNDWGENGYFRFIRGINDCEIEDTVAAGIVDVDSL 343 
 
Figure 3.11 AC-4 sequence comparison with supercontig_0005737  
Amino acid alignment of the previously identified AC-4 protease and the protease identified on 
supercontig_0005737. Amino acid changes highlighted in green. 
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AC-5sc   MRYLVLALYLYLCRTLGADTDDAQGIPLHAQMLTGAPLVEYLQKNQDLFEVRTTPTPGFK 60 
AC-5     MRHIVLALYLYLCRTLGADTDEAQEIPLHAQMLTGAPLVEYLQKNQDLFEVRTTPTPGFK 60 
 
AC-5sc   YKLMDKAFANANQNLNPVVNADNDTGADLPESYDPRIVWRNCSSFHIIRDQANCGSCWAV 120 
AC-5     YKLMDKAFANANQNLNPVVNDDNDTGADLPENYDPRIVWKNCSSFHTIRDQANCGSCWAV 120 
 
AC-5sc   STAAAISDRICIATKGKKQVYVSDTDILTCCGAPCGMGCRGGWPIEAWKFFEYDGVVSGG 180 
AC-5     STAAAISDRICIATKGKKQVYASDTDILTCCGARCGLGCRGGWPIEAWKFFEYDGVVSGG 180 
 
AC-5sc   PYLGKGCCSPYPLHPCGRHGNDTFYGNCAGMAATPPCKRRCQPGFRGMYRVDKRYGESRK 240 
AC-5     PYLGKGCCSPYPLHPCGRHGNDTFYGNCVGMAPTPPCKRKCQPGFRGMYRVDKRYGEPGR 240 
 
AC-5sc   AYRLPSSEVKIRRDIMERGSVVAVFAVYEDFSHYQSGIYKHTAGRFTGGYHAVKMIGWGK 300 
AC-5     TYTLPRSEVKIRRDIKERGSVVAVFAVYEDFSHYQSGIYKHTAGRFTGGYHAVKMIGWGK 300 
 
AC-5sc   DNGTDYWLIANSWHDDWGENGFFRMVRGTNHCGIEGQVDAGIVDVESL 348 
AC-5     DNGTDYWLIANSWHDDWGENGFFRMIRGINNCGIEEQVDAGIVDVESL 348 
Figure 3.12 AC-5 sequence comparison with supercontig_0008756  
Amino acid alignment of the previously identified AC-5 protease and the protease identified on 
supercontig_0008756. Amino acid changes highlighted in green. 
3.2.2.2  Structure and function of cysteine proteases 
Cysteine proteases contain a number of important conserved amino acid domains 
within their structures. Sequence comparisons were carried out and the 
sequences aligned using Clustal W2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) (Figure 3.13). There are three 
active site residues; cysteine, histidine and asparginine, which are essential for 
activity. Rehman and Jasmer (1999) identified a number of structural features 
relating to the cysteinyl active sites that can be used for classification within the 
cysteine protease family. This work identified that in Cathepsin B proteases, the 
cysteinyl active site is followed by one of two predominant signature sequences 
(Type A; FGAVE or Type B; VSTAA). For the proteases studied, Type A was found 
to be most common in C. elegans and Type B in H. contortus. The BAC-encoded 
and AC proteases are all Type B, with only a substitution of A to S in SJ02 and 
SJ06. CBL cysteine proteases also contain a 28 AA ‘occluding loop’ which is 
responsible for blocking off one end of the substrate binding cleft, contributing 
to enzyme stability and conferring exopeptidase activity (Illy et al., 1997). Three 
S2 subsites in cysteine proteases are also important for enzyme specificity, with 
these regions interacting with substrate residues P1-P3 (Illy et al., 1997). In a 
study carried out by Rehman and Jasmer (1999) using rat cathepsin B sequence 
(P00787) as a reference, the identified subsites were; tyr75, pro76, ser77, 
ala173, ala200 and glu245 (or Y, P, S, A, A and E in the rat cathepsin B 
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sequence), with numbering based on the mature enzyme. The Y, P and S are 
located next to one another and the A, A and E at separate locations. As can be 
observed from Figure 3.13 and Table 3.5, the cysteinyl active site signature 
sequence for all of the BAC-encoded and AC proteases is very highly conserved, 
with only the one amino acid change in SJ02 and SJ06. Although some of the S2 
sites are conserved, there are also a number of amino acid changes, particularly 
at the YPS (75-77) and E245 subsites, which may have consequences for 
substrate specificity. 
In addition to the conserved active and S2 subsites, there is a proposed 
haemoglobinase motif (YWLVANSW--DWGD) located around the region of the 
aspargine active site (294-307). It has been suggested that enzymes containing 
this motif are able to degrade haemoglobin based on their expression in blood 
feeding stages (Baig et al., 2006). This haemoglobinase motif is highly conserved 
in the CBLs of helminth blood-feeders, though AC-1 and AC-2 (and therefore 
SJ04) have a variation at position 1 of this motif. The substitution of Y to F is 
speculated to alter the function of the motif and these proteins may provide 
more of a housekeeping role (Baig et al., 2006).  
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  SJ01         ------------------------------------------------------------ 
  SJ02         MKFLVFTFCTYLCAASGTGVYATQDVPLKARTLSGEPLVAYLRENQNLFEVNSHPTPNFE 60 
  SJ04         MKYLVLALCTYLCSRTGADENAAQGIPLEAQRLTGEPLVAYLRRSQNLFEVNSDPTPNFE 60 
  SJ03         M-YFVVTLCAYLYVACVADANAAREIPLEAQTLSGEPLVAYLRKNQNLFEVNSDPTPGFE 59 
  SJ05         MMYLMFTLCTYLYVASGADVNAAQEIPLEAQTLSGEPLVAYLRKNQNLFEVNSTPTPGFK 60 
  SJ06         MKYLSLVFCFCVCRASNTDEVAAKKIPLEAQMLSGEALVEYLKINQNLFEVNSDPTPGFE 60 
  SJ07         MRCIVLALYLYLCQASGAGVDAAGEIPLEAQRLSGEALVEYLRRNQDLFEVNPDPTPGFE 60 
  SJ08         MKFFTLALYVCLCQADVVSWSATRKIPVEAQRLSGKPLVEYLRKDQDLFEVNPDPTPDFE 60 
                                                                             
      I 
  SJ01         ------------------------------------------------------------ 
  SJ02         QKIMDTIFGNQKLNFEVKDDPEPEVDIPESYDPRIIWANCTTFY-IRDQANCGSCWAVST 119 
  SJ04         QKIMDIKYKHQKLNLMVKEDPDPEVDIPPSYDPRDVWKNCTTFY-IRDQANCGSCWAVST 119 
  SJ03         RKIMDIRFKYQNQDLIVKDDSEPVDNIPERYDPRTVWKNCSTFY-IRDQANCGSCWAVST 118 
  SJ05         QKIMDIKFRNRNPNLTVKDNPEPEEDIPERYDPRKIWSNCTSFY-IRDQANCGSCWAVST 119 
  SJ06         LKLMDIKFEKQVPNPVLKDDPDPGDDIPESYDLRTIWPNCSSLFTIRDQANCGSCWAVST 120 
  SJ07         LKIMDKKFASRNINPIVKEDNDTGEGIPESYDLRTIWPNCTSLFTIRDQANCGSCWAVST 120 
  SJ08         LKIMDKKFATKNINYIVKDDNDTGEDIPE------------------------------- 89 
                                                                             
 
  SJ01         ------------------------------------------------------------ 
  SJ02         ASAISDRICIATKAEKQVNISATDILSCCSPQCGRGCHGGWSIKAWEYYIYDGVVSGGEY 179 
  SJ04         AAAISDRICIASKAEKQVNISATDIMTCCRPQCGDGCEGGWPIEAWKYFIYDGVVSGGEY 179 
  SJ03         AAAISDRICIATGAKNQVNISATDFMTCCRPKCGYGCDGGLPIRAWEFFVYDGVVSGGEY 178 
  SJ05         AAAISDRICIATKARKQVNISATDLVTCCTPTCGFGCDGGWSIKAWEYFTYAGLVSGGEY 179 
  SJ06         ASAISDRICIATKGQKQVYISASDIVTCCTTQCGSGCNGGWAYKAWEYFVEDGIVSGGHY 180 
  SJ07         AAAISDRICIATKGEKQVYISATDILSCCSDCGLGYCLGGWTLDAWHFFVEDGVVSGGKY 180 
  SJ08         ------------------------------------------------------------ 
                                                                             
 
  SJ01         -----------------------------------------------------GKDAYFV 7 
  SJ02         LTKGVCRPYPIHPCGHHGNDTYYGECRGTAPTPLCTRRCQPGVRKQYRIDKRYGKDAYMV 239 
  SJ04         LTKGVCRPYPIHPCGHHGNDTYYGECRGTAPTPPCKRKCRPGVRKMYRIDKRYGKDAYIV 239 
  SJ03         LSKGVCRPYPLHPCGHHGNNTYYGECPEEAVTPPCKKKCQRGYRKLYRMDKRYGKEAYIV 238 
  SJ05         RSKRCCRPYPIHPCGHHGNDTYYGECPEEAATPPCKKKCQPGYRKLYRMDKRYGTDAFQL 239 
  SJ06         HSKGCCRPYPLHPCGHHGNDTYYGECPEKAKTPACKRRCQPGFRKPYRLDKLYGKDVYLL 240 
  SJ07         RSKDCCRPYPLHPCGHHGNDTYYGDCNGTAPTPPCKRTCQAGLRKQYRLDKRYGKTAYEL 240 
  SJ08         ------------------------------------------------------------ 
                                                                             
 
  SJ01         KESVKAIQSEILKNGPVVASFAVYEDFSHYKSGIYRHTAGRQRGFHTVKMIGWGHENGTD 67 
  SJ02         KS-VKAIQTEILKNGPVVAAFAVHEDFSHYNSGIYKHSAGPLRGYHAVKMIGWGKENGTD 298 
  SJ04         KQSVKAIQSEILKNGPVVASFAVYEDFRHYKSGIYKHTAGELRGYHAVKMIGWGNENNTD 299 
  SJ03         KPTVKAIQSEILKNGPVVATFEVFRDFSLYKSGIYRHTAGGSRGLHAVKMIGWGTENGTD 298 
  SJ05         PQSVKAIQKELMKNGPVTASFAVYEDFSLYKSGIYKHTAGELRGYHAVKMIGWGKENGTE 299 
  SJ06         PKSIKAIQRDIMENGPVVASFKVYEDFRHYKSGIYKHTAGQLQGYHAVKMIGWGKENGTD 300 
  SJ07         PISVKAIQREIMNHGTVVVTFAVHEDFKHYKSGIYKNAAGKIKGHHAVRMIGWGKENGTD 300 
  SJ08         ------------------------------------------------------------ 
                                                                             
 
  SJ01         YWLIANSWHNDWGEKGYFRMIRGINHCGIEGVVTAGHVDIESL 110 
  SJ02         YWIIANSWHNDWGEKGYFRMIRGINDCGIEGTVAAGLVAVDSL 341 
  SJ04         FWLIANSWHNDWGEKGYFRIVRGSNDCGIEGTIAAGIVDTESL 342 
  SJ03         YWIIANSWNNDWGEDGYFRMIRGINDCGIEDTIAAGLVDVENL 341 
  SJ05         YWLIANSWHDDWGEKGYFRIIRGINDCGIEENVAAGFIDVESL 342 
  SJ06         YWLIANSWHDDWGEKGFFRTLRGSNHCGIEAIVCAGLVDVNSL 343 
  SJ07         YWILANSWHDDWGEQGYFRMARGVNECDIEEGATAGLVDVDSL 343 
  SJ08         ------------------------------------------- 
 
Figure 3.13 Amino acid alignment of the H. contortus proteases encoded by BAC 18f22  
The signal peptide region is highlighted in yellow, the putative pro-region cleavage site indicated by 
I, the active site regions in orange and the S2 subsites in blue. The occluding loop region is 
highlighted in grey and the haemoglobinase motif indicated in green. Intron/exon boundaries are 
indicated by the black lines and un-sequenced regions, in SJ01 and SJ08, by dashed lines. 
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S2 Subsite  
Sequence 
Cysteinyl 
active site 
signature 
sequence 
(111-115) 
Y, P, S 
(160, 161, 
162) 
 
A         
(258) 
A         
(285) 
E         
(332) 
 
Haemoglobinase motif 
(301-315) 
ratcatB FGAVE YPS A A E YWLVANSW--DWGD 
SJ01 - - S T V YWLIANSW--DWGE 
SJ02 VSTAS WSI A A T YWIIANSW--DWGE 
SJ03 VSTAA LPI T A T YWIIANSW--DWGE 
SJ04 VSTAA WPI S A T FWLIANSW--DWGE 
SJ05 VSTAA WSI S A N YWLIANSW--DWGE 
SJ06 VSTAS WAY S A I YWLIANSW--DWGE 
SJ07 VSTAA WTL T A G YWILANSW--DWGE 
SJ08 VSTAA WVL V A A YWIIANSW--DWGE 
AC-1 VSTAA WPI S A T FWLIANSW--DWGE 
AC-2 VSTAA WPI S A T FWLIANSW--DWGE 
AC-3 VSTAA WPI S A N YWLIANSW--DWGE 
AC-4 VSTAA WPI S A T YWLIANSW--DWGE 
AC-5 VSTAA WPI V A Q YWLIANSW--DWGE 
 
Table 3.5 Conserved regions within the BAC and AC CBL cysteine protease families 
Regions in the haemoglobinase motif in which tyr294 (Y) have been replaced with phe294 (F) have been highlighted in bold. 
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3.2.2.3  Analysis of synonymous and non-synonymous substitutions in 
cathepsin B cysteine proteases 
It was of interest to determine if any regions of the proteases showed any 
evidence of selection for amino acid diversity which could potentially alter 
function and/or antigenicity. Datamonkey 
(http://www.datamonkey.org/dataupload.php) is used to detect positive 
selection and the rate of synonymous (silent) and non-synonymous (where 
nucleotide changes alter the amino acid) substitutions in genes. For this analysis 
the full BAC exonic gene sequences of sj02-sj08 were used. All input sequences 
are required to be of the same length to allow the programme to function, and 
for this reason the first codon of exon 2 was removed in genes sj02, sj04, sj05, 
sj06, sj07 and sj08 as they all contain one codon more than sj03. For this reason 
one codon in exon 5 of sj06, sj07 and sj08 was also removed. Figure 3.14 
obtained from this analysis indicates regions that are highly variable if there is a 
peak in the positive direction and conserved if the peak is in the negative 
direction. Peaks in the positive direction occur if the rate of non-synonymous 
substitution is higher than synonymous. Non-synonymous substitutions are more 
likely to occur by chance, and have an effect on the function of the protein, 
compared to synonymous substitutions. The higher the peaks in the positive 
direction the more evidence there is for positive selection in that region and 
subsequent advantageous genetic diversity. From analysis of the amino acid 
alignments of the BAC encoded and AC proteases it is easy to identify regions 
that are less well conserved, however visual analysis of the DNA sequence to 
detect base pair changes resulting in non-synonymous substitutions is more 
difficult. The Datamonkey programme is useful for detecting synonymous 
substitutions that are not apparent on analysis of the amino acid sequence 
alone; these may or may not be significant. 
Figure 3.14 indicates the rate of synonymous and non-synonymous substitutions 
in the BAC genes sj02-sj08 and the AC genes AC-1, AC-3, AC-4 and AC-5. 
Although some of these genes were duplicated, for example AC-1 & sj04 and AC-
3 & sj05, they were added to the analysis to help increase the reliability of the 
results. Ideally at least 10 different sequences would be used to increase the 
reliability of the results. This was not possible as there are a limited number of 
genes on BAC 18f22 and in the AC family that are not duplicated. Areas of 
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interest have been added to this figure to aid interpretation. Within the signal 
peptide region there are a number of peaks in the positive direction indicating 
variation in this region. This finding is not surprising as the signal peptide, which 
is cleaved and therefore not involved in protease function, is commonly a very 
variable region. The size of the peaks in the positive direction is also indicative 
of the degree of positive selection, with the higher peaks having more positive 
selection. In addition to this, the region from codons 145-156 has a number of 
peaks in the positive direction, indicating variation. In alignment of the BAC 
genes this region appears to misalign and leave gaps in the sequence in order to 
maintain the highest percentage identity. It is therefore unsurprising that this 
region is highlighted as having numerous non-synonymous substitutions. Other 
areas of interest include the ‘GSCWAV’ active site, the occluding loop region, S2 
subsites and the region of the haemoglobinase motif, where there are no peaks 
indicating non-synonymous substitutions, but are peaks in the negative direction 
indicative of synonymous substitutions.  
 
Figure 3.14 Graph indicating the rate of synonymous and non-synonymous substitutions in 
the BAC and AC genes  
Non-synonymous substitutions are indicated by peaks in the positive direction, with those above 1 
indicating evidence for positive selection. Conversely synonymous substitutions are indicated by 
peaks in the negative direction. Areas of interest are highlighted. 
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3.2.3  Naming the genes encoded by BAC 18f22 
Work presented within this chapter indicates that the previously characterised 
AC gene family (Pratt et al., 1992) has additional members identified on H. 
contortus BAC 18f22. Evidence suggests that AC-1, AC-2 & SJ04 are encoded by 
the same gene and AC-3 & SJ05 are encoded by the same gene and thus are 
already published sequences. Table 3.6 indicates the BAC names for which the 
genes will be known, indicating those which have high sequence identity to 
already published sequences. 
Initial gene name 
used (this work) 
New BAC gene 
name 
Associated 
published 
sequence 
sj01 hc-BAC18f22-1 - 
sj02 hc-BAC18f22-2 - 
sj03 hc-BAC18f22-3 - 
sj04 hc-BAC18f22-4 AC-1, AC-2 
sj05 hc-BAC18f22-5 AC-3 
sj06 hc-BAC18f22-6 - 
sj07 hc-BAC18f22-7 - 
sj08 hc-BAC18f22-8 - 
Table 3.6 Re-naming the genes present on H. contortus BAC18f22 
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3.3 Discussion 
The aim of this chapter was to use the available BAC sequence information to 
identify and characterise a H. contortus cathepsin B-like (CBL) protease gene 
family. Six novel H. contortus CBL cysteine protease genes were identified, and 
both bioinformatic and phylogenetic analysis indicate that they are additional 
members of the AC protease gene family. RT-PCR analysis of the BAC protease 
genes identified expression in adult but not infective larvae stages, a finding 
which is consistent with previous analysis of the AC protease gene family (Pratt 
et al., 1990). This could be due to lifecycle adaptation, as transcripts for these 
proteases are enriched in the intestine (Jasmer et al., 2001) and are likely to 
have a role in digestion. For this reason their requirement in the young 
larval/non-blood feeding stages would be redundant (Ray and McKerrow, 1992). 
CBLs have received considerable attention as vaccine candidates or drug targets 
due to their abundance and speculated role in blood feeding (Pratt et al., 1990). 
Work carried out by Jasmer et al., (2001) identified that 17% of H. contortus 
intestinal transcripts (from EST data at that time) were represented by CBL 
genes. De Vries et al., (2009) carried out a vaccine trial using 
excretory/secretory (ES) products from H. contortus enriched with the AC-5 CBL 
cysteine protease, as previous work indicated protective properties of ES 
antigens enriched for cysteine proteases (Bakker et al., 2004). A reduction in 
egg output was identified when using AC-5 enriched products, and together with 
previous evidence, indicates the potential protective effect afforded by 
vaccination with cysteine proteases. 
Work has been carried out looking at CBL cysteine proteases in other blood 
feeding parasites, namely the hookworms A. caninum and N. americanus (Ranjit 
et al., 2008). Ranjit et al., (2008) identified a family of four CBL cysteine 
proteases in N. americanus, Na-CP-2, -3, -4, -5, which are expressed in the 
intestine and considered potential vaccine targets. Phylogenetic analysis 
indicated that this family is related to CBLs in other nematodes, most closely to 
A. caninum (Ac-CP-1 and Ac-CP-2) and the H. contortus HmCP protease family 
(Skuce et al., 1999). Loukas et al., (2004) examined the effect of vaccination of 
dogs with Ac-CP-2. Ac-CP-2 is suggested to be involved in haemoglobin digestion 
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and was chosen as a vaccine candidate for this reason. Expression as an active 
enzyme resulted in reduced fecal egg counts, a decrease in worm size and a 
decrease in the ratio of female to male worms. Antibodies were generated and 
bound to the intestinal lumen of the hookworms, thus it is expected that they 
cause interference with protein function. Although no decrease in worm burden 
was found, vaccination reduced clinical symptoms.  
In this study, annotation and analysis of BAC 18f22 showed that the genes 
encoding AC proteases are tandemly arranged within the genome, with eight AC 
genes contained in a 114 kb genomic region. It is a common occurrence, across a 
number of parasitic and free-living nematode species, for CBL cysteine protease 
genes to be present as multigene families (Larminie and Johnstone, 
1996;Shompole and Jasmer, 2001). However, with the exception of 
Caenorhabditis species, it was not known how these are organised in the 
genome. In C. elegans, the identified cysteine proteases are not tandemly 
arranged in the genome. Data presented here indicates that members of the H. 
contortus AC protease family have arisen by duplication and divergence of a 
common ancestor. The tandem arrangement of these genes suggests this is likely 
to be a recent duplication and/or there is selection for those to be in the same 
genomic region, possibly for co-ordinated expression. 
The individual genes within multigene families may have different functions and 
gene family organisation may therefore indicate how diverse these functions are 
e.g. the globulin gene family in mammals. Members of the globulin gene family 
are all located in the same region of the genome, suggesting that their 
expression is co-ordinated. Different forms of haemoglobin result from 
expression of different members of the gene family (Walsh and Stephan, 2008). 
Pratt et al., (1992) hypothesised that the occurrence of the AC protease family 
in H. contortus may be due to the requirement for a large quantity of protease 
in a short period of time, a requirement for functional diversity or alternatively, 
diversity in antigenicity to avoid immune recognition. Analysis of the amino acid 
residues around the active site regions, the S2 subsites and putative 
haemoglobinase domain, revealed some alterations. Whether these give rise to 
variations in activity and/or antigenicity requires biochemical and immunological 
studies. 
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5’ RACE confirmed the correct location of the start codon, which had been 
difficult to identify bioinformatically as the first exon contained only the start 
methionine. This feature was first noted in the AC proteases identified by Pratt 
et al., (1990) and has been identified in other parasitic nematodes, and in the C. 
elegans cysteine proteases CPR-1, CPR-4 and CPR6 (Larminie and Johnstone, 
1996). It is unknown how widely or frequently this short first exon is found in 
parasitic species, if it is a feature found in all gene types and ultimately if it has 
any significance on protease expression.  
Analysis of introns present in the BAC genes was carried out as previous work 
indicated that they may have important roles in gene expression. Work carried 
out by Nam et al., (2002) identified a 7.2 kb intron in the C. elegans run gene 
that is important for control of gene expression. This gene is a homologue of the 
Drosophila runt gene. The mammalian homologues of this gene have roles in 
haematopoiesis and osteogenesis, and in C. elegans run was detected in the 
intestine. Deletion constructs were generated (with varying sizes of deleted 
intronic sequence) and showed variation in expression levels. The presence of 
large introns in C. elegans is unusual and thus there may be a functional 
relationship between these large introns and those observed in H. contortus. In 
addition, a number of introns have been identified as causing an intron-
mediated enhancement (IME) of genes (Mascarenhas et al., 1990). Rose et al., 
(2008) explored IME in Arabidopsis thaliana genes, by carrying out bioinformatic 
analysis on a number of introns to predict their enhancing ability. A number of 
motifs were identified as being present in these introns and potentially having a 
role in IME. The A. thaliana intron motifs were compared to those identified in 
the BAC introns, however there was no consensus. This was not unexpected 
given the divergence between these organisms. Work carried out by Ho et al., 
(2001) and Okkema et al., (1993) suggests that C. elegans may also display IME 
effects as intron inclusion in expression work often leads to an increase in mRNA 
and protein. This is also found in reporter genes such as Lac-Z and GFP, where 
introns enhance expression (Fire et al., 1990). As H. contortus genes have been 
identified as having an increased number and size of introns compared to C. 
elegans, any IME occurring in H. contortus may be significant. Large scale 
examination would need to be carried out to determine this, as data obtained to 
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date has not indicated any obvious relationship between intron size and 
expression level in the H. contortus BAC genes. 
As a pattern, most of the intron sizes are well conserved in the AC genes, 
although a few introns were of varied length. The first intron was relatively 
short in all AC genes which is in contrast to the findings of Bradnam and Korf 
(2008) who indicated that in the model species Arabidopsis thaliana, Drosophila 
melanogaster and C. elegans, longer first introns are a general property. 
Previous work has also suggested that early introns may have important roles in 
the function of gene expression and for this reason are significant regions for 
analysis (Mascarenhas et al., 1990). The fourth intron of the BAC genes, with the 
exception of sj07, is longer than the other introns (2,190-13,388 bp). This intron 
is located at the junction between the pro and mature enzyme and could 
potentially have a function in regulating processing of the mature enzyme. 
During intron analysis a repeat sequence was identified in intron nine of sj04. 
This repeat sequence shares >80% identity to repeat sequence M84609, 
identified in H. contortus by Callaghan and Beh (1994) and is preceded by 
repeats of GTCT. Hoekstra et al., (1997) identified another repeat (HcREP1) that 
shares only a 48% sequence identity with the repeat sequence M84609. 
Interestingly, Laing et al., (2011) identified repeats related to HcREP1 on the H. 
contortus BAC BH4E20, at a duplication break point, between two closely 
related genes. In the work presented here, neither HcREP1 nor M84609 repeat 
sequences were found between the different AC genes on the BAC, suggesting 
repeat sequences are not contributing to gene duplication events in this case. A 
BLASTn was carried out using M84609 against the H. contortus assembled 
supercontigs (21/08/08)(all reads) on the Sanger webpage to determine if this 
sequence is present in other parts of the genome. Over seventy supercontigs 
were identified as having the sequence present, it is repeated and shares over 
>80% identity in the majority of the genome hits. This finding may be significant 
as this repeat sequence may contribute to genetic diversity of the population. 
Phylogenetic analysis helped compare the relationship of the proteases encoded 
on the BAC to one another and to previously identified AC proteases. The 
phylogram contains additional information about the divergence that has 
occurred since the proteases shared a common ancestor. From this phylogenetic 
tree, the previously identified AC-4, AC-5 and newly identified SJ03 and SJ07 
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have the longest branch lengths indicating that they have undergone more 
genetic change than some of the others. There is no indication of time on this 
graph, thus it is not known whether those genes that are more diverse occurred 
earlier, later or in concurrence with the less diverse genes. It does however 
suggest that there has been adaptation of the genes within the family in order to 
maintain a number of different functions. The mechanisms responsible for 
diversification, specifically the pattern of nucleotide substitution is therefore of 
interest to examine.  
Hughes (1994) described a model depicting the evolution of new proteases, and 
termed this ‘the model of evolution of functionally novel proteins by mutation 
during non-functionality’ or the MDN model. This indicated that after duplication 
has occurred, one gene copy is redundant, thus any nucleotide changes occurring 
to this gene will be selectively neutral. This accumulation of amino acid changes 
may be occurring due to Darwinian selection in which nucleotide changes favour 
new functions. There is however no definitive evidence of the mechanism of 
gene duplication. Hughes (1994) outlined a new model with the aim of further 
understanding the evolution of multigene families. This suggests that during the 
period before duplication, genes may perform more than one function and thus 
after duplication each protease would perform one of these functions. Post-
duplication, natural selection may favour certain amino acid changes that aid 
further changes to benefit the protease in its specific function.  
In conclusion, bioinformatic annotation of BAC 18f22 has enabled the coding and 
non-coding regions of the eight tandemly arranged genes to be studied in detail. 
This showed that the encoded proteases belong to the AC family and identified 
six additional members. The duplication and divergence of these tandemly 
arranged genes may be to enable co-ordinated gene expression and/or 
differences in specificity. At this point, the exact function and importance of H. 
contortus AC cysteine protease genes is unknown; this family is not closely 
related to the C. elegans CPR cathepsin B proteases (35-57% identity) and 
therefore cannot be studied by reference to C. elegans. Currently sj01 is 
incomplete and it is unknown if previously identified AC-4 and AC-5 are linked to 
the other members. Further sequence data as well as improved assembly, should 
enable the complete characterisation of this cysteine protease gene family in H. 
contortus. 
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4.1 Introduction 
Cathepsin B-like (CBL) cysteine proteases have been identified as potentially 
important vaccine candidates and for this reason the diversity and possible roles 
of CBL proteins is of great interest (Jasmer et al., 2004). The work presented in 
Chapter 3 identified additional members of the previously identified AC protease 
family (Pratt et al., 1990) and indicated that they arose from gene duplication. 
Genes encoding related CBL proteases have been previously identified. In H. 
contortus these include the HmCP family (Skuce et al., 1999) containing six 
members (HmCP1-6), and an additional gene named gcp-7 (Rehman and Jasmer, 
1998). Interestingly, the proteases discussed so far (AC family, HmCP family and 
GCP-7) do not show strong similarity to C. elegans CBL proteases and other 
related parasitic nematodes, suggesting their functions may be specific to H. 
contortus. An exception to this is the Ce-CPR-6 protease which shows significant 
identity to a CBL enzyme from Ascaris suum, named As-CP-1 (Rehman and 
Jasmer, 1999). The strong sequence conservation suggests that cpr-6-like genes 
may have a house keeping function and for this reason are well conserved 
between species. To date, CPR-6-like sequences from other parasitic nematodes 
have not been well characterised, therefore it is not known how widely 
conserved this protease is nor whether it is also present as a multigene family.  
Thus, a number of H. contortus protease genes have been identified, however 
their genomic organisation and whether they represent different genes or alleles 
of the same gene is unknown.  
 
The main aims of this chapter were to;  
• Identify and annotate H. contortus cathepsin B protease genes related to 
the HmCP gene family as well as to gcp-7. 
• Annotate and characterise H. contortus cpr-6 and try to determine the 
potential conserved role the CPR-6 protease may play in nematodes. 
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4.2 Results 
4.2.1 Multigene families in H. contortus 
4.2.1.1 H. contortus cysteine protease genes related to the HmCP gene 
family 
After the discovery of the tandemly arranged multigene family present on BAC 
18f22, work was carried out to determine if other H. contortus proteases are 
members of large gene families and if they are also tandemly arranged. The 
HmCP gene family was characterised by Skuce et al., (1999) and encodes six 
cathepsin B cysteine proteases (HmCP1-6). The amino acid sequence of HmCP4 
was used to carry out a tBLASTn search against the H. contortus assembled BAC, 
contig and supercontig data (21/08/08)(all reads) on the Sanger webpage. The 
highest level of similarity was found with supercontig_0059492 (1.7e-117) and 
the partial sequence of seven genes on this supercontig was subsequently 
annotated in Artemis. The genes identified were all very similar to the 
previously identified H. contortus six member HmCP cysteine protease family. 
Figure 4.1 is an Artemis screenshot indicating the structure of the genes present 
on the supercontig. sc-0059492-2 has the most sequence available and from this 
annotation 11 exons can be identified, it is predicted that the start codon is 
located on a separate exon as observed with the AC family of protease genes on 
BAC 18f22. By identifying the conserved GT splice acceptor site sequence 
present after an ATG sequence, as found for the BAC 18f22 proteases, it was 
possible to predict the start methionine codon for the five protease genes on 
supercontig_0059492 for which the location of the second exon was known. The 
ATG start codons are located between 72 and 80 bp upstream from the start of 
the second exon. The exact size and positioning of the genes cannot be 
confirmed as there are un-sequenced regions within this supercontig and the 
possibility of assembly errors. One example of this is the fifth gene present on 
the supercontig. From Figure 4.1 there appears to be two very long introns. 
However, comparison of the genomic sequence with available cDNA sequence 
shows that there are three exons missing due to gaps in the sequence within 
these introns (indicated by Ns in the supercontig sequence). 
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The percentage identity of the previously identified HmCP cysteine proteases 
and the proteases encoded by the supercontig was calculated and the results 
shown in Table 4.1. The sequence of HmCP3 and sc-0059492-4 encoded by the 
supercontig share 96% amino acid identity and 97% DNA identity, suggesting that 
they are the same gene. Similarly, HmCP4 and sc-0059492-5 encoded by the 
supercontig show 99% amino acid identity and 98% DNA identity. This indicates 
that they are also the same gene, with the sequence changes likely due to 
variation in the parasite population. From the genomic information available, 
only four exons for sc-0059492-7 present on the supercontig could be identified. 
Similarly, for sc-0059492-3 and sc-0059492-6, only five and three exons, 
respectively could be identified. The sc-0059492-6 and sc-0059492-7 proteases 
show 79% amino acid identity and 92% DNA identity, and combined with EST data 
(see later) suggest that they are the same gene. Apart from HmCP3 and HmCP4 
none of the other HmCP proteases could be identified from the supercontig data 
on the Sanger website. The sequence gaps as well as the difficulty in defining 
closely related genes highlights some of the challenges in trying to annotate the 
available genome sequence.  
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Figure 4.1 Annotation of the HmCP-related protease genes on supercontig_0059492  
Boxes indicate exons and lines introns. The order displayed is the order present on the supercontig, however the precise locations of the genes in relation to each 
other may not be correct due to unsequenced regions and possible assembly errors. Intron sizes are not exact due to the presence of un-sequenced regions. The 
full gene sequence is predicted to contain 11 exons (excluding the start codon exon) with only sc-0059492-2 being identified in full, with exons missing from other 
genes. RNA sequence data is shown at the top and helped confirm correct gene annotation.  
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Protease HmCP1 HmCP2 HmCP3 HmCP4 HmCP5 HmCP6 sc-
0059492-1 
sc-
0059492-2 
sc-
0059492-3 
sc-
0059492-4 
sc-
0059492-5 
sc-
0059492-6 
sc-
0059492-7 
HmCP1 100 66 44 44 44 39 41 40 36 39 38 41 19 
HmCP2  100 41 40 42 36 38 38 40 39 36 44 13 
HmCP3   100 68 62 58 65 69 72 96 65 64 65 
HmCP4    100 65 60 67 72 69 69 99 63 61 
HmCP5     100 51 61 61 51 66 57 64 37 
HmCP6      100 75 62 47 66 56 72 58 
sc-0059492-1       100 73 27 68 45 68 48 
sc-0059492-2        100 68 70 72 65 61 
sc-0059492-3         100 0 69 0 73 
sc-0059492-4          100 37 64 50 
sc-0059492-5           100 23 60 
sc-0059492-6            100 79 
sc-0059492-7             100 
 
Table 4.1 Percentage identity at the amino acid level of proteases encoded by supercontig_0059492 and the H. contortus HmCP family  
Indicated in red are the percentage identities of particular interest. High percentage identities for HmCP3 and sc-0059492-4 and HmCP4 and sc-0059492-5 are 
shown. In addition to this are the 0% noted for a number of the proteases that do not have overlapping sequence and the high percentages indicated for the short 
regions of sc-0059492-3 and sc-0059492-6 that overlap with sc-0059492-7. HmCP1 and HmCP2 are more similar to each other than to any of the other proteases 
encoded by this supercontig. 
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The expression profiles of the genes on supercontig_0059492 were analysed. 
Transcriptome information for the genes has been included in Figure 4.1 using 
data obtained from adult and infective L3 stages of H. contortus worms (R. 
Laing, J. Gilleard and M. Berry unpublished data). This information helped 
confirm the correct annotation of the supercontig and also identified that no 
other genes are present on this supercontig. The transcriptome data indicates 
whether gene sequences are expressed, however it cannot be used to determine 
the level of expression. Further to this, Nembase 
(http://www.nematodes.org/nembase4/) was used to search the H. contortus 
EST data to examine transcript abundance. The genomic DNA sequence for all of 
the genes present on supercontig_0059492 was used in BLAST search against 
Nembase, using a 95% sequence identity as a cut off. This analysis identified sc-
0059492-5 as having the highest (38) number of associated ESTs, followed by sc-
0059492-6 and sc-0059492-7 (28), which are associated with the same Nembase 
Cluster, then sc-0059492-4, sc-0059492-1 and sc-0059492-3 (Table 4.2). No EST 
data was identified for sc-0059492-2 which was interesting considering 
transcriptome data is evident. sc-0059492-6 and sc-0059492-7 show high identity 
with Nembase cluster HCC00328_1. Alignment of sc-0059492-6 and sc-0059492-7 
sequences with the cluster sequence shows that these are different, but 
overlapping, regions of the same gene.  
Gene Nembase 
cluster 
number 
Percentage 
DNA identity 
Sequence 
coverage (bp) 
Number of 
ESTs 
sc-0059492-1 HCC06366_1 98 625/702 15 
sc-0059492-2 - - - - 
sc-0059492-3 HCC03301_1 98 516/549 3 
sc-0059492-4 HCC01418_2 99 394/477 23 
sc-0059492-5 HCC00020_2 99 546/816 38 
sc-0059492-6 HCC00328_1 100 254/546 28 
sc-0059492-7 HCC00328_1 96 144/291 28 
 
Table 4.2 EST data for the genes present on supercontig_0059492  
Information obtained from Nembase BLAST searches using the maximum sequence information 
available for each gene. All cluster sequences from adult H. contortus stage 
(http://www.nematodes.org/nembase4/).  
Phylogenetic analysis was used to identify the relationship of the proteases 
encoded by supercontig_0059492 to one another and to the HmCP family (Figure 
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4.2). As expected from the percentage identity, HmCP4 and sc-0059492-5 group 
together, as do HmCP3 and sc-0059492-4. sc-0059492-3 was not included in 
phylogenetic analysis as only a short region of sequence is available on the 
supercontig, and thus no reliable comparison could be carried out. Consistent 
with the low percentage identity that HmCP1 and HmCP2 share with the HmCP-
related proteases, these also group separately by phylogenetic analysis. This 
raises the question of whether HmCP1 and HmCP2 are members of this family. 
 
Figure 4.2 Phylogenetic tree indicating the relationship between both the H. contortus 
cysteine proteases and the related genes on supercontig_0059492  
HmCP1 and HmCP2 are in an out-group together and thus are most likely more distinct from the 
other HmCPs. sc-0059492-6 and sc-0059492-7 have been grouped together as they have a high 
percentage identity in the 19 amino acids in which they overlap. Scale bar indicates the degree of 
change with those proteases furthest away from the node being the most divergent. C. elegans 
cysteine protease CPR-2 is included as outgroup. 
 
The proteases present on supercontig_0059492 were further analysed to 
determine individual relationships. The seven proteases were aligned using 
Clustal W2 and the results indicated in Figure 4.3. As previously observed for the 
cysteine proteases encoded by BAC 18f22, intron/exon boundaries are very 
highly conserved and these are indicated on the alignment.  
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Where sequence was available, analysis of the active site regions (cysteine, 
histidine and asparginine) and associated amino acids was carried out. The 
proteases encoded by this supercontig are all Type B (VSTAA; Chapter 3.1.2.2) as 
found for the AC proteases. Analysis of HmCP1 and HmCP2 identified that 
although these are Type B, the middle T is replaced with an A, consistent with 
them being divergent from the other HmCP proteases. Interestingly, sc-0059492-
2 present on the supercontig has a G in place of the cysteine active site and thus 
is likely to be a pseudogene.  
As mentioned in Chapter 3.1.2.2, using a rat cathepsin B sequence as a 
reference, Rehman and Jasmer (1999) identified S2 subsites Y75, P76, S77, A173, 
A200 and E245 influencing substrate specificity. The S2 subsites have been 
identified for each of the HmCP proteases and the results displayed in Table 4.3, 
with the AC-2 sequence included as a reference. In most instances there is a 
high level of conservation around the active site regions. One sequence 
difference to note is that in sc-0059492-2 present on the supercontig there is an 
S instead of the A at position 287. There is also significant divergence in the 
conserved WPI S2 subsite sequence at positions 161-163, for HmCP1, HmCP2 and 
HmCP3, while other HmCPs show conservation with the AC proteases in these 
positions, suggesting that they may have similar specificities.  
In addition to the conserved active and S2 subsites, there is a proposed 
haemoglobinase motif (YWLVANSW--DWGD) located around the region of the 
aspargine active site (306) (Baig et al., 2006). This motif is present in all the 
HmCP proteases identified; however there are a number of sequence variations 
within this family, particularly in HmCP1, 2 and 5, again suggesting these may 
have specificities and functions different to the others.  
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  sc-0059492-6 -------------------------------------------------------HSQNM 5 
  sc-0059492-4 KYVVLAFCIYLSRIAFASEADVLWKIPLEAQLLRGEELINYLKTNQNFFEVAITPQSYNF 60 
  sc-0059492-1 RYIVVALCICLSHVAFASKADVLQEIPLAAQVLSGEELVKYLQKNQNFFEVDVTPHSYNV 60 
  sc-0059492-5 EYLVLALCIYLSQAAVLPEADVLEEIPLQAQVLSGDELLEYLKKNQRLFEVEATPAGHNF 60 
  sc-0059492-3 ------------------------------------------------------------ 
  sc-0059492-2 RHIVFAFCICLSHVAFASEADVLEGIPLAAQVLSGEELVKYLKKSQNLFEVEITPHSYNV 60 
  sc-0059492-7 KYVILALCIYISQAAPASEADVLKKISTEAQMLSGEQLLKYLKTNQNLFEVEVTPHSENV 60 
        I 
  sc-0059492-6 VHKLMDFKYIDQNRMPVAGDADDDEDDDIPESFDARLHWSNCPSLRHIRDQANCGSCWAV 59 
  sc-0059492-4 KRNLMDRRFIKHNRKP-IVEDVNDDGDDIPESFDARTHWPNCSSLTHIRDQADCGSCWAV 113 
  sc-0059492-1 QHKLMDLRFVNQNRKP-AVENEDDEGDDIPESFDARTHWPNCTSIRHIRDQANCGSCWAV 113 
  sc-0059492-5 DRKLMDLSFINQNRKP-VFDDKNDKGEDIPE----------------------------- 84 
  sc-0059492-3 ------------------------------------------------------------ 
  sc-0059492-2 QHKLMDLRFINQKRKT-VVEDANDEGDDIPESFDARTRWPYCKSLTHIRDQANCGAGWAV 113 
  sc-0059492-7 VHKLMDFKYIDQKQ---------------------------------------------- 68 
 
  sc-0059492-6 SSASAFSDRVCIATGGEKQV---------------------------------------- 85 
  sc-0059492-4 STASALSDRICIASKGAKQVYVSATDILSCCHSCGDG----------------------- 156 
  sc-0059492-1 STASALSDRICIESNGETQVHISSIDFVSCCESCGYGCDGGWPILAFDFYTYEGAVTGGD 179 
  sc-0059492-5 -------------------------------------CNGGWPIQAFNYFSKQGAVTGGD 113 
  sc-0059492-3 -------------------------------------CDGGYVIDAFKFFAEQGAVTGGD 23 
  sc-0059492-2 STASALSDRICIASKGTKQVYISSVDFISCCDSCGYGCEGGWPIEAFDYFSNQGTVTGGD 169 
  sc-0059492-7 ------------------------------------------------------------ 
 
  sc-0059492-6 ------------------------------------------------------------ 
  sc-0059492-4 ------------------------------------------------------------ 
  sc-0059492-1 YGSKDGCRPYPFHPCGHHGNDTYYGECPKGAKTPKCRRRCQRSYKKAYYMDKSY------ 233 
  sc-0059492-5 YKATSGCRPYPFHPCGHHGKDTYYGECPNEATTPKCVRKCQKSYKKSYKKDRSIGKDAYE 173 
  sc-0059492-3 YGAKDCCRPYPFHPCGHHENQTYYGECLGYEDTPKCQRKCQKSYNKSYRRDRMRGKDAYD 83 
  sc-0059492-2 YGAKNGCLPYPFHPCGRHGNETYYGECPNKASTPKCVRKCQKGYRRSYRRDRKYGVDAYE 230 
  sc-0059492-7 ------------------------------------------------------------ 
 
  sc-0059492-6 ------------------------------------------------------------ 
  sc-0059492-4 ------------------------------------------------------------ 
  sc-0059492-1 ------------------------------------------------------------ 
  sc-0059492-5 VPNSEKAIQREIMKNGPVVGAFTVYEDFSYYKKGIYKHTAGKARGGHAIKIIGWGKEGGV 232 
  sc-0059492-3 VPQSVKAIQREIMTHGPVVTGIIVYEDLVYYEKGIYKHTAGAETGGHAVKIIGWGTENGV 143 
  sc-0059492-2 VPNSVKAIQREIMKNGPVVSTMSVYQDFPLYRKGIYKHRAGLALGYHSIKIIGWGTEKGV 299 
  sc-0059492-7 ------------------------------------------------------------ 
 
  sc-0059492-6 ----------------------------------------- 
  sc-0059492-4 ----------------------------------------- 
  sc-0059492-1 ----------------------------------------- 
  sc-0059492-5 PYWLIANSWHNDWGENGYFRILRGNNHCGIEENVVAGHV-- 272 
  sc-0059492-3 PYWLIANSMNYDWGENGYFRMIRGINDCEIEQYVVAGHV-- 181 
  sc-0059492-2 PYWLIANSWHNDWGEKGYFRMLRGTNHCRIEEDVVAGHVRV 339 
  sc-0059492-7 -----------------YFRMVRGINDCGIETNVVAGKFKP 98                                          
Figure 4.3 Amino acid alignment of the proteases on supercontig_0059492  
The signal peptide region is highlighted in yellow, the three active site regions in orange and the S2 
subsites in blue. The occluding loop region is highlighted in grey and the haemoglobinase motif 
indicated in green. Intron/exon boundaries are indicated by the black lines and un-sequenced 
regions by dashed lines. The pro-peptide cleavage site is indicated by I.  
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S2 Subsite  
Sequence 
Cysteinyl 
active site 
signature 
sequence 
(113-117) 
Y, P, S 
(161-163) 
 
A         
(251) 
A         
(287) 
E         
(331) 
 
Haemoglobinase motif 
(301-315) 
AC-2 VSTAA WPI S A T FWLIANSW--DWGE 
HmCP1 VSAAE MDH A A - YWNVANSW--DW-- 
HmCP2 VSAAS YDH A A V YWTVANSW--DWGG 
HmCP3 VSTAS YVI A A N YWIIANSW--DWGE 
HmCP4 VSTAS WPI A A N YWLIANSW--DWGE 
HmCP5 VSTAA WPI A A - YWIVKNSW--DW-- 
HmCP6 VSTAS WPI A A E YWLIANSW--DWGE 
sc-0059492-1 VSTAS WPI - - - - 
sc-0059492-2 VSTAS WPI T S D YWLIANSW--DWGE 
sc-0059492-3 - YVI G A Y YWLIANSM--DWGE 
sc-0059492-4 VSTAS - - - - - 
sc-0059492-5 - WPI A A N YWLIANSW--DWGE 
sc-0059492-6 VSSAS - - - - - 
sc-0059492-7 - - - - N - 
 
 
Table 4.3 Conserved regions within the H. contortus cysteine proteases and the proteases present on supercontig_0059492  
AC-2 has been added to the table as a reference to the previously characterised AC protease family and those proteases identified on 
BAC 18f22. Missing sequence is indicated by dashed lines. 
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New H. contortus sequence data has recently been generated and assembled at 
the Wellcome Trust Sanger Institute and is available on the Sanger ftp site 
ftp://ftp.sanger.ac.uk/pub/pathogens/Haemonchus/contortus/genome/ 
(folder12062012, James Cotton unpublished data). A BLASTn search against the 
haem_supercontigs.12062012 file using the supercontig_0059492 sequence 
identified high similarity with scaffold161. This scaffold is almost 250 kb in 
length and thus provided extra information about the sequence surrounding this 
supercontig. sc-0059492-3 and sc-0059492-4 for which the end and start, 
respectively, were known have been re-positioned and combined to give a 
complete protease sequence. There is additional sequence added between sc-
0059492-6 and sc-0059492-7, providing complete protease sequence and 
confirming these as one gene. Sequence information that was previously missing 
for a number of the proteases is now present and it is likely that there are five 
complete proteases from the partial proteases initially identified on the 
supercontig. Also encoded on this scaffold are an additional seven proteases that 
are related to the HmCPs. One of these new proteases has a high percentage 
identity, 90% AA with HmCP5. The newly completed sc-0059492-1 present on the 
supercontig has a 72% AA identity with HmCP6. This suggests that all the highly 
similar HmCP proteases previously published are closely located in the genome. 
Figure 4.4 is an Artemis screenshot of scaffold161 indicating the structure of the 
genes present, how the genes previously present on supercontig_0059492 have 
been reorganised and the names for these genes. Figure 4.5 is a phylogenetic 
tree indicating the relationship between all the proteases on scaffold161 and the 
HmCP family. The tree indicates that on the scaffold there are proteases with a 
high percentage identity to all of the HmCPs except HmCP1 and HmCP2. It also 
indicates that the Hc-scaffold161-3 sequence is not the most similar to HmCP3, 
this would have been expected given the high percentage identity of the original 
partial sc-0059492-4 on the supercontig. Instead with more sequence data there 
is a higher similarity of Hc-scaffold161-5 to HmCP3. 
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Figure 4.4 Annotation of the CBL protease genes on scaffold161 (12062012 file)  
The order displayed is the order of proteases on the scaffold. The scaffold sequence obtained from the ftp site has been reversed so that proteases are displayed 
on the positive strand in the forward orientation. The region covered by supercontig_0059492 is indicated, with 5 complete proteases in this region. Of the 12 
proteases identified on the scaffold, those highlighted in red have a high identity with previously published partial and complete gene sequences. The accession 
numbers for these sequences are in Appendix 3 Table 1.  
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Figure 4.5 Phylogenetic tree indicating the relationship between all the proteases on 
scaffold161 and the HmCP family  
Neighbour joining tree, with 500 replicates.  
The sequence information gathered from the annotation of supercontig_0059492 
and scaffold161 shows that there are additional members to the already 
identified H. contortus HmCP cysteine protease family. It also suggests that 
those HmCP proteases which are most similar are situated closely in the 
genome, suggesting that like the AC family, these have undergone recent 
duplication and sequence divergence. 
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4.2.1.2  A H. contortus multigene family related to Hc-gcp-7 
Rehman and Jasmer (1998) sequenced protease genes from H. contortus gut 
extracts. One sequence identified was similar, but distinct from the already 
characterised H. contortus AC and HmCP families, and was designated gcp-7 
(AF046229). To identify any related sequences a tBLASTn search using H. 
contortus gcp-7 sequence, was carried out against the H. contortus supercontig 
data (21/08/08)(all reads). Two supercontigs were identified with high similarity 
to this sequence; supercontig_0041161 and supercontig_0059702.  
Initial analysis of supercontig_0041161 (16 kb) identified three genomic regions 
that had high sequence similarity to gcp-7. Of the three genes identified on this 
supercontig, the first was missing the start of the sequence and the third was 
missing the end, as they were not included on this supercontig. The third gcp-7 
related gene was additionally missing the first four exons. The second gene 
present on the supercontig was the only gene for which almost the full sequence 
was available, missing only the first two exons and part of the second last exon. 
Analysis of supercontig_0059702 identified eight genomic regions with high 
sequence similarity to gcp-7. These genes were numbered 4-11, to continue 
chronologically from the genes identified on supercontig_0041161. The first two 
exons were not able to be identified for any of the genes, most likely due to 
sequence divergence. 
Figure 4.6 is an Artemis screenshot indicating the structure of the genes present 
on supercontig_0041161 and supercontig_0059702. The exact location and size of 
the genes cannot be confirmed as there are un-sequenced regions (represented 
by Ns) within the supercontigs and potential assembly errors. The percentage 
identity of the proteases encoded by the two supercontigs was calculated and 
the results indicated in Table 4.4. GCP-7 and sc-0041161-2 share a 99% amino 
acid identity and 97% DNA identity, suggesting that they represent the same 
gene. The sequences for proteases sc-0059702-8 and sc-0059702-10 are almost 
complete, with nine and ten exonic sequence regions available, respectively. 
These proteases share an 89% identity at the amino acid level and a 93% identity 
at the DNA level. Based on EST evidence (see later EST data) it is likely that sc-
0059702-8 and sc-0059702-10 represent the same gene and have been positioned 
separately on the supercontig due to assembly errors. 
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Figure 4.6 Annotation of the protease genes on supercontig_0041161 and supercontig_0059702  
Boxes indicate exons and lines introns. The order displayed is the order present on the supercontig, however the locations of the genes in relation to each other 
may not be correct due to assembly errors. Intron sizes are not exact due to the presence of un-sequenced regions. The full gene sequence contains 11 exons 
(excluding the start codon exon) and it can be observed for the genes present on these supercontigs that there are a number of exons missing from a number of 
genes. RNA sequence data is shown at the top and helped confirm correct gene annotation. 
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Protease sc-
0041161-1 
sc-
0041161-2 
sc-
0041161-3 
sc-
0059702-4 
sc-
0059702-5 
sc-
0059702-6 
sc-
0059702-7 
sc-
0059702-8 
sc-
0059702-9 
sc-
0059702-10 
sc-
0059702-11 
GCP-
7 
sc-0041161-1 100 51 68 64 64 65 55 60 58 65 63 59 
sc-0041161-2  100 69 51 56 57 49 49 46 57 52 99 
sc-0041161-3   100 48 72 70 55 68 0 67 64 55 
sc-0059702-4    100 77 74 59 64 69 69 69 58 
sc-0059702-5     100 68 68 64 66 65 69 57 
sc-0059702-6      100 65 65 64 67 69 59 
sc-0059702-7       100 72 73 77 67 55 
sc-0059702-8        100 66 89 73 54 
sc-0059702-9         100 73 70 56 
sc-0059702-10          100 78 57 
sc-0059702-11           100 59 
GCP-7            100 
 
Table 4.4 Amino acid identities of GCP-7 and the proteases encoded by supercontig_0041161 and supercontig_0059702   
Indicated in red are the high percentage identities for GCP-7 & sc-0041161-2, and sc-0059702-8 and sc-0059702-10. In addition to this is the 0% noted for the third 
and ninth proteases with only partial sequences available. 
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Transcriptome data is available for supercontig_0059702 and has been included 
in Figure 4.6. From this information it is evident that for a number of the genes 
there is a very low signal, with only sc-0059702-4, sc-0059702-6, sc-0059702-8, 
sc-0059702-10 and sc-0059702-11 having easily identifiable peaks. The Nembase 
webpage was also used to search the H. contortus adult stage EST data for 
expression of all of the gcp-7 related sequences, using BLAST analysis. A 95% 
sequence similarity was used as a cut off when identifying potential matches. No 
EST data was obtained for sc-0059702-5, sc-0059702-7 and sc-0059702-9, 
indicating that they may either not be expressed or be expressed at a low level. 
sc-0059702-8 and sc-0059702-10 have the highest number of associated ESTs and 
are both associated with the same Nembase Cluster indicating, as mentioned 
previously, that they may be the same gene (Table 4.5).  
In addition to providing information about expression, the EST data was used to 
identify the second exon of a number of the proteases however the start 
methionine codon was unable to be identified due to it being on a separate 
exon. The Nembase protease sequences were used to carry out tBLASTn analysis 
against the H. contortus supercontig data (21/08/08)(all reads) on the Sanger 
webpage and the second exon was identified for all proteases except sc-
0041161-1, sc-0059702-4 and sc-0059702-9. The complete sequence for sc-
0041161-3 on the supercontig was identified from the Nembase EST data. Thus 
on analysis of the supercontig, the second exon could be identified, however 
downstream of this there is an un-sequenced region between this exon and the 
latter exons. The full Nembase sequence was aligned with the other proteases to 
ensure that there was no duplication or assembly error; this protease was 
confirmed to be a separate gene. The Nembase sequence that was absent on the 
supercontig was used in tBLASTn against the H. contortus supercontig data 
(21/08/08)(all reads) on the Sanger webpage in an attempt to identify the rest 
of the protease at a different location within the H. contortus genome, however 
no matches were identified.  
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Gene Nembase 
Cluster 
number 
Percentage 
DNA identity 
Sequence 
coverage (bp) 
Number of 
ESTs 
sc-0041161-1 HCC00986_1 96 579/756 1 
sc-0041161-2 HCC00166_1 97 877/969 6 
sc-0041161-3 HCC03318_1 95 263/273 3 
sc-0059702-4 HCC00310_2 97 391/684 9 
sc-0059702-5 - - - - 
sc-0059702-6 HCC01012_1 97 960/981 6 
sc-0059702-7 - - - - 
sc-0059702-8 HCC01173_3 98 409/933 10 
sc-0059702-9 - - - - 
sc-0059702-10 HCC01173_2 96 602/1002 10 
sc-0059702-11 HCC01124_1 
 
95 565/852 3 
 
Table 4.5 EST data for the genes present on supercontig_0041161 and supercontig_0059702  
Information obtained from Nembase BLAST searches using the maximum sequence information 
available for each gene. All cluster sequences from adult H. contortus stage 
(http://www.nematodes.org/nembase4/).  
Phylogenetic analysis was used to identify the relationship between the 
proteases encoded by the two supercontigs. Figure 4.7 is a phylogram which 
contains additional information about the divergence of the proteases with a 
scale bar to indicate the degree of change. Those proteases furthest away from 
the node are the most divergent. sc-0059702-9 has been removed from the 
analysis due to low sequence coverage. As expected from analysis of the 
percentage identity, GCP-7 and sc-0041161-2 group together. In addition to this, 
sc-0059702-8 and sc-0059702-10 group together, further supporting the 
hypothesis that these are the same genes.  
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Figure 4.7 Phylogenetic tree indicating the relationship between all the proteases encoded 
by supercontig_0041161 and supercontig_0059702  
As expected sc-0041161-2 and GCP-7 group together as do sc-0059702-8 and sc-0059702-10. 
Neighbour joining tree, with 500 replicates. 
The proteases present on the supercontigs were aligned using Clustal W2 and the 
results shown in Figure 4.8. The highly conserved intron/exon boundaries are 
indicated as are the active site regions, S2 subsites and haemoglobinase motif 
(Figure 4.8 and Table 4.6). One notable difference between these proteases and 
those previously described is around the cysteinyl active site. The GCP-7 like 
proteases are all Type B, however the sequence changes in the motif are the 
same as the sequences identified in HmCP1 and HmCP2. For all of the GCP-7 
related proteases, T129 has been replaced by an A (VSAAE). Interestingly, GCP-7 
differs from the others by having VSAAQ rather than VSAAE, which may influence 
activity. Within the proposed haemoglobinase motif, the YWTV sequence of the 
GCP-7-related proteases also occurs in HmCP2, it is unknown as to whether this 
change would affect activity and/or specificity.  
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 sc-0059702-4  ------------------------------------------------------------ 0 
 sc-0059702-5  --VLLIFTSILFHDSFEKVLTIEEFADRPIPKYAEQLSGEALVDYVNRQQPFFEAEYLPE 38 
 sc-0059702-7  --VSLIFVLFSVSNSIQRELTAEAFAAQPIPMHAQELTGEALVEYVNEKQSYFEAEYYPE 38 
 sc-0059702-9  ------------------------------------------------------------ 
 sc-0059702-8  --VSLIFITFFVSNSLQRELTVEEFAAQPIPKYAQELTGKALEEYVNKKQSFFKQAKYSE 43 
 sc-0059702-10 --VSLIFITLFVSKSLQRELTVEEFAAQPIPKYAQELTGKALEEYVNKKQSFFKAEYSAE 43 
 sc-0059702-11 --VPLILVIFVISTSSQRGPSTEEFAAQPIPKYAEELTGKALEEYVNTKQSYFK------ 33 
 sc-0059702-6  --ALLIFCAFCVVRSERTVLTAEQFAAKPISKEAQKLTGKALVDYVNEQQSFFKAEYSPD 38 
 GCP-7         MLVLLVLLSFFTVSSSQKFTRLEEFLAQPITKEAEQLTGEALVEYVNNRQSFFKAKYSPE 60 
 sc-0041161-2  --VLLVLLSFFTVSSSQKFTRLEEFLAQPITKEAEQLTGEALVEYVNNRQSFFKAKYSPE 38 
 sc-0041161-3  --VLLAFSFLLVIHSSYATLTI-------------------------------------- 
 sc-0041161-1  ------------------------------------------------------------ 
 
               I 
 sc-0059702-4  ------------------------------------------------------------ 
 sc-0059702-5  VAEKRLGSLMKMDFLLLPAGMDNVTMVGEPVTNEELPESFDSREKWKDCP-SISYIRDQS 97 
 sc-0059702-7  VAEKRLGSLMKMEYLRSPPGEYLAMMLEESNAKEEIPESFDAREKWKNCT-SIGYIRDQS 97 
 sc-0059702-9  ------------------------------------------------------------ 0 
 sc-0059702-8  VAEKRLNNLMKMEFLHAPPGEYLTMMPEELDTNQALPESFDARDKWKNCSSVIGYIRDQS 103 
 sc-0059702-10 VTEKRLNNLMKMEFLHASPGERLTMMPEELDTNEVIPESFDARDKWKNCSSVIGYIRDQS 103 
 sc-0059702-11 ---------------------------------------------WKNCT-SIDYIRDQS 47 
 sc-0059702-6  VIEQRKRTLMKMELLEHPMQKEIVAKAKKLVINEDIPESFDAREKWKECP-SIRYIRDQS 97 
 GCP-7         VVKKRRQFLLKPQFIERSYNQENVLPIANITSNDDIPESFDSREKWKDCP-SLRVIPDQS 119 
 sc-0041161-2  VVKKRRQFLLKPQFIERSYNQENVLPIANITSNDDIPESFDSREKWRDCP-SLRVIPDQS 97 
 sc-0041161-3  --------------------------------------SFDSRQKWKDCP-SIRDIRDQS 21 
 sc-0041161-1  --------------------------------------SFDSRDQWKDCP-SLRYIRDQT 21 
 
 
 sc-0059702-4  --GSCWAVSAAETMSDRLCIHSNSTLQTLISDTDLLSCCGSSCGHGCEGGSIFYAWVYAK 58 
 sc-0059702-5  NCGSCWAVAAASTMSDRLCIQSKGKFQTLISDTDILSCCQPLCGDGCNGGSLMRAWYYAR 157 
 sc-0059702-7  NCGSCWAVSAAETMSDRLCIHTYGKLQTILSDTDILSCCGTYCGYGCEGGYAIRAWGFAR 157 
 sc-0059702-9  ------------------------------------------------------------ 0 
 sc-0059702-8  NCGSCWAVSAAETMSDRLCIGTNGRLQTILSDTDILSCCGMFCGDGCEGGYTIRAWGYAR 163 
 sc-0059702-10 NCGSCWAVSAAETMSDRLCIGTNGRLQTILSDTDILSCCGMFCGDGCDGGYAIRAWGYAK 163 
 sc-0059702-11 NCGSCWAVSAASAMSDRVCIATDGKLQRIISDTDILSCCGIYCGFGCEGGYSIRAWSYAR 107 
 sc-0059702-6  NCGSCWAVSAAETMSDRLCIHSNGTFQTMISDTDMLSCCGLACGFGCDGGLAIGAWFYAQ 157 
 GCP-7         NCGSCWAVSAAQCMSDRLCIHSQGRKKVLLSATDILACCGKFCGYGCDGGYNARAWKWAT 179 
 sc-0041161-2  NCGSCWAVSAAQCMSDRLCIHSQGRKKVLLSATDILACCGKFCGYGCDGGYNARAWKWAT 157 
 sc-0041161-3  NCGSCWAVSAAETMSDRACIHSKGKFKVL-SDTDILSCCGEFCGYR-------------- 66 
 sc-0041161-1  KCGSCWAVSAASVMSDRLCIHTQGKVKVMLSDTDILACCGKFCGYGCEGGYNGRAWKWAT 81 
 
 
 sc-0059702-4  KHGVCSGGRYGAEKVCKPYVFHPCGRHQGQKYYGECPK-HMYKTPVCKRYCQYGYGKRYE 117 
 sc-0059702-5  DHGVCSGGRYEEKGVCKPYAFHPCGRHKGQKYHGECPR-HIYKTPLCKPYCQYGYGKRYK 216 
 sc-0059702-7  DSGVCSGGRYETT-----------------------------------VYCQYGYGKRYK 182 
 sc-0059702-9  -------------DNCKPYVFQPCGWHSGHKYYGECPYDHTYATPPCKEYCQYGYGKRYK 47 
 sc-0059702-8  DSGVCSGGRYDTTGNCKPYVFHPCGFHDGQKYYGMCPRDHTFKTPVCKKYCEYGYGKRYN 223 
 sc-0059702-10 DSGVCSGGRYDTKGNCKPYVFYPCGFNEGQKAYGVCPRDHAYKTPVCKKYCQYGYGKRYN 223 
 sc-0059702-11 DKGVCSGGRYESTGNCKPYVFHPCGRHAGQKFYGDCPRDHLFKTPVCKNYCQYGFGKRYK 167 
 sc-0059702-6  DFGVCSGGRYEEEGVCKPYVFHPCGFHKGQKYYGQCPK-HVYKTPKCKSYCQYGYGKRYQ 216 
 GCP-7         IAGVVTGGAYKEKGNCKPYVFPQCGAHKGKAFN-NCPS-HPYATPACKPYCQYGYGKRYE 237 
 sc-0041161-2  IAGVVTGGAYKEKGNCKPYVFPQCGAHKGKAFN-NCPS-HPYATPACKPYCQYGYGKRYE 215 
 sc-0041161-3  ------------------------------------------------------------ 66 
 sc-0041161-1  ISGVVSGGRYGEKGVCMPYVFHPCGSHKNQRFYGVCPT-HSYRTPACKPYCQYGYGKRYM 140 
 
 
 sc-0059702-4  NDKFYAKAVYGIF-SFEPAIQMNIMKNGPVQAAFTVYEDFAYYKSGVYVHTAGKDTGGHA 176 
 sc-0059702-5  DDKIYAKAVYGIF-SFEDAIRMIIMKKGPVSAAFTVYEDFAYYRRGVYVHTAGKKTGRHA 275 
 sc-0059702-7  DDKFFVKGAFILP-QNERVIQSQIMKRGPVQAAFIVYDDFSYYRKGVYVHTAGKARGAHA 241 
 sc-0059702-9  DDKFFVEGAFTLP-QNERVIQSQIMKRGPVQAAFIVYDDFSYYKSGVYVHTAGKARGAHA 106 
 sc-0059702-8  RDKFFAKGAYMLP-QNEALIQSQIMRKGPVQAAFVVYEDFSSYKSGIYVHTAGKDRGAHA 282 
 sc-0059702-10 RDKVFVKGAYMLP-QNEALIQSQIMRKGPVQAAFVVYEDFGAYKSGIYVHVGGREAGAHA 282 
 sc-0059702-11 LDKVFAHKAYILP-EHEGAIKEQIMTKGPVQAAFTVYEDFSLYKGGVYVHTGGKSRGAHA 226 
 sc-0059702-6  ADRVFAKKVYGLY-KDEDIIRMDIMKKGPVQTAFEVFEDFYSYKKGVYVHTAGEQNGLHA 275 
 GCP-7         NDKIKARTWYWLP-NDERTIQLEIMQKGPVHATFNIYEDFEHYEGGVYIHTAGAMEGGHS 296 
 sc-0041161-2  NDKIKARTWYWLP-NDERTIQLEIMQKGPVHATFNIYEDFEHYEGGVYIHTAGAMEGGHS 274 
 sc-0041161-3  ------------------------------------------------------------ 
 sc-0041161-1  KDKVKAKTWYYLPQKDEEAIKAEIFQRGPVHATFNVYEDFASYKGGVYIHTAGKMKGGHS 200 
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 sc-0059702-4  VKIIGWGVENGTNYWTVANSWNTDWGENGGYFRILRGENHCGIESQVFAGDF 228 
 sc-0059702-5  VKIIGWGVQNGTKYWTVANSWNTDWGEDGGYFRILRGKKHCGIESSIYTGDF 327 
 sc-0059702-7  VKVIGWGVQNGTKYWTVANSWNTYWGEEGGYFRILRGVNHCEFESEMIAGDF 293 
 sc-0059702-9  VKVIGWGVQNGTKYWTVANSWNTYWGEEDGYFRILRGMNHCEFESEMIAG-- 156 
 sc-0059702-8  VKVIGWGVENGTKYWTIANSWNTDWGEKG----------------------- 311 
 sc-0059702-10 VKVIGWGVENGTKYWTIANSWNTDWGENGGYFRILRGVNHCEIESEMVAGTF 334 
 sc-0059702-11 VKVIGWGVENGTKYWTIANSWNTDWGENGGYFRILRGVNHCGIEGDMVAGEF 278 
 sc-0059702-6  VKIIGWGVENGTKYWTVANSWNTDWGEDGGYFRFLRGVNHCSIEGYVLAGDF 327 
 GCP-7         IKIIGWGVDKGVKYWLIANSWSTDWGEDGGYFRVVRGINNCDIEGGVLAGTF 348 
 sc-0041161-2  IKIIG------------------------GYFRVVRGINNCDIEGGVLAGTF 302 
 sc-0041161-3  ---------------------------------------------------- 
 sc-0041161-1  VKIIGWGVENGTKYWTIANSWSEDWGENGGYFRVVRGIDNCYIESGVLAGTF 252 
                                                                     
Figure 4.8 Amino acid alignment of all the proteases in the GCP-7-like family  
The signal peptide region is highlighted in yellow the three active site regions in orange and the S2 
subsites in blue. The occluding loop region is highlighted in grey and the haemoglobinase motif 
indicated in green. Intron/exon boundaries are indicated by the black lines and un-sequenced 
regions by dashed lines. The pro-peptide cleavage site is indicated by I.  
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S2 Subsite Sequence Cysteinyl 
active site 
signature 
sequence 
(127-131) 
Y, P, S 
(170-172) 
 
A         
(269) 
A         
(296) 
E            
(342) 
 
Haemoglobinase motif 
(310-323) 
AC-2 VSTAA WPI S A T FWLIANSW--DWGE 
HmCP1 VSAAE MDH A A - YWNVANSW--DW-- 
HmCP2 VSAAS YDH A A V YWTVANSW--DWGG 
GCP-7 VSAAQ YNA T S G YWLIANSW--DWGE 
sc-0041161-1 VSAAS YNG T S G YWTIANSW--DWGE 
sc-0041161-2 VSAAQ YNA T S G - 
sc-0041161-3 VSAAE - - - - - 
sc-0059702-4 VAAAS SIF A A Q YWTVANSW--DWGE 
sc-0059702-5 VSAAE SLM A A S YWTVANSW--DWGE 
sc-0059702-6 VSAAE LAI A A Y YWTVANSW--DWGE 
sc-0059702-7 VSAAE AIR A A E YWTVANSW--YWGE 
sc-0059702-8 VSAAE YTI A A - YWTIANSW--DWGE 
sc-0059702-9 - - A A E YWTVANSW--WGEE 
sc-0059702-10 VSAAE YAI A A E YWTIANSW--DWGE 
sc-0059702-11 VSAAS YSI A A D YWTIANSW--DWGE 
 
 
Table 4.6 Conserved regions within H. contortus GCP-7 and the proteases present on supercontig_0041161 and 
supercontig_0059702  
AC-2, HmCP1 and HmCP2 have been added to the table as a reference to the previously characterised AC protease family and  
those proteases identified as being similar to GCP-7.  
 
 
 C
h
apte
r
 4
 
 
 
 
 
 
 
 
 
 
 
105
 
Chapter 4  106  
The newly released H. contortus sequence data has been analysed in an attempt 
to complete the sequences for these GCP-7-related proteases. A BLASTn search 
against the haem_supercontigs.12062012 file on the Sanger ftp site, using the 
complete sequence for both supercontig_0041161 and supercontig_0059702, 
identified that both are present on scaffold306. This scaffold is 186 kb in length 
and provided the full coding sequence for a number of the proteases that on the 
supercontigs were incomplete. Ten additional GCP-7-like proteases were also 
identified and for the majority of these the coding sequence is complete. Figure 
4.9 is an Artemis screenshot of scaffold306 indicating the structure of the genes 
present, how the scaffold relates to the previously identified supercontig 
sequences and also the names of the new proteases. Analysis of the cysteinyl 
active site regions suggested that the previously identified HmCP1 and HmCP2 
are more like GCP-7 than the other HmCP proteases. Interestingly, proteases 
with high percentage identity to HmCP1 (Hc-scaffold306-3, 93% AA identity, 98% 
DNA identity) and HmCP2 (Hc-scaffold306-4, 88% AA identity, 97% DNA identity) 
were identified on this scaffold, further supporting the hypothesis that GCP-7, 
HmCP1 and HmCP2 are closely related. Figure 4.10 is a phylogenetic tree 
indicating the relationship between all the proteases on scaffold306, GCP-7, 
HmCP1 and HmCP2. This figure indicates that the majority of the proteases 
present on this new scaffold and not previously identified on the supercontigs 
are more similar to HmCP1 and 2 than to GCP-7.  
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Figure 4.9 Annotation of the protease genes on scaffold306 (12062012 file)  
The order displayed is the order of proteases on the scaffold. The scaffold sequence obtained from the ftp site has been reversed so that proteases are displayed 
on the positive strand in the forward orientation. The regions covered by supercontig_0041161 and supercontig_0059702 are indicated. There is only one exon 
present on the scaffold for the last protease therefore the protease sequence on supercontig_0059702 has been included to complete the family. Of the 21 
proteases identified, those highlighted in red have a high identity with previously published partial and complete gene sequences. The accession numbers for these 
sequences are in Appendix 3 Table 2. 
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Figure 4.10 Phylogenetic tree indicating the relationship between all the proteases on 
scaffold306, GCP-7, HmCP1 and HmCP2  
Neighbour joining tree, with 500 replicates. 
The sequence information gained from the annotation of the two supercontigs 
and scaffold306 indicates that there are at least 21 GCP-7-like proteases in the 
H. contortus genome. In the study by Rehman and Jasmer (1998) only one GCP-7 
sequence was identified. This is the first analysis to show GCP-7, like the AC and 
HmCP proteases, is a member of a multigene family of tandemly arranged 
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cathepsin B proteases. It also provides evidence that both HmCP1 and HmCP2 
are more closely related to GCP-7 than to the other HmCPs. 
4.2.2 Analysis of H. contortus cpr-6, a unique protease gene   
4.2.2.1 Completion and annotation of the conserved H. contortus cysteine 
protease gene cpr-6 
Larminie and Johnstone (1996) identified a cathepsin B cysteine protease gene 
family in C. elegans containing six members named cpr1-6. However the C. 
elegans cpr genes are not highly similar, with the encoded proteases showing 
only 40-65% identity. Southern blotting, together with genome data confirmed 
that each of the six identified genes is single copy. RT-PCR showed that cpr-6 
was the only gene in which transcript levels increased abundantly during the L4 
and adult stages, with a 17.9-fold difference between minimum and maximum 
levels. This C. elegans cysteine protease is highly conserved in A. suum and 
partial sequences identified in H. contortus (Rehman and Jasmer, 1999). This is 
in contrast to other cathepsin B cysteine proteases which are not highly 
conserved between C. elegans and parasitic nematodes. It was of interest to 
determine if the Hc-cpr-6 gene is tandemly repeated and part of a multigene 
family. tBLASTn analysis was carried out using the C. elegans cpr-6 sequence 
against the database of H. contortus assembled supercontigs (21/08/08)(all 
reads). This identified a region on supercontig_0059515 which was annotated 
using Artemis. There are no other genes similar to cpr-6 on this supercontig or 
elsewhere in the genome, confirming that, in contrast to all the other cathepsin 
B sequences, H. contortus cpr-6 is a single copy gene. The complete H. 
contortus cpr-6 gene could not be identified on this supercontig nor could any 
additional sequence be identified from the parasite EST database website 
http://www.ebi.ac.uk/Tools/sss/wublast/parasites.html.  
Sequence information was missing at both the start and end of H. contortus cpr-
6 therefore 5’ and 3’ RACE were carried out on adult worm cDNA (Chapter 
2.3.1.3). A proposed start methionine codon was identified, and similar to the H. 
contortus CBL cysteine protease genes annotated previously, it is located on a 
separate exon. The 3’ end was identified, however due to sequencing gaps, 
alignment to supercontig_0059515 was not possible. A BLAST search of the H. 
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contortus cpr-6 5’ RACE sequence was carried out against the newer supercontig 
database on the Sanger website, H. contortus supercontigs (26/08/2009), and a 
high similarity match of this region was identified on supercontig_0005815. 
Sequence alignments showed that this supercontig contained large stretches of 
identity to supercontig_0059515. On both supercontigs the sequence at each side 
of the gaps corresponds to the other and from this it can be assumed that these 
supercontigs cover the same genomic region and provide the complete H. 
contortus cpr-6 sequence (Figure 4.11). BLAST analysis of the 12062012 
sequence file also confirmed this gene annotation, and that cpr-6 is a unique 
gene within H. contortus.  
 
  
Figure 4.11 Diagrammatic representation of the complete H. contortus cpr-6 gene  
Green boxes indicate exons and purple boxes represent the un-sequenced region on each 
supercontig. Sizes are not to scale. The Hc-cpr-6 genomic region is approximately 6 kb.  
4.2.2.2  CPR-6 conservation in other parasitic nematodes 
Due to the high level of conservation of cpr-6 in H. contortus, C. elegans and A. 
suum, other parasitic nematode genomic and EST sequences were analysed. This 
aimed to determine whether CPR-6 is highly conserved over a wider range of 
nematodes and what the putative function of CPR-6 may be. CPR-6 related 
sequences for a number of nematodes were identified; C. elegans from 
wormbase, H. contortus, Nippostrongylus brasiliensis, Teladorsagia circumcincta 
and Globodera pallida from the Sanger Blast server, A. suum and Brugia malayi 
from NCBI and Heligmosomoides polygyrus, Dirofilaria immitis, and 
Litomosoides sigmodontis from the 959 Nematode Genome Blast Server  
http://xyala.cap.ed.ac.uk/downloads/959nematodegenomes/blast/blast.php.  
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The percentage identity of CPR-6 across the different nematode species was 
calculated and the results shown in Table 4.7. Unsurprisingly CPR-6 from the 
clade V nematodes (H. contortus, T. circumcincta, N. brasiliensis, H. polygyrus 
and C. elegans) all share a higher percentage identity with each other than 
nematodes in different clades. Interestingly, A. suum (clade III) CPR-6 shows the 
highest similarity to clade V rather than other clade III nematodes (L. 
sigmodontis, B. malayi and D. immitis).  
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Species H. 
contortus 
C.    
elegans 
A.       
suum 
N. 
brasiliensis 
T. 
circumcincta 
H.      
polygyrus 
D.     
immitis 
B.       
malayi 
L. 
sigmodontis 
G.     
pallida 
H. contortus 100 70 68 83 82 78 63 58 61 61 
C. elegans  100 65 71 66 73 57 55 56 61 
A. suum   100 67 66 69 62 62 59 62 
N. brasiliensis    100 78 79 63 59 60 61 
T. 
circumcincta 
    100 64 57 57 55 53 
H. polygyrus      100 60 58 58 59 
D. immitis       100 72 69 55 
B. malayi        100 70 56 
L. 
sigmodontis 
        100 55 
G. pallida          100 
 
Table 4.7 Percentage identity at the amino acid level of CPR-6 in a number of parasitic species  
Species with the highest percentage identities have been highlighted in red. 
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Phylogenetic analysis was carried out to identify the relationship between the 
cysteine proteases (Figure 4.12). As expected from the percentage identity, 
those species in the same clade are located closer together in the tree. The 
clade V nematodes are grouped together with the addition of A. suum, which 
also groups with this clade rather than the other clade III nematodes. The 
remaining clade III nematodes group together as expected.  
 
Figure 4.12 Phylogenetic tree indicating the evolution of CPR-6 between a number of 
parasitic nematodes 
Neighbour joining tree, with 500 replicates. CPR-6-like sequences from a number of parasitic 
nematode species, Hc-AC-2 included as outgroup. 
The CPR-6 proteases were aligned using Clustal W2 and the results indicated in 
Figure 4.13 with active site regions highlighted. As mentioned previously CBL 
cysteine proteases contain a number of important conserved regions within their 
structure (Figure 4.13 and Table 4.8). In contrast to all the other H. contortus 
cathepsin B proteases identified, CPR-6 proteases can be characterised as Type 
A (FGAVE) (Rehman and Jasmer, 1999). The three filarial clade III nematodes 
have a slightly different sequence from the others (VAAVE). The S2 subsites are 
also shown in Table 4.8, and again CPR-6 sequences from clade III nematodes are 
more divergent.  
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The UniProt website (http://www.uniprot.org/uniprot/P43510) was used to 
identify structural characteristics of C. elegans CPR-6. This website provided 
information about the signal peptide region and cleavage site, and indicated 
that there is a pro-peptide region, from amino acid 17-104, resulting in a mature 
protein from amino acid 105-379. As the CPR-6 cysteine proteases show strong 
conservation at the amino acid level it would be expected that known structural 
features identified in C. elegans will be very similar in the other species 
analysed. Six disulphide bonds have been identified in the C. elegans CPR-6 
sequence (Figure 4.13) and the cysteines involved are conserved in all nematode 
CPR-6 proteases identified here, suggesting conserved folding.    
           
D.immitis        ------ISGLLICIYFHITKR-----RIEQKSLKNVKKNVSEGRDDQ----DEYKNKKIS 45 
B.malayi         MYLLPLLWFFLLPLYYLTAVV-----ALVTDPESSTKSLWQSSKEKKRFVIDKYRNTKIA 55 
L.sigmodontis    ---------ICIITTFASSHF-----DRKIEMDENEWERIWERKHFQGRKLDEYRNIEIG 46 
H.contortus      ------MKGLLVCLFFVLADR-----RIELDSSSEEYQKEGRDFQNRRSTLESFRNRRIP 49 
T.circumcincta   ------MRGFLVCLLFVLVEC-----RIKIDLSSEEEYPE-KDFTNRRSTLESFRNRKIP 48 
N.brasiliensis   ------MRGYLVCLLFALAQC-----RVELYSSSEEYDVKPQR-QLRRSTLESFRNRKIP 48 
H.polygyrus      ----------------------------------------------------------IP 2 
C.elegans        ------MKTLLFLSCIVVAAY-----CACN--------------DNLESVLDKYRNREID 35 
A.suum           ------MRYTFLVALLAIANSSADRRHLIDDSSSSDESYGSRYYGDGRSVLDEFRDRKIS 54 
G.pallida        ---------------------------DSSSESSETSPARGAYTGRVSIAAGELRTARPS 33 
 
D.immitis        SNARNLSGQELIDYINSYQTLWKAEVNK-FNLYS---DEVKYGMLGVNNLKQLLTNKKN 100 
B.malayi         PEAENLSGQELIDYVNSHQTLWKAGMNK-FNLYS---DTVKYGLLGVNNRKKSVEHKKN 110 
L.sigmodontis    PEARNLSGQELIDYVNSRQTLWKAGNTK-FNSYD---ATVKYGLLGVSDLE-----KKK 96 
H.contortus      TEAEELTGRELIDYVNSHQSLWRAKENRRFARYP---DRTKWGLMGVNNVRLSVRAKQH 105 
T.circumcincta   TEAEELTGKELIDYVNSHQSLWKAKENRRFARYP---DRTKWGLMGVNHVRLSVMAKQH 104 
N.brasiliensis   AEAEQLTGRELIDYVNSKQSLWKAKENRRFKHYP---DHTKWGLMGVNHVRLSVKAKQH 104 
H.polygyrus      SEAE-LTGKDLIDYVNRKQSLWKAKEHRRFSRYP---DRTKWGLMGVNNVRLSVKAKQH 57 
C.elegans        SEAAELDGDDLIDYVNENQNLWTAKKQRRFSSVYGENDKAKWGLMGVNHVRLSVKGKQH 94 
A.suum           HEAEKLTGYALANYVNRKQNLWKAKFNNKFRNYS---DRVKYGLMGVNNVRLSVKAKKN 110 
G.pallida        PRAEQLRGQSLVDYVNGRQGLWRAELSPKFESYD---ESVKWRMMGVNNVRHSIKAKKM 89 
   I         *      *             *     
D.immitis        LSPTRHFAIHVPESFDAREKWPECASLRNIRDQSSCGSCWAVAAVEAMSDRICIMSKGK 159 
B.malayi         LSPIRHSNIFIPESFDARKNWPECASLRNIRDQSSCGSCWAVAAVEAMSDRICITSKGK 169 
L.sigmodontis    LPVMQYSNSYIPESFDAREKWPECESLRNIRDQSSCGSCWAVAAVEAMSDRICIMSKGK 155 
H.contortus      LSTTKDLDIDIPESFDAREEWPDCDSIKVIRDQSSCGSCWAFGAVEAMSDRICIASKGE 164 
T.circumcincta   LSTTKDLDIDIPESFDSREEWPNCESIKVIRDQSSCGSCWAFGAVEAMSDRICIASKGE 163 
N.brasiliensis   LSATKDLDIDIPETFDSREQWPECDSIKVIRDQSSCGSCWAFGAVEAMSDRICIASKGE 163 
H.polygyrus      LSATKDLDIDIPESFDSREQWPECESIKNIRDQSSCGSCWAFGAAEAITDRICIESKGS 116 
C.elegans        LSKTKDLDLDIPESFDSRDNWPKCDSIKVIRDQSSCGSCWAFGAVEAMSDRICIASHGE 153 
A.suum           LSPTRFYDIYIPEAFDAREKWDQCASLKNIRDQSSCGSCWAFGAVEAMSDRICIASNGK 169 
G.pallida        LGKTRFLDLDLPDSFDARQQWPFCPSIGLIRDQSSCGSCWAFGAVEAMSDRTCIASGQK 148 
      **   *   *                *       * 
D.immitis        IQVTLSADDLLSCCKTCGFGCYGGNPIEAWKYWVSDGIVTGSNYTNHSGCRPYPFPPCEH 219 
B.malayi         KQVILSADDLLSCCKTCGFGCFGGEPMAAWKYWVLSGIVTGSDYTNHSGCRPYPFPPCEH 229 
L.sigmodontis    VQVTLSAEDLLSCCRTCGFGCYGGIPVAAWKYWISSGIVTGSSYTNHTGCRPYPFPPCEH 215 
H.contortus      IQVSLSADDLLSCCKSCGFGCNGGDPLAAWKYWVKDGIVTGSNFTANQGCKPYPFPPCEH 224 
T.circumcincta   IQVSLSADDLLSCCKSCGFGCNGGDPLAAWKYWVRDGIVTGSNFTANQGCKPYPFPPCEH 223 
N.brasiliensis   IQVSLSADDLLSCCKSCGFGCNGGDPLAAWKYWVKSGIVTGSNFTMNEGCKPYPFPPCEH 223 
H.polygyrus      FKPEISADEILACCDTCGEGCNGGDPLSAWKYWVKDGIVTGSNFTANQGCKPYPIPPCGH 176 
C.elegans        LQVTLSADDLLSCCKSCGFGCNGGDPLAAWRYWVKDGIVTGSNYTANNGCKPYPFPPCEH 213 
A.suum           IQVSLSADDLLSCCKSCGFGCDGGDPMAAWKYWVKEGIVTGSNFTMKQGCKPYPFPPCEH 229 
G.pallida        IQITLSADDLLSCCRKCGFGCDGGEPLQAWRFWVKEGIVSGSNFSVHGGCRPYPFPPCEH 208 
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           *         *   *  
D.immitis        HNNKTHYKQCRHDLYPTPKCYKKCRKDYG-KSYEADKYYGKQAYSVGNDVESIQKEIMTM 278 
B.malayi         HSNKTHYEPCKHDLYPTPKCYKQCDKNYT-KSYKADKYYGEQAYNVENDVESIQKEIMTL 288 
L.sigmodontis    HSNKTHYKPCKHDLYPTPKCVRKCDKNYK-KSYRSDKYYGKKAYGVDSDVEAIQREIMTM 274 
H.contortus      HSNKTHYDPCRHDLFPTPKCERKCVPTYNEKTYNDDKYYGRNAYGVKDDVTAIQKEVLTH 284 
T.circumcincta   HSNKTHYDPCRHDLFPTPKCEKKCVPTYNEKS---DEFSGATAYAVSKKVTDIQKEIMTN 280 
N.brasiliensis   HSNKTHYDPCRHDLYPTPKCEKTCVPSYKGRSYTEDKYYGRSAYGVKDDVTAIQKEIMTH 283 
H.polygyrus      HANETYFGPCPTDEYDTPVCTKKCIAGYA-TAYADDKHYGKNAYGVKDDVTAIQKEILTY 235 
C.elegans        HSKKTHFDPCPHDLYPTPKCEKKCVSDYTDKTYSEDKFFGASAYGVKDDVEAIQKELMTH 273 
A.suum           HSNKTHYQPCKHDLYPTPKCEKKCLDIYTEKTYAEDKFFGETAYGVEDDVTSIQKEILTH 289 
G.pallida        HSNKTHFEPCKTELYPTPKCERTCQNSYNIRQYKQDKFYGKSAYAVENSMKAIQNELYVN 268 
 
D.immitis        GPVEVSFEVHTDFLNYAGGIYKHVAGSMIGGHAVKMLGWGIDQGVPYWLAANSWNTDWGE 338 
B.malayi         GPVEASFEVYTDFLHYTSGIYKHVAGSVGGGHAVKILGWGIDQGVSYWLAANSWNNDWGE 348 
L.sigmodontis    GPVEASFEVYSDFLQYTGGIYKHLAGSVGGGHAVKLIGWGIDQGVPFWLAANSWNTDWGE 334 
H.contortus      GPVEVAFEVYEDFLNYAGGIYVHTGGRLGGGHAVKLIGWGVEQGMPYWLIANSWNTDWGE 344 
T.circumcincta   GPVEVSYNVYEDFEHYTGGIYVHTWGAESGGHAVKVIGWGTEKGTPYWLVANSWHNDWGE 340 
N.brasiliensis   GPVEVAFEVYEDFLNYAGGVYVHTGGKLGGGHAVKMIGWGVDQGMPYWLVANSWNTDWGE 344 
H.polygyrus      GPVEVAFEVYEDFLNYAGGVYVHTGGKLGGGHAVKMIGWGVDQGMPYWLVANSWNTDWGE 295 
C.elegans        GPLEIAFEVYEDFLNYDGGVYVHTGGKLGGGHAVKLIGWGIDDGIPYWTVANSWNTDWGE 333 
A.suum           GPVEVAFEVYEDFLMYDGGIYVHTGGKIGGGHAVKMLGWGVEQGVPYWLVANSWNTDWGE 349 
G.pallida        GPVEVAFEVYEDFMNYKGGVYYHVGGKLGGGHAVKLLGWGADNGIPYWLVANSWNTDWGE 328 
 
D.immitis        D---GYFRILRGVDECGVESGIVGGIPK------------------------ 363 
B.malayi         DVFSGYFRILRGADECGIESGIVAGIPRKDARSKAR---------------- 384 
L.sigmodontis    D---GYFRIIRGIDECGIESGIVAGIPKRRGKSKFH---------------- 367 
H.contortus      D---GYSRILRGVDECGIESGVVGGVPKLNSIHRRRHVAASSYTDDFF---- 389 
T.circumcincta   K---GF-RI------------------------------------------- 345 
N.brasiliensis   D---GYFRILRGVDECGIESGVVGGIPKINSIHRRRRHHR-WYTDD------ 385 
H.polygyrus      D---GFFRILRGVDECGIESGVVGGVPKINSI-------------------- 324 
C.elegans        D---GFFRILRGVDECGIESGVVGGIPKLNSLTSRLHRHHRRHVYDDNY--- 379 
A.suum           D---GFFRIIRGIDECGIESSVVGGLPKLNRTYKKYHRRYRLDNDEDDDIIF 398 
G.pallida        D---GFFRILRGKDECGI---------------------------------- 343 
  
 
Figure 4.13 Amino acid alignment of CPR-6 from H. contortus and other parasitic nematodes 
The signal peptide region is highlighted in yellow, the three active site regions in orange and the S2 
subsites in blue. The occluding loop region is highlighted in grey and the haemoglobinase motif 
indicated in green. The pro-peptide cleavage site is indicated by I. All cysteine pairs, potentially 
linked by a disulphide bond are indicated (star). Highlighted in brown are the peptide regions 
described in Section 4.2.2.5.   
 
 
Chapter 4  116        
  
 
 
 
 
S2 Subsite  
Sequence 
Cysteinyl 
active site 
signature 
sequence 
(147-151) 
Y, P, S  
(189-191) 
 
A         
(290)   
A         
(317) 
E         
(362) 
 
Haemoglobinase motif 
(331-344) 
H. contortus FGAVE DPL A A G YWLIANSW--DWGE 
C. elegans FGAVE DPL A A G YWTVANSW--DWGE 
A. suum FGAVE DPM A A S *  YWLVANSW--DWGE 
N. brasiliensis FGAVE DPL A A G *  YWLVANSW--DWGE 
T. circumcincta FGAVE DPL S A - *  YWLVANSW--DWGE 
H. polygyrus FGAVE DPL A A G *  YWLVANSW--DWGE 
D. immitis VAAVE NPI S A G YWLAANSW--DWGE 
B. malayi VAAVE EPM S A G YWLAANSW--DWGE 
L. sigmodontis VAAVE IPV S A G FWLAANSW--DWGE 
G. pallida FGAVE EPL A A - YWLVANSW--DWGE 
 
Table 4.8 Conserved regions within the CPR-6 protease in a number of nematodes  
A star indicates the parasites in which the haemoglobinase motif is conserved with the consensus. Dashed lines indicate where sequence 
is unavailable. 
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4.2.2.3  cpr-6 expression in H. contortus adult and larval stages 
BLAST analysis was carried out against Nembase 4 
(www.nematodes.org/nembase4/) to identify ESTs for H. contortus cpr-6. 95% 
sequence identity was used as a cut off when identifying potential matches and 
four ESTs (adult stage) in total were found using these criteria. Cluster number 
HCC01809_1 has a 97% sequence identity (663/679 bp) and has three associated 
ESTs. Cluster number HCC09542_1 has a 98% sequence similarity (433/439 bp) 
and has one associated EST. This information indicates that H. contortus cpr-6 is 
expressed, albeit at a lower level than other H. contortus cathepsin B genes. 
Previous analysis has shown that H. contortus cathepsin B genes (HmCP family) 
are expressed only in L4 and adult stages, suggesting a role in feeding (Skuce et 
al., 1999). Given the strong conservation of CPR-6 across a range of nematode 
species it was of interest to examine the temporal expression of the Hc-cpr-6 
gene. cpr-6 expression levels were examined in adult and larval stages of H. 
contortus worms, relative to constitutively expressed Hc-sod-1 (Liddell and 
Knox, 1998). Male, female (both 28 days post infection), early L3 (24 hour 
cultured) and late L3 (72 hour cultured) cDNA was used to test expression 
(Chapter 2.3.1.3). RT-PCR was carried out using gene specific primers designed 
to give a product size of 271 bp for cpr-6 and 403 bp for Hc-sod-1(primers in 
Appendix 2 Table 4.1) (Figure 4.14). This semi-quantitative RT-PCR approach 
indicated that Hc-cpr-6 is slightly more highly expressed in the L3 stage than in 
day 28 adult worms, albeit expression level is quite low.  
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Figure 4.14 RT-PCR of H. contortus cpr-6 expression relative to Hc-sod-1 
2% agarose gel indicating the RT-PCR products from different lifecycle stages of H. contortus 
(chapter  2.3.1.5). Both primer sets added to each reaction and Hc-sod-1 used as a control for 
expression. RT-PCR was repeated four times with consistent results.  
4.2.2.4 Attempts to localise CPR-6 using specific antibody 
To examine localisation of CPR-6 in H. contortus and C. elegans, CPR-6 
antibodies were generated. Two peptide regions highly similar in H. contortus 
and C. elegans CPR-6 were identified: SFDSRDNWPKCDSIKV and 
PHDLYPTPKCEKKCV (Figure 4.13). These two sequences were used to generate 
antibody in rabbits (Chapter 2.1.6.1).  
The antiserum generated was tested by western blotting to confirm recognition 
of CPR-6, using extracts of C. elegans N2 wild-type, a C. elegans cpr-6 mutant 
strain (allele tm408) and H. contortus adult worms. The C. elegans CPR-6 
mutant contains a 310 bp deletion in the cpr-6 coding sequence. In both C. 
elegans and H. contortus the CPR-6 pro-enzyme is predicted to be 43 kDa and 
the mature protease 30 kDa. Bands of the expected sizes were observed for C. 
elegans wild-type worms. An additional protein of approximately 35 kDa was 
detected which is most likely due to non-specific reactivity and could be 
observed in the mutant extract. A band of approximately 32 kDa was detected in 
the H. contortus adult extract which may represent the mature protease (Figure 
4.15). However, despite reactivity by western blotting, the CPR-6 antibody 
showed no specific binding to C. elegans or H. contortus by 
immunofluorescence, therefore an alternative approach was taken. 
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Figure 4.15 Western blot obtained using the CPR-6 antiserum 
Total extracts of C. elegans wild-type, C. elegans cpr-6 (tm408) mutant and H. contortus adult 
worms were separated by SDS-PAGE and probed with rabbit anti-CPR-6 (IgG).  
4.2.2.5 Temporal and spatial expression of a C. elegans cpr-6 translational 
reporter    
Previous studies have demonstrated that temporal and spatial expression driven 
by parasite gene promoters can be identified in transgenic C. elegans (Britton et 
al., 1999). Expression of a Hc-cpr-6::gfp::lac-Z transcription fusion in C. elegans 
was attempted (primers in Appendix 2 Table 4.2). However, using a 1.2 kb 
upstream region of Hc-cpr-6 fused to GFP/Lac-Z failed to show any detectable 
expression. As cpr-6 is not highly expressed in H. contortus, it is possible that 
the promoter is not highly active. Analysis of Ce-cpr-6 was therefore carried out. 
A PCR product was amplified containing 1.7 kb promoter sequence and the 
complete Ce-cpr-6 gene sequence with the omission of the stop codon (primers 
in Appendix 2 Table 4.3). A transgenic line containing this translational fusion 
construct was obtained and GFP expression was visible under the bench 
microscope in adult worms, and in both adults and larvae at high power. Ce-cpr-
6::gfp localised to intestinal cells and was present down the entire length of the 
worm (Figure 4.16). Interestingly, GFP expression increased in older worms (>10 
day old adults) and in some dauer stage larvae.  
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Figure 4.16 Ce-cpr-6::gfp translational fusion in transgenic C. elegans worms  
(A and B) Young adult stage showing GFP fluorescence foci in hypodermal and gut basement 
membrane regions, image at x40 magnification. (C-E) Older adult worms showing GFP 
accumulation in anterior gut. C and D at x10 magnification and E and F at x40 magnification. 
Arrows indicate GFP fluorescence, additional fluorescence in panel F is autofluorescence. The 3.3 
kb Ce-cpr-6 gene sequence was cloned into GFP Fire vector pPD95.75 and injected into C. 
elegans wild-type hermaphrodites (10 ng/µl).  
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4.3 Discussion 
The aim of this chapter was to examine the organisation and expansion of other 
cathepsin B multigene families from the H. contortus genome data. Novel genes 
related to the H. contortus cysteine protease HmCPs and the gcp-7 gene were 
identified. In addition to this Hc-cpr-6 was identified as a single copy gene which 
is found in a number of parasitic species and the level of conservation was 
analysed. 
Work by Skuce et al., (1999) identified the six member HmCP family; in addition 
to this a gut cysteine protease was identified by Rehman and Jasmer (1998) and 
termed GCP-7. It was unknown whether this seventh gut cysteine protease gene 
was an additional member of this protease family. Analysis contained in this 
chapter identified that HmCP1 and HmCP2 share only a 36-42% identity at the 
amino acid level with the other HmCPs within the family and also those 
proteases identified on supercontig_0059492 (for which a significant amount of 
sequence data was available). In addition, phylogenetic analysis grouped HmCP1 
and HmCP2 separately and the cysteinyl active site signature sequence also 
differed from others within this family. On analysis of GCP-7 and the GCP-7-like 
proteases identified on supercontig_0041161 and supercontig_0059702 it became 
apparent that HmCP1 and HmCP2 are more similar to these proteases with 47-
64% amino acid identity. Thus HmCP1 and HmCP2 are most likely to be part of a 
multigene protease family with GCP-7 and the GCP-7 related proteases and not 
the six member HmCP family identified previously. Therefore, in addition to the 
8 member tandemly arranged AC cysteine protease gene family identified in 
Chapter 3, there appears to be a CBL cysteine protease multigene family related 
to the HmCPs, containing 12 members, and a family of 21 tandemly arranged 
genes that are related to gcp-7. 41 individual genes have been identified here 
and it is possible that more cathepsin B genes are present in un-sequenced 
regions.   
Rispe et al., (2008) carried out a study of CBL cysteine protease genes in aphids 
and identified approximately 28 gene copies in the pea aphid Acyrthosiphon 
pisum. This finding was interesting as aphids feed on plant phloem which is high 
in sucrose and it was thought that sucrose hydrolysis occurred in place of food 
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digestion, thus it may be expected that there would be no requirement for 
proteases. In addition to genes with expression supported by EST data, there 
were CBL gene copies in the A. pisum genome that had no associated EST data. 
This indicates that they may be pseudogenes and on closer examination of the 
gene structure a stop codon was identified in one A. pisum CBL gene. As a 
number of the cysteine proteases identified in H. contortus had no associated 
ESTs it was of interest to examine the coding sequence for any stop codons or 
mutations resulting in the protein being unstable. While no stop codons were 
identified within any of the proteases, for three gcp-7-like genes on 
supercontig_0059702 with no EST data, the two in which the second exon could 
be identified have no start methionine codon upstream with the correct splice 
sequence after it. This may be a potential explanation for the lack of expression 
data. 
CBL genes have been identified as being members of multigene families in other 
parasitic helminths. Work carried out by Harrop et al., (1995) identified two CBL 
cysteine proteases Ac-CP-1 and Ac-CP-2 in Ancylostoma caninum, and found that 
Ac-CP-1 has a 61% identity with H. contortus AC-1. Therefore like H. contortus, 
A. caninum contains more than one CBL cysteine protease gene. Other species in 
which CBL gene families have been identified include Fasciola hepatica, FCP1-7 
CBL cysteine proteases (Heussler and Dobbelacre, 1994) and Schistosoma 
mansoni, Sm31 and Sm32 proteins (Klinkert et al., 1989). In the protozoan 
parasite Leishmania major >20 CBL protease genes have been identified 
(Mottram et al., 1998). In contrast, species such as the rat, bovine and human 
have only one CBL cysteine protease gene. As more genome data becomes 
available, particularly for the other clade V nematodes, it will be interesting to 
determine if CBL gene expansion occurs more widely. 
In addition to potentially allowing high level or co-ordinated expression, changes 
in the active site regions could result in multiple CBL activities/specificities 
being expressed. Rehman and Jasmer (1999) identified that for the twenty 
cysteine protease genes analysed over a number of species, not one had 
conservation of the S2 subsite glu245. From analysis of all the H. contortus CBL 
cysteine proteases studied in this chapter and the previous chapter, only HmCP6 
and six of the proteases on scaffold306 (GCP-7-like) have a glutamine in this 
position. It has been speculated that glu245 leads to cathepsin L, rather than 
Chapter 4                                                                                                                                        123   
cathepsin B type activity (Rehman and Jasmer, 1999), consistent with cathepsin 
L activity associated with gut extracts.    
Characterisation of the CBL cysteine protease gene families in H. contortus is of 
interest due to their importance as potential vaccine candidates and it is 
possible that the large degree of diversity may interfere with vaccine efficacy 
(Jasmer et al., 2004). Previous work by Redmond and Knox (2004) identified that 
a 38% reduction in H. contortus worm burden could be achieved after 
vaccination with the mature forms of purified HmCP-1, 4 and 6 expressed in 
bacteria, however no concurrent decrease in FEC was observed. A subsequent 
vaccine trial identified a 29 and 27% decrease in worm burden and FEC 
respectively (Redmond and Knox, 2006). From the gene family classification 
work carried out in this chapter, it has become apparent that the three HmCP 
proteases used in these trials may be members of different families and thus 
may have slightly different functions. It is possible that targeting proteases that 
are in the same family and more highly conserved, may enhance vaccine 
outcome. Also, the use of a higher number of family members may also produce 
higher degrees of protection, as at this point it is unknown which members of 
the family are the most active and/or most highly expressed. 
Relevant to this is CPR-6 which is a single copy protease of H. contortus and is 
also highly conserved in a range of nematodes, suggesting evolutionary pressure 
for sequence conservation. Although cpr-6 mutants of C. elegans are 
superficially wild-type, it was observed that on long-term storage, the cpr-6 
mutant allele tm408, produced very few dauer larvae compared to wild-type C. 
elegans. In addition, expression of a cpr-6::gfp fusion construct increases in 
some dauer larvae and in ageing worms. Additional experiments are planned to 
examine in more detail the functional role(s) of nematode CPR-6, in particular a 
potential role in autophagy which is important for tissue re-modelling during 
dauer development and in ageing (Melendez et al., 2003).  
In conclusion, bioinformatic annotation has greatly increased the number of 
family members for both the HmCP and GCP-7-like CBL proteases of H. contortus 
and shown that these are tandemly arranged on the genome, most likely due to 
recent gene duplication. This has provided evidence for at least 42 individual 
CBL genes within the H. contortus ISE strain. In contrast, cpr-6 was found to be 
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present as a gene with no expansion. This is the only H. contortus CBL gene to 
be highly conserved across a range of nematode species, suggesting an important 
role. Further functional analysis of the H. contortus CBL proteases and vaccine 
studies targeting specific families may help in defining which proteases are 
important for parasite survival.  
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5.1 Introduction 
The ever expanding genomic information available for parasites is enabling in 
depth analysis of genes and their promoters. Many studies have been carried out 
looking at the promoter regions of parasite genes and their potential role in 
gene regulation (Britton et al., 1999;Pillai et al., 2005;Zhao et al., 2007). In 
previous chapters H. contortus gut genes have been identified and 
characterised. Gut genes are relevant for analysis due to the role of the gut and 
associated enzymes in blood digestion. Thus identification of factors that control 
expression of these genes may lead to novel mechanisms to interfere with gut 
gene expression in general, rather than attempting to target individual gut 
enzymes. Hawkins and McGhee (1995) identified that a number of Transcription 
Factors (TFs) are important in the regulation of gut development and gene 
expression in C. elegans. 
Promoter analysis combined with deletion/mutation studies have helped identify 
regulatory motifs in a number of C. elegans genes (Okkema et al., 1993). Work 
by Egan et al., (1995) identified that a 36 bp region of DNA at the 5’ end of the 
ges-1 gene, containing two GATA sequences, results in a loss of gene expression 
when deleted. Additionally when only one GATA sequence is removed, 
expression is lost in the posterior but not the anterior gut. This paper concluded 
that GATA sequences present in either orientation within the promoter region 
are involved in gene expression. It also suggests that different motifs or regions 
within a promoter can be responsible for gene expression in the anterior and 
posterior gut. It is thought that this may reflect a gradient of TF activity within 
the gut. Additionally, if there is a loss of the region directly upstream or 
downstream of these GATA sequences a decrease in expression in the posterior 
gut cells is also observed. Subsequent studies showed that ELT-2 was the major 
TF controlling gut genes, such as ges-1 (McGhee et al., 2007). As the ELT-2 GATA 
TF has been identified as being essential for gut gene regulation in C. elegans, it 
is reasonable to presume that there may be a TF having a similar effect in H. 
contortus. Couthier et al., (2004) identified an elt-2 homologue in H. contortus 
that has similar expression both temporally and spatially to that observed in C. 
elegans. Moreover, ectopic expression of Hc-elt-2 in C. elegans embryonic cells 
resulted in an increase in gut cells. The demonstration of functional 
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conservation of ELT-2 in gut development in these two species suggests that Hc-
elt-2 is also important for gut gene expression in later stages. 
As well as experimental studies in C. elegans, parasite promoters can be 
analysed bioinformatically for motifs identified as being important for gene 
regulation in C. elegans. In addition, more general TF databases, such as 
TRANSFAC (http://www.biobase-international.com/product/transcription-
factor-binding-sites), MEME (http://meme.sdsc.edu/meme/cgi-bin/meme.cgi) 
and LocalMotif (http://en.bio-soft.net/dna/localmotif.html) can search parasite 
promoters for any putative conserved motifs. However, caution must be 
exercised in such analysis as motifs may occur by chance and not be relevant to 
gene control. For example, putative binding sites for the DAF-16 TF (Gao et al., 
2010) have been identified in a large number of genes but the relevance of this 
is not known. 
In the previous chapters, a number of multigene families were identified and 
annotated in H. contortus. Transcriptome and EST data has been used for 
analysis and to confirm expression of these genes. It is of interest to determine 
if any patterns or motifs are present in the promoter regions of these genes and 
progress our understanding of parasite gene regulation.  
The main aims of this chapter were to;  
• Carry out bioinformatic promoter region analysis of previously identified 
H. contortus CBL genes. 
• Generate transgenic C. elegans worm strains containing H. contortus gene 
promoters linked to GFP and/or Lac-Z and use these in TF RNAi studies. 
• Generate an integrated C. elegans transgenic strain containing a gut 
promoter fused to GFP as a tool to study gene control. 
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5.2 Results 
5.2.1 Bioinformatic analysis of H. contortus promoters 
5.2.1.1 H. contortus gut gene promoter motifs 
As the 5’ upstream promoter region of genes has been identified as containing 
binding sites for TFs, these regions were analysed for any potential TF binding 
motifs. The upstream promoter regions for a number of the H. contortus CBL 
gut-expressed genes, discussed in previous chapters, were identified by 
annotation of the genomic data and in some cases from 5’ RACE data. As the H. 
contortus genome has not yet been fully sequenced and assembled, upstream 
promoter region could not be identified for some genes and these were 
therefore omitted from this analysis. A number of motifs have previously been 
identified as potential regulatory motifs within promoters of C. elegans gut 
genes (Hawkins and McGhee, 1995). These include the GATA, TATA, CAAT and 
CANNTG (E box) motifs. Figure 5.1 is a diagrammatic representation of the 
upstream promoter regions of the H. contortus protease genes on BAC 18f22 
indicating the location of these motifs. Studies in C. elegans have supported an 
important role for motifs close to the start codon. Work by MacMorris et al., 
(1992) identified that just 200 bp of promoter region is required for expression 
of the C. elegans vitellogenin (vit-2) gene, for this reason analysis of the 
protease genes focussed on the proximal 1 kb upstream sequence.  
As previously mentioned, in C. elegans ELT-2 has been shown to be the major 
GATA-type TF regulating gut gene expression, therefore it was of interest to 
identify the number and positioning of GATA motifs within the H. contortus gut 
gene promoters. Within 1 kb upstream of the ATG start codon of the H. 
contortus AC protease family on BAC 18f22, all have a GATA motif on the 
negative strand at approximately position -85 bp. Additional GATA motifs either 
on the positive or negative strand were found further upstream in all of the AC 
gene promoters. Abundance of GATA motifs did not appear to correlate with 
level of expression, based on EST data (Table 5.1). However, further analysis of 
the BAC genes identified that for those genes in which no EST data is available 
(sj02, sj07, sj08), a GATAG motif is present, either on the positive or negative 
strand, between the start ATG and the GATAA motif at position -85 bp. Although 
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both GATAA and GATAG are consensus sequences, in this instance this GATAG 
motif could potentially be having a negative effect on gene expression. Work has 
been carried out looking at the effect of mutation of promoter GATA motifs and 
one study by Britton et al., (1998) identified that the mutation of GATA motifs 
that are situated in the forward orientation resulted in a decrease in expression 
however mutation of those in the reverse orientation did not. Therefore, it may 
be speculated that in addition to the orientation of GATA motifs, the make-up of 
the consensus sequences may also have an effect on expression.   
Analysis of the AC family gene promoters also identified a number of E box 
(CANNTG) motifs within 1 kb of the start codon. The first E box motif was within 
23-120 bp upstream with positions indicated on Figure 5.1. It is unknown 
whether the position of the first E box motif upstream of the start ATG, or if the 
number of E box motifs within the 1 kb promoter region may have an effect on 
gene expression. In a study carried out by Zhao et al., (2007) examining C. 
elegans arg-1 gene expression, a GT motif (inverted E box motif GTNNAC) was 
identified that is thought to be important for motif function as its mutation 
resulted in a loss of gene expression. This inverted E box motif was found within 
20-30 bp of other E box motifs. For this reason the 30 bp immediately upstream 
and downstream of all the E box motifs of the Hc-AC genes were identified and 
aligned in an attempt to identify any significant motifs or alignments that may 
be important for control of gene expression. Only one inverted E box motif was 
identified, upstream of the second E box motif in the sj02 promoter indicating 
that this is not a common motif in the Hc-AC related genes. Interestingly, the 
first upstream E box motif in the sj04 and sj05 promoters have two GATA motifs 
within 30 bp upstream, a finding which may account for the observed higher 
number of associated ESTs associated with sj04 and the reasonable number 
associated with sj05. Therefore, interactions between GATA TFs at closely 
positioned sites may enhance gut gene expression, particularly close to the start 
site. In contrast, genes sj02, sj03 and sj07 have E boxes rather than GATA motifs 
located within 30 bp of each other, which may have a less stimulatory effect, 
based on EST data (Figure 5.2).  
Also included in Figure 5.1 is the location of the TATAA motif, positioned closely 
upstream of the start ATG. The TATAA motif, where present, tends to be located 
25-30 bp upstream of the transcription start site and is associated with an 
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Initiator element (Inr) (Shi and Zhou, 2006). The position of the TATAA binding 
site is thought to be important as it determines the location of the transcription 
start site. As the function of the TATAA motif is also dependent on binding of 
transcription binding proteins (TBP) to surrounding sequences, the orientation of 
the TATAA motif sequence and subsequent location of these TBP can have an 
effect on transcription (Juo et al., 1996). O’Shea-Greenfield and Smale (1992) 
showed that inversion of a TATAA motif led to less activity indicating that this 
motif is important for gene expression. Despite this evidence however, there are 
many promoters that do not contain TATAA elements and thus the TATAA motif 
may ultimately not be essential in certain gene promoters. One example sj05, 
has no TATAA motif close to the start ATG. However, EST data and RNA 
sequence data indicate expression of this gene, suggesting that the TATAA motif 
is not required, and for this gene the CAAT motif may be important for gene 
expression.
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Figure 5.1 Promoter motif analysis of cathepsin B genes identified on BAC 18f22  
Diagrammatic representation of the 1 kb promoter region of each of the BAC genes upstream of the start ATG on the right. Motifs are indicated by coloured boxes 
and located on either the positive (top) strand or negative (bottom) strand. Motifs were identified by carrying out searches using Artemis and this figure generated 
using PowerPoint. 
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Gene Family Number of GATA 
motifs 
Position of TATAA 
motif 
Position of CAAT 
motif 
Number of CANNTG 
motifs 
Nembase ESTs 
AC family on BAC 18f22 
sj02 10 -40 -37 4 0 
sj03 8 -191 -89 7 7 
sj04 9 -40 -28 3 72 
sj05 11 - -11 4 7 
sj06 13 -48 -66 5 6 
sj07 11 -52 -67 5 0 
sj08 13 -51 -15 5 0 
HmCP family supercontig_0059492 
1 9 -33 -121 7 15 
2 8 -37 -124 3 0 
4 9 -33 -50 4 23 
5 4 - -19 2 38 
7 9 -33 -128 5 28 
gcp-7 like family on supercontig_0041161 and supercontig_0059702 
2 6 -382 -93 5 6 
5 14 -503 -99 4 0 
6 7 -14 -72 3 6 
7 5 -137 -113 5 0 
8 2 -288 -136 0 10 
10 11 -724 -44 2 10 
11 10 -437 -45 8 3 
Table 5.1 Number of conserved motifs in the 1 kb promoter region of a number of H. contortus genes 
Motif identification carried out using Artemis. 
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 5’  3’ 
 sj03-2    ACATTCAAAACTGTTGATACACAATTGGCACATATGACAAAGTAGTGAGGCATAAAAGAGTCATCG 66 
 sj03-3    TCAAATAAGACATTCAAAACTGTTGATACACAATTGGCACATATGACAAAGTAGTGAGGCATAAAA 66 
 sj03-6    TAGCAAAATTTTGAAATGTTTCGAGGTTGTCAAATGGCACTAATCACTTTATATGACAGCCGTCAA 66 
 sj05-3    TTGAGAGTTGTTTTCTTCGTTTGATACCTTCAATTGGCACTGTGCACAATCGTATGCCAGCCAACA 66 
 sj03-4    ACAATTGTAACAACGATGTGGGAAGGAGAGCAATTGCTATGCAAAAATCTGTGGTTGAAATTCAAA 66 
 sj03-5    GCTCCTTCTTCTTTTACTGGAATGTCGCAACAATTGTAACAACGATGTGGGAAGGAGAGCAATTGC 66 
 sj02-3    AAAGTGCTCTCCATATGCAGCTTCCGTTTGCAATTGCAGCAGAAATTCTGGCTAGAGTGAGAGGGT 66 
 sj02-4    TGGGTGAAACTCCAAAATTAAAGTGCTCTCCATATGCAGCTTCCGTTTGCAATTGCAGCAGAAATT 66 
 sj04-2    ATACTCGGTTCAAAGTGAAAGCGTCTCCAACATCTGCACCCTTTTATCATGAACTCAGGGTTGAAT 66 
 sj05-4    GACTCTGTCACTGTCAAAATCTCACCGTTCCATTTGGCTTCCGCTCCGCCGTAGTAGAACTCGACA 66 
 sj06-4    GACTATTTATCCGAGTGACTTCTGCTGTTTCATGTGCTACTTATCCAGAGTTGGTGGTGCTTGCAA 66 
 sj02-2    GATTAGTTAACTGATAATAGTGCAAGAGAACACTTGCACTGACATCAGAACTCAAAAACTTTACAA 66 
 sj08-5    ATAACTCCGTTTAACCCAGTGATAATAGTGCATCTGAACCCTCAAACTACCTCGTTTTTTAACCAA 66 
 sj04-3    CGTTGCTTTAACAATGAATTCCGATAATCGCAGTTGTTCCGCACTGGAAGAACATACTCGGTTCAA 66 
 sj03-1    TTATCATAAGCGGAGCTGGTTTTCTTATGACAGCTGGTTAAAAGCAAACTAAGCAGAATACGACAC 66 
 sj04-1    CTTATCATAGCCAAAGTAGTTATCTTTTGACAGGTGGTTAATACCAATATAAGCAGAATTCGACAT 66 
 sj05-1    TTATCATAGCCGGAGCTGCCTATCTCATGACAACTGGTCAAAAACGTTACATGCAGGACCCAACGC 66 
 sj02-1    ATTCTTCGTATCATGGCCAGACCTTATTATCATATGACAGCAGGATAGAACCAATATAAGCAGAAG 66 
 sj03-7    ATTGTAATAATTAAGGTCTAACGAAGGCATCATATGCCGAAAGCTTACCAATAAAAAGTGAAGGGT 66 
 sj06-1    ACCGCTGTTATAGCGAACATAAGCAGAAGCCAGCTGACACCTTCATAGCCGCTTCAGGA------- 59 
 sj07-5    AACAATGCCGGTGAAACTCGTCCGAGGATACACATGAGTCAATCTTTGAGCCTGTATAACGCGTCA 66 
 sj06-3    TCCCGAAACCAACTTATTGACATACACATCCAAATGCAAACGAGTTCTCCCAAAGTGTTGTAGAGG 66 
 sj08-4    CTGAACCCTCAAACTACCTCGTTTTTTAACCAAATGCAAACGAGACGAAAAAAAAAATAAAGAAGT 66 
 sj08-2    GACTGTTGCAGCATCATAAACTGAGTAATACAGTTGCCTACTCTTTGAAAAAGTTTTGAAAGATAT 66 
 sj07-4    GCGCTACTGCAGCATCGTTAATTTAGTGTCCAACTGAGTCATCACGGAGGCCTCTCAAAAAGTGAA 66 
 sj07-2    TTGACTTAGAGTTCTGACTTCACGTGTCTACAGTTGGCTCCTGAAAACGACTTGAAACGAAATATG 66 
 sj07-3    TTCAGAGACGTTGACTTAGAGTTCTGACTTCACGTGTCTACAGTTGGCTCCTGAAAACGACTTGAA 66 
 sj05-2    AAAAGGGACTTCAAGAAAAAGTTCTTACATCAACTGCCCCGCTTATCGAACTTATTTTGCACTGTA 66 
 sj06-5    GAGATCAAGACAAAAGCTTTACAGGAACTTCACTTGACCATACGATCGATTTCGTCATAATCGTTC 66 
 sj07-1    CAAGTCGGAAATCGTGGGGCAACACTTTTTCAGCTGTTCAACTACGTTATCTACAACATCTTCTCG 66 
 sj08-1    TTTGCGAGGCAATTTTTTAAGCTTTTCTGCCACGTGTCTAGCACTTCTTATCACAGCAGGAAATAG 66 
 sj06-2    TGAATTAGGCTGAGCCTCTAAGACCACTTTCATATGCAGATCATTCTCGCACTCTCCTTATCATAA 66 
 sj08-3    AAAAATCAAAAAATTACCCTTTCCAACTATCACTTGCAGTACTTTTCTCACAGTTTCACCTTCTGC 66 
 
Figure 5.2 Sequence alignment around the E box motifs of the BAC 18f22 genes  
Motifs associated with each gene are numbered, with 1 being closest to the start ATG. The E box 
motif is highlighted in grey, GATA motifs in red and GT motif in yellow. Highlighted in orange are 
the E box motifs found within 30 bp of each other. Clustal W2 was used to generate alignment 
http://www.ebi.ac.uk/Tools/msa/clustalw2/. 
Analysis of the H. contortus AC cathepsin B genes showed that they all have a 
TATAA and/or CAAT motif within 90 bp of the start codon. A TATAA or CAAT 
motif close to the start codon (19-37 bp upstream) was also identified in the 
promoters of HmCP cathepsin B genes on supercontig_0059492 (Figure 5.3, Table 
5.1). Of the five HmCP gene promoters analysed, the second is the only one with 
no associated ESTs, however there is no obvious explanation for this. 
Interestingly, most of the gcp-7-like genes on supercontig_0041161 and 
supercontig_0059702 contained no TATAA motif and where CAAT motifs were 
found, these were often further upstream of the start codon than in the AC 
genes (Figure 5.4, Table 5.1). The region surrounding the first E box motif 
upstream of the start ATG was analysed for both the HmCP family and gcp-7-like 
genes (Figure 5.5). Interestingly, for the HmCP genes, the fourth, fifth and 
seventh, which have a high number of associated ESTs there is either a GATA or 
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another E box motif found within 30 bp of each of these. This feature is not 
found in the first (15 ESTs) or the second (0 ESTs) of the HmCP genes. However, 
it is difficult to generalise that GATA motifs close to E box sequences enhance 
activity as this situation exists for some of the gcp-7-like genes, which have low 
or no associated ESTs. 
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Figure 5.3 Promoter analysis of HmCP cathepsin B genes on supercontig_0059492  
Diagrammatic representation of the 1 kb promoter region of each of the HmCP genes, on supercontig_0059492, upstream of the start ATG on the right. Motifs are 
indicated by coloured boxes and located on either the positive (top) strand or negative (bottom) strand. Motifs were identified by carrying out searches using Artemis 
and this figure generated using PowerPoint. 
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Figure 5.4 Promoter analysis of gcp-7-like genes on supercontig_0041161 and supercontig_0059702  
Diagrammatic representation of the 1 kb promoter region of the gcp-7-like genes upstream of the start ATG on the right. Motifs are indicated by coloured boxes and 
located on either the positive (top) strand or negative (bottom) strand. Motifs were identified by carrying out searches using Artemis and this figure generated using 
PowerPoint. 
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HmCP family on supercontig_0059492 
5’  3’ 
2   TTATCGGATTTAAGACTAATCCTTATATGACAGCTGACTTAATGAATATAAATAAGGAGATGCTCT 66 
7   TCGGAAGTCAAAAGTCTAATCCTTAAATGACAGCTGAGCGTAACGAATATAAGGAGATACTCACGT 66 
5   AGGCTAATCCTCCCATGCAGTCACCTGACCCAAATGAATTTAAGGAGGTGCTGACTTGGCCTAATT 66 
1   GATGACGGGTTCAACTCAAAAAACCATGACCAAGTGAAATCCTTAAGTAAACTGTGAAACGACTTT 66 
4   GATAGTGCGCCATTTGCCACTACACCATCTCAGGTGAACCGTTTCCCGGCGGTCGTCCGCGCGACC 66 
 
 
gcp-7-like on supercontig_0041161 and supercontig_0059702 
5’  3’ 
7   ACTGATTATTATCGAATGTTTTTGCTATGCCACATGCCTTTTTATAAAGTCATCTAGAGATAAGGC 66  
11  CTTCACTTATTCTTTTTGCGACTATTTATTCATTTGCTACTGATGTAGAAATTGAGGCGATAACAT 66  
6   TGAAATGGAATGTATATGGTTTTTCTTTTCCATATGACATGACTCCTGATAAAGTTCTCTGTGACA 66  
10  CCCCGTTAATGGCGATTGCTTTACTTATTCCATTTGAGGAAAAAGTTGACATAATAAG 58  
5   GGCACTCTATCCCTGTACGAAGGCAAAGCCCAAATGTCATGCGATAGAATTGTTTGTAATTTGTTG 66  
2   TAAGTCTTTTCAAAATAAGAGTAGTCAATGCATATGTGGCCCATGAAATGACTTGGTGGGGCCGGT 66 
 
Figure 5.5 Sequence alignment around E box motifs of the HmCP family and gcp-7-like 
genes  
The E box motif is highlighted in grey, GATA motifs in red and the E box motifs found within 30 bp 
of each other highlighted in orange. Clustal W2 was used to generate alignment 
http://www.ebi.ac.uk/Tools/msa/clustalw2/. 
The cpr-6 gene promoters for both H. contortus and C. elegans were also 
analysed for conserved motifs. CPR-6 proteases have a high level of conservation 
but despite this there is little sequence conservation within the promoter 
regions. Alignment of both 1 kb and 2 kb promoter regions was carried out and 
interestingly, when 2 kb of upstream region for each species was aligned there 
was a much higher percentage identity (Figure 5.6). Spaces were left in the 
alignment to ensure the best fit, which suggests that in H. contortus the 
promoter region may have extra sequence with binding sites potentially being 
more dispersed. This is consistent with the larger genomic size of H. contortus 
and increased intron lengths compared to C. elegans (Laing et al., 2011). While 
the previously mentioned promoter motifs, GATA, TATA and CANNTG could all 
be identified, the location of these was not conserved between C. elegans and 
H. contortus. As found with some of the other H. contortus cysteine protease 
genes analysed, these motifs are located reasonably close to the start ATG of 
Hc-cpr-6, with the first GATA, TATA, CAAT and CANNTG motifs being identified 
between positions -12 to -65 bp. However, in C. elegans these motifs are located 
further from the start ATG, between positions -64 to -335 bp. This was 
unexpected as even with the addition of sequence to the H. contortus promoter, 
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it appears that these motifs are located closer to the start ATG than in C. 
elegans.  
 C.elegans    -340  CTG-----------------ACATCTGACTTTTT--------ATTAGGTTTTTCCAT-CA  
 H.contortus  -624  TCCGAGGAGGTAAGCCCTTAGCTTCTTACTCTTTGAGAAAAAATAAAGGGAAACCATGCA  
                                         * *** *** ***        ** * *     **** ** 
 C.elegans    -306  TAT--AACCCTTTCAAACGAAATTA------------------------ATGTGCTAAAT  
 H.contortus  -564  AATGGAAAACAAGTGAGCGACTTGAGAGAATCCTAAGGTCGGATCCACGATGATCTTAAA  
                     **  **  *     * ***  * *                        ***  ** ** 
 C.elegans    -272  CTG---TTAAGTTTCAATATT--------TTCCTTGTCTTTAGGT---------CAATCT  
 H.contortus  -504  AAAGACTTAGATTTCAATCATTCAGAAAATACAAGAACTTTTTGTGTTACTTTCCTTTCC  
                          ***  *******  *        * *     ****  **         *  **  
 C.elegans    -232  TCTTTGCCACACAG-TTCAAACTACT---------ACCGCCGAGTCACGT----------  
 H.contortus  -444  TCTTAGCTATTTCGCTTCAATAGTCTTTGGTGATCTCCTGCAGGTCTTGAGAATTTGTAA  
                    **** ** *    * *****    **          **  *  ***  *           
 C.elegans    -192  ----CACACCATCACAGGATAGTGACCGGTCCTAG-----GATGTAC-----CCTGACAC  
 H.contortus  -384  TATGTACACTCCCTTTGGACAGCTCGACGTTCTAGCTATTGGTGAACGAACTACAATTCA  
                         ****   *   *** **      ** ****     * ** **      * 
 C.elegans    -146  TGTGATGGACGCAGCCG----------ACACTCTTATCGAAATGCACAGGGCC-------  
 H.contortus  -324  TGGAATAGGAGAATCCAGAAAAGCGATGCTAAAACATCCATATTCAAGGGGCCGAAGTGC  
                    **  ** *  * * **            *      *** * ** **  *****        
 C.elegans    -103  -------------------AAATTTGATAACG---AAAACATGTTCTATAAAAG------  
 H.contortus  -264  TAACGTAAGATCTCTGTGGAAATTTGTTTTCGGCGGTGATCTGATATGGGAACGGGTCAC  
                                       ******* *  **      *  ** * *   ** *       
 C.elegans    -71   -----CATG---CTGATAAAAGCG-----AGCAGTCAAGC-----------GACGAC---  
 H.contortus  -204  TTCTTCATTGCTCTTATCAAACCGTACCTGACCGTCAATCTCCCTGATAAAGTCGTCTCG  
                         ***    ** ** *** **       * ***** *           * ** *    
 C.elegans    -38   ----AACTTGCGATCAACACGCTGACCGTCG--ACGCCAACATG 
 H.contortus  -44   TATAAAATAGCCGACAACAAAGTGGTCTTCAGTTGGACACGATG 
                        ** * **   *****   **  * **     * **  ***      
Figure 5.6 DNA alignment of the H. contortus and C. elegans cpr-6 promoters  
A segment of the 2 kb promoter alignment closest to the start ATG containing the promoter motifs. 
GATA motifs are in red, TATAA in blue, CAAT in green and E box motif in grey. Conserved bases 
are indicated by a star. Clustal W2 was used to generate the alignment 
http://www.ebi.ac.uk/Tools/msa/clustalw2/.    
In addition to the conservation of regulatory motifs within promoter regions, it 
has been suggested that the presence of repeat sequences either within the 
promoter region, upstream to this or within intronic regions may have an effect 
on gene expression (Liu et al., 2002). Work carried out in Chapter 3 identified 
transcript data for all the genes present on BAC 18f22 except for sj08, suggesting 
that sj08 is not expressed. Analysis of the promoter regions of the AC genes on 
the BAC identified a very large repeat sequence 1.5 kb upstream of the sj08 
predicted start ATG. The repeat sequence is approximately 1,200 bp in length 
and has a conserved ‘ACAGACAGACAG’ pattern. As yet there is no other repeat 
sequence identical to this identified in the H. contortus genome. Work carried 
out by Liu et al., (2002) on Mycoplasma gallisepticum showed that the presence 
of a trinucleotide (GAA)12 repeat, in the promoter, was essential for expression 
of the pMGA gene. As well as repeat sequences being essential, it is also possible 
that repeat sequences at specific locations may have a negative effect on gene 
expression. 
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In this study a number of motifs potentially involved in TF binding have been 
identified in the H. contortus protease genes, some close to the start and 
occasionally clustered. Further genome data as well as comparative genomics, 
will aid in determining if these are likely to be important for gene expression. 
5.2.2 Practical analysis of gut gene expression 
5.2.2.1  Expression pattern of H. contortus sj04 (AC-2) promoter in 
transgenic C. elegans 
EST analysis using Nembase (http://www.nematodes.org/nembase4/blast.shtml) 
identified 72 ESTs for Hc-AC-2, higher than any of the other BAC genes. For this 
reason it was chosen to experimentally test expression in C. elegans. Previous 
work has already been carried out by Britton et al., (1999) examining expression 
of this (AC-2) gene in C. elegans and looking at the effect of removing a GATA 
motif in the promoter region. In the previous study 2.3 kb of upstream sequence 
was inserted into the Fire vector pPD95.03 which contains a lac-Z reporter (Fire 
et al., 1990). In an attempt to increase the level of expression and enable 
analysis in live worms the newer Fire vector pPD96.04 was used as this contains 
both GFP and Lac-Z reporters. In addition to this the first intron of Hc-AC-2 was 
included in the construct as it has previously been demonstrated by Ho et al., 
(2001) and Fire et al., (1990) that intron inclusion can increase gene activity in 
C. elegans. Primers were designed to amplify a 1 kb promoter region and intron 
one (primers in Appendix 2 Table 5.1). This construct in pPD96.04 was injected 
in conjunction with a rol-6 marker gene, into the gonad of C. elegans wild-type 
worms (25 ng/µl and 100 ng/µl respectively). GFP expression was not 
demonstrated for any of the transgenic lines, but they were Lac-Z positive after 
staining of larvae and adult stages. The majority of the worms displayed staining 
restricted to the anterior and posterior regions of the gut however in some 
worms staining was observed down the entire length of the gut (Figure 5.7 panel 
A and B). 
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Figure 5.7 Lac-Z expression of C. elegans adult worms transformed with H. contortus AC-2 
promoter reporter construct  
(A and B) Lac-Z expression is detected specifically in gut cells in adult transgenic worms. Staining 
varies from entire gut length to anterior and/or posterior expression only. (C and D) Transgenic L4 
larvae exposed to elt-2 RNAi by feeding for 3 days and then Lac-Z stained. Worm development is 
slower and Lac-Z expression reduced. All images at x10 magnification. 
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5.2.1.2 RNAi of Ce-elt-2 in C. elegans Hc-AC-2 transgenic worm strain 
As mentioned previously, the AC-2 promoter region contains seven GATAA motifs 
in the 1 kb promoter region and may therefore be positively regulated by a GATA 
TF. To determine whether the C. elegans ELT-2 GATA TF can control H. 
contortus gut gene expression, elt-2 RNAi of the Hc-AC-2::lac-Z transgenic strain 
was carried out using the RNAi feeding method (Chapter 2.1.5). Any decrease in 
Lac-Z expression was then examined visually. RNAi of elt-2 in the Hc-AC-2 
promoter strain shows reduced expression, in most worms staining of Lac-Z was 
absent or only in 1-2 gut cells (Figure 5.7 panel C and D). This is in contrast to 
worms fed on L4440 control plasmid where approximately 85% showed 
expression throughout the gut. Attempts were made to quantify Lac-Z expression 
by RT-PCR but this proved difficult. 
5.2.1.3 RNAi of Ce-elt-2 in C. elegans Ce-cpl-1::gfp transgenic worm strain 
The C. elegans transgenic worm strain containing the H. contortus AC-2 
promoter exhibited mosaicism between individual worms. In addition, no GFP 
expression was detected and therefore analysis of living worms was not possible. 
Significant work has been carried out examining cpl-1 gene expression in both C. 
elegans and H. contortus (Britton and Murray, 2002). This is a cathepsin L-like 
cysteine protease gene that is required for embryonic development and 
accumulates in the adult C. elegans gut with some additional expression in the 
hypodermal cells. Hashmi et al., (2002) generated a Ce-cpl-1 reporter construct 
containing 1.7 kb of promoter sequence in Fire vector pPD95.75 (Fire et al., 
1990), that was co-injected with an unc-76 rescue plasmid to generate a 
transgenic C. elegans worm line. This C. elegans cpl-1 promoter::gfp strain was 
used to determine whether Ce-elt-2 RNAi could cause a clear reduction in GFP 
expression. elt-2 RNAi feeding of L3/L4 stage transgenic larvae was carried out 
as described for the H. contortus AC-2 reporter strain (Section 5.2.1.2). This 
resulted in significant reduction or complete loss of gfp in gut cells, in contrast 
to worms fed control plasmid (Figure 5.8 panels A and B). This confirmed that 
ELT-2 GATA TF is required for cpl-1 expression in C. elegans gut cells. GFP 
expression could still be observed in hypodermal cells, particularly in larval 
stages, suggesting involvement of another TF, possibly GATA-3 (Spieth et al., 
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1991). This also confirmed a specific effect of elt-2 RNAi in gut cells and not just 
a general reduction in gene expression. 
5.2.1.4 Generating an integrated C. elegans cpl-1::gfp strain as a drug 
screening tool 
The specific and significant effect of Ce-elt-2 RNAi on the C. elegans cpl-1::gfp 
strain as well as the ease of working with live GFP expressing worms indicated 
that this strain would be useful for screening compounds as potential inhibitors 
of ELT-2 function and testing for a decrease in GFP level (Chapter 6). This 
transgenic strain has a transmission rate of approximately 70% and therefore to 
make expression studies easier an integrated line was developed (Chapter 
2.1.4). After integration, the transgene was present in 100% of the worms and 
strong GFP fluorescence was visible in the gut and hypodermal cells (Figure 5.8 
panels C and D). To ensure that the Ce-cpl-1 insert was still present in the 
integrated strain (named CLB01), single worm lysis PCR was carried out on both 
the integrated strain and on wild-type worms as a control. Gene specific and 
vector specific primers were used (Primers in Appendix 2 Table 5.2). All the 
integrated worms produced specific bands with both sets of primers, while wild-
type worms only produced a band with the gene specific primers, indicating that 
all integrated worms carried the transgene. This integrated C. elegans cpl-1::gfp 
strain could then be used in drug screening assays (Chapter 6). 
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Figure 5.8 Effect of elt-2 RNAi on C. elegans cpl-1::gfp promoter and C. elegans CLB01 
worm strain with GFP staining in the gut and hypodermal cells  
(A) Adult worm indicating GFP expression in gut cells and faint hypodermal expression. (B) Adult 
worm 3 days after L4 exposed to elt-2 RNAi feeding. Image indicates hypodermal GFP expression 
(white arrows) and loss of gut GFP expression. Both images are shown at x40 magnification. (C 
and D) Larval and adult stages of the CLB01 (cpl-1::gfp) integrated strain indicating GFP 
expression. Larval stages contain both hypodermal and gut GFP expression, whereas adult worms 
show mainly gut expression. Both C and D at x10 magnification.   
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Chapter 5                                                                                                                                        144   
5.3 Discussion 
The aim of this chapter was to examine the regulation of gut gene expression in 
H. contortus using both bioinformatic and practical analysis. Prior to this, only 
limited analysis of selected H. contortus promoter regions had been carried out. 
However, with the availability of genome data combined with gene annotation, 
it is now possible to examine and compare promoter sequences for any 
conserved patterns. 
Hawkins and McGhee (1995) identified that GATA TFs are important for the 
regulation of gut genes in C. elegans and more recent work by Couthier et al., 
(2004) suggested that the same may be true in H. contortus. Bioinformatic 
analysis of the H. contortus gut gene promoters carried out here identified an 
abundance of GATA motifs in the 1 kb promoter region, with some genes having 
up to seven GATA motifs. Interestingly however, there does not appear to be any 
correlation between number of GATA motifs and gene expression. For example, 
sj04 with seven motifs has 72 associated ESTs and sj06 also with seven motifs has 
only 6 associated ESTs. This finding is perhaps not surprising as examination of 
the promoter regions of C. elegans genes, Ce-pho-1 (Fukushige et al., 2005) and 
Ce-cpr-1 (Britton et al., 1998), identified that where a number of GATA motifs 
were present in the upstream region, deletion studies identified that only one of 
these motifs was essential for gene expression. The current work raised the 
possibility that positioning of GATA motifs (and possibly E box motifs) relative to 
one another may influence level of expression. 
Numerous studies examining the expression of parasite genes and gene 
promoters in C. elegans have concluded that they are functional and useful for 
comparative genomics (Britton et al., 1999;Gomez-Escobar et al., 2002;Kwa et 
al., 1995). While C. elegans promoter-reporter constructs most often produce 
robust expression, consistent in the majority of transgenic worms, parasite 
promoters expressed in C. elegans have been found to be expressed at lower 
levels. This most likely reflects lack of complete conservation of transcription 
factors and motifs across nematode species and while heterologous expression is 
possible, it may not be optimal. In this study, Lac-Z staining was required to 
detect any expression from the Hc-AC-2 promoter construct, which is more 
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sensitive than GFP visualisation. However, Lac-Z staining results in worm losses 
throughout the process and also requires fixation and therefore death of the 
worms. In contrast, the C. elegans CLB01 cpl-1 promoter::gfp integrated strain 
generated in this work expresses GFP strongly in all worms, making subsequent 
RNAi or drug treatment assays easier and more reliable. 
Studies aimed at using C. elegans elt-2 RNAi to examine whether H. contortus 
AC-2 is regulated by the ELT-2 GATA TF produced variable results which were 
difficult to reliably quantify. An alternative approach was also taken to examine 
Hc-AC-2 regulation. This made use of a construct termed pAC9 (Couthier et al., 
2004), consisting of a Hc-elt-2 cDNA clone inserted downstream of hsp16-2 heat 
shock promoter, in vector pPD49.78 (Fire et al., 1990). This worm strain has the 
ability to over-express Hc-elt-2 after heat shock at 33.5OC for 2 hours. The pAC9 
construct was injected into the Hc-AC-2 promoter transgenic C. elegans worms 
(Section 5.2.2.1) together with myo-2::gfp pharyngeal marker. Positive lines 
were obtained and were exposed to the heat shock process to determine if any 
increase in Hc-AC-2 expression could be observed, which would demonstrate 
that the Hc-AC-2 promoter is regulated by the ELT-2 GATA TF. Unfortunately no 
increase in gene expression occurred. This finding could be due to there already 
being a high level of elt-2 in the transgenic worms and therefore even with 
increased elt-2, no enhanced expression occurs.  
RNAi of C. elegans elt-2 was carried out using both the feeding and soaking 
method. Of the two approaches, feeding produced the most reliable reduction of 
C. elegans cpl-1::gfp expression. This could be due to worms not being as 
healthy while exposed to dsRNA in liquid and also to the shorter exposure time 
which could be applied due to worms starving after an extended period. In C. 
elegans ELT-2 is required for gut development (Fukushige et al., 1998). As 
previously indicated, the ELT-2 GATA TF has been identified as important for the 
study of gene expression in both C. elegans and H. contortus (Geldhof et al., 
2006). elt-2 is required for gut development and thus removal of this results in 
worms that are smaller and starved. As noted by the RNAi results, elt-2 RNAi 
efficacy varies depending on the stage of the worm. It was identified that initial 
exposure of worms at the L1-L3 stages, show the greatest elt-2 RNAi effect. This 
is in comparison to testing L4 and adult stages in which the RNAi effect was less 
severe. The reasoning for this may be due to the requirement of elt-2 for gut 
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differentiation (Fukushige et al., 1998) and it is also the main TF regulating 
expression of functional gut genes during larval development (McGhee et al., 
2007). In the work carried out here, more reliable reduction of Ce-cpl-1::gfp 
could be monitored by using transgenic worms at the L3/L4 stage in RNAi feeding 
assays. In these worms gut formation as well as expression of gut genes have 
already occurred and healthy worms develop. In contrast, when embryos or L1-
L3 stage larvae were applied to elt-2 RNAi plates, abnormal, smaller and starved 
worms were observed and monitoring of cpl-1::gfp expression was difficult. 
Therefore interfering with elt-2 activity in early development has a significant 
detrimental effect on gut function. If the same is true in parasitic species, 
targeting ELT-2 is likely to have severe consequences. 
Another putative role of elt-2 is in the C. elegans immune response to bacteria. 
Reece-Hoyes et al., (2005) identified 934 TF genes in the C. elegans genome and 
applied strict criteria to this list to identify those thought to be important in 
immunity. ELT-2 was one of the five identified and experimental work indicated 
a decrease in immunity after elt-2 RNAi. As elt-2 is required for normal 
intestinal differentiation it was important to determine that the observed results 
were not due to the intestinal effect of the elt-2 RNAi. An immune effect was 
confirmed and therefore elt-2 ablation is a realistic target for the control of 
nematode worms, both through an increased susceptibility to bacteria and due 
to a decrease in intestinal growth and development.   
In conclusion, bioinformatic analysis of parasite gut gene promoters has 
identified that GATA motifs are over-represented in the 1 kb upstream region. 
This feature may be significant as previous work by Britton et al., (1999) has 
identified that gene expression can be abolished with the removal of these 
motifs. Additionally, it was demonstrated that expression of gut gene promoter-
reporter constructs can be reduced by Ce-elt-2 RNAi. The ability to interfere 
with gut development and gut gene expression is useful for future parasite 
control as compounds that have the same effect as elt-2 RNAi may provide an 
alternative to current parasite control methods.   
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6.1 Introduction 
The increasing problem of anthelmintic resistance has led to the requirement for 
new effective anthelmintic drugs. Traditional anthelmintic drug discovery 
methods have relied on whole parasite screening. This method of screening 
involves testing a number of compounds against whole parasites to identify 
active compounds and subsequently identifying the target (Geary et al., 2004). 
For parasitic nematodes, whole organism based screening has the advantage of 
only focussing on compounds taken up by the parasite. The three main classes of 
current anthelmintic drugs, as well as the amino-acetonitrile derivatives (AADs), 
were discovered using this approach and their mechanism of action subsequently 
identified using C. elegans. The use of model organisms in chemical screening 
relies on the presumption that there will be high biological conservation 
between the model organism and the parasite of interest. C. elegans has been 
used as a model to identify not only anthelmintic targets but also resistance 
mechanisms in parasitic species, focusing on molecules conserved between this 
organism and the parasite (Gilleard et al., 2005). For example, the macrocyclic 
lactones were shown to affect glutamate-gated chloride channels, causing 
paralysis of the nematode due to an increased permeability of the muscle to Cl-. 
Work using C. elegans enabled the protein structure to be used to identify the 
inter-species conservation of motifs in the ligand-gated ion channels (Cully et 
al., 1996). Another advantage of using C. elegans is the ease of generating 
mutants to allow identification of the mode of action for drugs. For example 
AAD-resistant C. elegans mutants were generated using ethane methyl 
sulphonate (EMS) mutagenesis (Kaminsky et al., 2008b). Of the 44 AAD-resistant 
mutants studied, 36 had mutations within the acr-17 and acr-23 genes. These 
genes belong to the DEG-3 nAChR subgroup and this work resulted in 
identification of the possible mechanism of action for the AADs (Kaminsky et al., 
2008a).  
More recently, for human drug discovery, cell screening methods have been 
replaced with mechanism based approaches in an attempt to identify compounds 
interacting with specific targets. The shift to mechanism based screening allows 
chemists to use structural information on the target to identify novel drugs, 
where the target is already identified (Woods and Williams, 2007). However this 
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requires a significant amount of work to identify appropriate targets and purify 
these in sufficient amounts for high throughput screen. 
Previously, screening compounds for human diseases has also relied on non-
targeted methods. For example Tamoxifen, the commonly used breast cancer 
drug which binds to oestrogen receptors, was discovered in the 1960s by the 
traditional screening method of testing a number of compounds against the 
disease of interest. It was first identified in a screen designed for new 
contraceptive drug discovery, however further insight into its mechanism of 
action identified it as being an effective anti-cancer drug (Jordan, 2003). Many 
drugs were initially identified in this way, because of their biological effects in 
certain screens. In many cases it was not until after their discovery that the 
mechanism of action and specific effects was identified (Latchman, 2000). 
Targeted screening has the potential advantage of designing drugs to specifically 
act on disease-associated molecules.  
There are a number of key requirements when developing new anthelmintic 
drugs; they must have broad-spectrum activity, be inexpensive to manufacture, 
safe and easy to dose, and for livestock, have short withdrawal periods (Lanusse 
and Prichard, 1993). Additionally, anthelmintic drugs must be toxic solely to the 
parasite and not interfere with host function. The identification of new 
anthelmintic targets will be dependent upon the parasite having a higher 
susceptibility to the drug, or drug being more concentrated in the parasite 
target area than the host (Geary et al., 1999). 
Large scale screening is routinely carried out in industrial environments. The 
majority of the experimental work for this chapter was carried out at Pfizer in 
Kalamazoo, Michigan. Small molecule compounds available for screening at 
Pfizer are located in the RGate database. This is an internal company database 
that contains approximately 3 million compounds. It provides information about 
the structure of each compound, any screens on humans or parasites that have 
previously been carried out and the results of experimental work. Screening is 
regularly carried out on a number of parasites including H. contortus L3 larvae. 
This parasite is widely used for anthelmintic screening as it is available relatively 
cheaply, in bulk and L3 stage H. contortus can be stored for several months. At 
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Pfizer, screening with C. elegans is less favoured as the data does not always 
correlate well with activity against parasitic nematodes. 
Transcription factors have been identified as potential drug targets, for example 
of anti-asthma drugs. Asthma is a chronic disease, characterized by increased 
expression of cytokines which in turn causes the increased activation of 
downstream TFs. The resulting effect of this TF stimulation is the increased 
expression of inflammatory genes (Adcock and Caramori, 2001). Corticosteriods 
are commonly used in anti-asthma therapy and act through TF inhibition (Barnes 
and Adcock, 1998). An aim of the current work was to determine whether it is 
possible to interfere with gut gene expression in nematodes in this way. Previous 
work identified that GATA TFs are important in the regulation of gut gene 
expression in C. elegans (Hawkins and McGhee, 1995).  
In this project, families of H. contortus protease genes potentially regulated by 
GATA motifs and expressed in the gut have been identified. A number of studies 
in C. elegans led to the identification of the ELT-2 GATA TF. Subsequent work 
has shown that elt-2 displays gut-specific expression with the ELT-2 protein 
being present in the nuclei of all gut cells. Additionally, it was shown that loss of 
elt-2 function is lethal in embryos and early larvae due to intestinal 
malformation (Fukushige et al., 1998). For this reason, targeting the ELT-2 GATA 
TF could potentially affect the expression of gut genes affecting gut 
development and function. The integrated transgenic C. elegans strain (CLB01) 
expresses GFP under the control of the C. elegans cpl-1 promoter and directs 
fluorescence in the gut and hypodermal cells. RNAi of Ce-elt-2 (Chapter 5) 
suggested that this promoter is controlled by the ELT-2 GATA TF and thus GFP 
fluorescence from this reporter construct can be used as a marker of ELT-2 TF 
activity. 
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The main aims of this chapter were to;  
• Generate an in vitro assay to screen compounds using the integrated 
CLB01 transgenic C. elegans worm strain. 
• Identify compounds that interfere with gut gene expression and 
potentially target the ELT-2 GATA transcription factor in C. elegans 
worms. 
• Screen compounds in H. contortus and look for effects on parasite survival 
and motility, as well as characterise the specific effects of identified 
compounds. 
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6.2 Results 
6.2.1 Determining the conditions required for screening C. 
elegans worms  
Initial drug screening was carried out at Pfizer, Kalamazoo, Michigan, using C. 
elegans worms in liquid medium in multi-well plates. As C. elegans is not 
routinely used by Pfizer for screening, all parameters had to be optimised. These 
included, sample volume, volume of OP50 bacteria food source, number of 
worms and concentration of DMSO, as each can influence the measurements 
recorded and worm viability. The initial sections of this chapter describe work 
required to establish a suitable assay. 
The CLB01 C. elegans worms show green fluorescence in gut and hypodermal 
cells. Prior to this work the level of fluorescence had not been measured. The 
EnVision 2103 Multilabel Reader was used to measure fluorescence levels. A 
blacked out 96 well plate was used for sampling to block out external light. 
Fluorescence readings were measured from the top of the wells as there was no 
plastic surface to penetrate. The settings used for the EnVision programme 
were; excitation filter FITC 485, emission filter FITC 535, a measurement height 
of 2 mm, excitation light of 5% and a detector gain of 10%.  
The first fluorescence reading of CLB01 worms in 200 µl of M9 buffer was 
recorded. This however was an excessive final volume and resulted in the worms 
being more dispersed, within individual wells, resulting in inaccurate readings. 
100 µl of CLB01 worms that were mixed stage and healthy, in M9 buffer, were 
then tested. As this was a more workable sample volume the readings should be 
more consistent and accurate. This sample condition was compared to: 100 µl of 
N2 worms that were mixed stage and healthy in M9 buffer, 100 µl of OP50 alone 
and 100 µl of M9 buffer alone. From these first samples the wells containing 
CLB01 worms gave higher readings than two of the other conditions. 
Unexpectedly high readings were observed for the OP50 wells with the 
fluorescence reading much higher than that for the wells containing CLB01 
worms. 
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To determine if the initial results observed were reliable, a 50 µl sample from a 
100 µl well containing the CLB01 worms was transferred to a different well. M9 
buffer was added to a total volume of 100 µl in each well and 5 µl of OP50 added 
only to the second well. The fluorescence reading in the original well decreased 
as expected. In the sample well containing OP50, the fluorescence reading was 
much higher than for the GFP worms alone, indicating that the fluorescence 
observed from the CLB01 worms was completely overpowered by the OP50. 
As the results for the drug screening were to be recorded using the fluorescence 
readings produced by the CLB01 worms, it was imperative that the OP50 did not 
interfere with this reading. For this reason it was necessary to identify a 
concentration of OP50 that did not interfere with the fluorescence reading but 
still provided enough food for the C. elegans worms to remain as healthy as 
possible for the duration of the screen.  
6.2.2 Determining the optimum OP50 concentration for 
compound screening 
As previously identified, the OP50 bacteria produced a fluorescence reading that 
interfered with the fluorescence readings from the CLB01 worms. It is not ideal 
to leave the CLB01 worms in the wells with no food for the duration of the 
screen thus a workable concentration was required.  
A concentration gradient of OP50 was performed to identify the highest 
concentration of OP50 that could be added to each well without interfering with 
the fluorescence readings. Ten different concentrations of OP50 overnight 
culture in 100 µl M9 buffer were analyzed using EnVision and were compared to 
wells containing M9 buffer with no bacteria added as a control. The 
concentrations tested were; 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% and 
0.0001%. As expected the fluorescence level decreased with decreasing 
concentration of OP50 until a point at which it levelled off. This is the baseline 
fluorescence level and will not interfere with the readings from CLB01 worms.  
Fluorescence readings were taken every hour for a period of 18 hours to identify 
if there was any change in the concentration of OP50 over time. From the 
results, there did not appear to be any significant change in concentration in 
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each well over time (results not shown). This confirms that there was no risk of 
the OP50 concentration increasing during screens and distorting the readings. An 
average of the readings at each concentration over the 18 hour period was taken 
to give the level of fluorescence at each concentration (Figure 6.1). 
Below a concentration of 0.5% OP50 the fluorescence level appeared to remain 
fairly constant and the fluorescence reading is the same as that observed in the 
control wells, containing M9 buffer and no OP50. At these lower concentrations 
the OP50 does not interfere with CLB01 fluorescence levels and a 0.1% OP50 
concentration was therefore selected for use in subsequent screens.    
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Figure 6.1 Average fluorescence readings at different OP50 concentrations  
OP50 concentrations are shown as percentages. Graph indicates the decrease in fluorescence 
reading with deceasing concentration of OP50. 
6.2.3 A test screen using C. elegans to identify optimum 
conditions 
An initial screen of CLB01 worms was set up to run over a period of four days. 
Fluorescence readings were taken every hour. Six wells were sampled at each 
condition so as to have enough data to allow for individual well variability and 
obtain a reliable average. The final volume in each well was 100 µl and the 
concentration of OP50 was 0.1%, conditions identified from the OP50 gradient. 
The test wells contained: CLB01 worms in M9 buffer and OP50; CLB01 worms in 
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M9 buffer; OP50 in M9 buffer; N2 worms in M9 buffer and OP50; N2 worms in M9 
buffer; and M9 buffer alone (Figure 6.2). In the 96 well plate, the six wells in the 
middle of each row were used for the samples as it was unknown what the level 
of evaporation would be throughout the test period. There was expected to be 
some degree of evaporation, therefore using wells in the centre of the plate and 
filling the rest of the wells with M9 buffer aimed to combat this.  
Taking the precaution to put the samples in the centre of the plate made no 
difference and evaporation occurred. During the entirety of the screen the plate 
was left in a darkened chamber, with no lid, inside the EnVision as opposed to it 
being brought out and the lid replaced after each hourly read. Evaporation was 
hoped to be at a minimum but on analysis of the plate at the end of the screen, 
evaporation had occurred in all the wells on the right hand side of the plate, 
possibly due to an uneven temperature distribution within the EnVision.  
 
Figure 6.2 Diagrammatic representation of the preliminary sample plate  
The different conditions are indicated. Samples were situated in the centre of the plate to try to 
minimize evaporation. M9 buffer was added to the remaining wells to also minimise evaporation. 
Wells in which there is an ‘X’ are those that had evaporated by the end of the screen. 
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Due to the evaporation, six readings per sample were not obtained for the entire 
screen period. It was possible to determine approximately when the plates dried 
up looking at the results. For this reason however only results for two or three 
wells were obtained for analysis of the samples. For subsequent assays, the 
plates were removed from the Envision and the lids replaced after every 
reading, thus minimising evaporation.  
Upon examination of the worms at the end of the sample period, both those 
with and without OP50 looked starved. This could be due to incubating the 
worms for a long period of time (4 days), but even with food the worms may not 
have been feeding as well as on bacterial seeded plates. There was however still 
some fluorescence under the GFP microscope at the end of the screen period. 
The adults showed no fluorescence but there was very faint gut fluorescence in 
some of the larvae and a number of the larvae also exhibited a degree of 
hypodermal expression. Although there was a decrease in fluorescence in worms 
kept under both conditions, fluorescence levels appeared slightly brighter in 
worms that had been fed on OP50. 
As expected the CLB01 worms showed a higher level of fluorescence when 
compared to wild-type worms. There was no measurable difference between the 
level of fluorescence in the wells with and without OP50. This indicated that the 
readings from the CLB01 worms in wells with OP50 were from the worms alone 
and that there was no background from the OP50. There was a degree of 
fluorescence expressed from the wild-type worms which was slightly higher than 
expected. This could be due to the presence of OP50 within the gut of the 
worms producing some fluorescence and giving a reading. Additionally there 
were more wild-type worms in the wells than CLB01 worms which could also 
explain the slight increase in fluorescence. Efforts were made to ensure similar 
worm numbers in any future samples. From these results it was concluded that 
wild-type worms produce a fluorescence reading at a low level. Wild-type values 
can be used as a baseline and anything above this can be taken as the actual 
level of fluorescence from the CLB01 worms (Figure 6.3). 
Initially it was presumed that the level of fluorescence would decrease over 
time, especially if the worms became less viable. This however was not the case 
Chapter 6                                                                                                                                        157   
and the level of fluorescence remained fairly constant throughout the screen 
period of 4 days.    
Analysis of the results from the first screen enabled a fluorescence range for 
each different sample condition and also the average reading to be identified 
(Table 6.1). The average of the two CLB01 sample conditions without OP50 in 
the wells gave the higher reads. This is not thought to be significant as there will 
be a certain degree of variation between worms, which in turn will result in 
variation between wells.  
Looking at the readings from the first test screen, CLB01 worms in OP50 had a 
minimum reading of 184,937 and a maximum reading of 349,969 (as shown in 
Table 6.1). The average reading for CLB01 worms in OP50 was 289,354 and was 
used as the approximate level of fluorescence to aim for in sample wells during 
the screening of compounds.  
The Z’ factor, a measure of assay quality and robustness, was calculated from 
the mean and standard deviation of the CLB01 and OP50 (positive) and N2 and 
OP50 (negative) samples. Z’=1-((3x(σp+σn))÷(µp-µn)) where σ is standard 
deviation, µ is the mean and p and n are positive and negative controls. The Z’ 
for the first 24 hours of this assay is 0.52, values of 0.5-0.7 indicate a high 
quality assay (Gosai et al., 2010). 
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Figure 6.3 Fluorescence readings in different sample conditions in a preliminary screen in 
the absence of compounds  
Graph indicates the difference in the level of fluorescence reading over the 4 day sample period for 
the three main conditions indicated. n = 2 for each time point for each treatment. 
Fluorescence at 535 nm Sample type 
Minimum Maximum Average 
CLB01, OP50, M9 184,937 349,969 289,354 
CLB01 in M9 244,005 352,777 303,577 
OP50 in M9 75,911 105,617 94,932 
N2, OP50, M9 122,561 210,671 161,933 
N2 in M9 137,513 236,179 188,391 
 
Table 6.1 Analysis of the fluorescence levels from the preliminary 4 day test screen  
Minimum, maximum and the average reading were taken from the wells over the complete period. 
6.2.4 Determining the number of CLB01 worms required per 
sample well 
Analysis of worms grown on 10 cm NGM agar plates seeded with OP50 identified 
that worms left for approximately 6-7 days at 19OC and 60% relative humidity, 
appear to be at the optimum health for use. At this time point, worms had 
grown well and were not starved, but there was very little OP50 remaining to 
contaminate the screen. The worms on one 10 cm agar plate were washed off 
using M9 buffer and a number of different volumes of worms in M9 buffer were 
added to different wells to give a variation in worm density and their 
fluorescence levels measured. Due to fluorescence from OP50, it was necessary 
to use only clean worms with no OP50 contamination. 
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One well that had a number of mixed stage worms and no OP50 contamination 
gave a reading of 429,360, much higher than had previously been observed, but 
the worm number in the well was large, approximately 200 adult worms. In 
comparison, a well with slightly less worms but OP50 contamination gave a 
reading of 406,984 indicating that OP50 contamination had affected this reading. 
The worms in the clean well were split between two wells and gave readings of 
269,254 and 279,435, with similar numbers of worms in each. The adult worm 
number in each well was counted, showing an average of 68 in the first well and 
81 in the second (Figure 6.4). It was therefore aimed to add approximately this 
number of adult worms to each well. In addition to adult worms, a number of 
larvae (~100) were present in each well and although these did fluoresce, levels 
were lower than the adult stage. 
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Figure 6.4 CLB01 worms in sample wells at 2x magnification  
The first image contains approximately 68 adult worms per well and the second 81 adult worms per 
well. Wells contain all stages of the CLB01 worms. 
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6.2.5 Determining the concentration of DMSO acceptable for 
screening 
DMSO is stored as a liquid at approximately 100% and is used to solubilise the 
compounds used for screening. A DMSO curve was set up at seven different 
concentrations (10%, 5%, 2%, 1%, 0.5%, 0.1% and 0.05%) to determine an 
appropriate concentration that will not kill the worms or interfere with the 
results of the screens. Solutions of DMSO were made at 5x the above 
concentrations and 20 µl of each added to 80 µl of CLB01 worms, OP50 and M9 
buffer, giving a final volume of 100 µl. Sample wells containing DMSO at 
different concentrations were left for 24 hours and the results analyzed at the 
end of this period.  
By manual microscopic examination, there did not appear to be a noticeable 
difference in the level of fluorescence over the first 24 hour period of exposure 
to DMSO. Similarly the fluorescence readings from the EnVision supported this 
observation. For this reason the percentage death in each well was recorded to 
estimate an acceptable DMSO concentration that could be used for sampling. 
Figure 6.5 indicates that at high DMSO concentrations (10, 5 and 2%) there was 
100% lethality. At 1% DMSO there is 75% lethality, which is too high for sampling. 
There is observed death at 0.5% but this is at a low level, thus for this reason 
anything below 0.5% DMSO would be an acceptable concentration to use for 
sampling. Similarly the 5% lethality observed at 0.1 and 0.05% could be 
attributed to natural death.  
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Figure 6.5 Percentage death of CLB01 worms at different concentrations of DMSO  
Death was estimated from the number of immotile worms identified microscopically after 24 hour 
exposure to DMSO. n = 4 wells at each concentration. 
6.2.6 ELT-2 RNAi as a control to confirm that a decrease in 
fluorescence will be measurable 
The level of fluorescence recorded in the initial 4 day screen using the EnVision 
did not show a decrease over the test period. Thus, a control was required to 
confirm that if fluorescence in the worms decreased, this could be identified by 
the EnVision readings.  
elt-2 RNAi was previously carried out on CLB01 worms by feeding on the ELT-2 
dsRNA expressing bacterial clone, available from the RNAi library (Kamath and 
Ahringer, 2003). A similar RNAi screen was carried out, but instead of bacterial 
feeding, the ELT-2 RNAi bacterial clone was added to the sample wells. 
A three day RNAi screen was carried out on CLB01 worms using the same 
conditions as when fed on OP50 bacteria. Readings were taken every hour and a 
reduction in fluorescence was expected if the RNAi had been successful. At the 
end of the test period the fluorescence level in the wells with CLB01 worms fed 
on elt-2 dsRNA expressing bacteria had not decreased (results not shown). The 
reason for this is likely to be because the worms were not feeding well when in 
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liquid and thus no RNAi effect was observed. Therefore it was examined whether 
CLB01 worms fed on elt-2 dsRNA expressing bacteria on agar plates produced a 
measurable decrease in fluorescence. 
A number of plates were seeded with bacteria to obtain a large enough worm 
number to sample. Initially (Day 0) worms were washed from an OP50 seeded 
plate, put into wells and the fluorescence level measured to give a baseline. On 
days one, two and three this was repeated and RNAi fluorescence readings 
obtained. As readings for worms maintained on plates were not taken 
automatically, it was not practical to obtain an hourly reading, however taking a 
reading every day would give an indicator of what reduction can be expected 
over a period of three days. In all of the sample wells there was a degree of 
bacterial contamination, especially with the day one sample where there was 
still some bacteria on the plates when worms were washed off. As with all 
samples, the worms were washed and the majority of the bacteria removed 
before sampling with the EnVision. 
On each day, six wells containing worms were measured for level of 
fluorescence. The average value for the six wells of CLB01 worms grown on 
standard OP50 plates was used as a baseline for maximum fluorescence. 
Similarly readings for six wells containing wild-type worms were used to indicate 
the background reading that is observed from wild-type worms.  
The results of the RNAi confirmed that a decrease in fluorescence is measurable 
by the EnVision. The readings on days two and three confirmed that the 
decrease in fluorescence is significant (p<0.05) compared to day 0. There was a 
decrease after one day on the RNAi plates but the most significant decrease was 
between the readings taken on day one and day two. After this time point the 
readings levelled off and no further decrease was observed (Figure 6.6). 
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Figure 6.6 Level of fluorescence of CLB01 worms before and during feeding with bacteria 
expressing C. elegans elt-2 dsRNA 
Shown are fluorescence levels of N2 worms fed on OP50 as a baseline reading for worms with no 
GFP fluorescence. Student’s t-test used to determine if the results are significant. The readings on 
Day 2 and 3 confirm that the decrease in fluorescence is significant (p<0.05) compared to Day 0 
(mean +STDEV and n = 6). 
6.2.7 Compound selection for use in C. elegans  
This study was designed to screen for compounds potentially interfering with C. 
elegans ELT-2 GATA transcription factor activity, indicated by a decrease in GFP 
levels. Therefore compounds which had previously shown detrimental effects on 
mammalian transcription factor activity were identified in the Pfizer drug 
database. Compounds are available in either liquid or powder form and can be 
grouped by selecting for different criteria. The mammalian Inhibitory 
Concentration resulting in half maximum activity (IC50) is one criteria that was 
used in the selection of compounds for screening. Compounds that are active at 
workable concentrations were identified. Ideally compounds that are active at 
concentrations below 1 µM were desired as it was an indicator of compound 
potency. Initial searches did not identify a large number of compounds matching 
these criteria, thus the search was widened to include compounds that had an 
IC50 between 1 (classified as high-medium potency) and 10 µM (classified as 
medium-low potency). Overall 594 compounds were selected based on the above 
criteria.  
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As the compounds identified showed high potency in mammalian species, there 
will be no selectivity for C. elegans. However potent compounds can be used to 
carry out searches to find structurally similar compounds that may have the 
same action, but are less potent for mammalian species. 
6.2.8 Initial compound screen and analysis of effects 
An initial drug screen was carried out on 22 compounds that were identified as 
being active below 1 µM in an RGate search. Due to the small number of 
compounds requested they were ordered in powder form and dissolved in DMSO, 
to produce a stock concentration of 30 mM. One well was sampled for each 
compound, with any of interest being looked at subsequently in duplicate. Each 
well consisted of 97 µl of CLB01 worms in M9 buffer, 1 µl diluted OP50 (giving a 
final 0.1% concentration) and 2 µl of 1/10 dilution of compound (final 
concentration 60 µM). One well containing 0.2% DMSO, CLB01 worms, but no 
compound and one well containing worms in M9 buffer alone were used as 
controls. The plates remained stacked in the EnVision at room temperature for 
the duration of the screen and fluorescence readings taken every hour. 
Ideally a stock concentration of 10 mM would be obtained for the compounds. 
This concentration would ensure that the compounds were fully dissolved. 
However due to the low tolerance of C. elegans to DMSO a higher stock 
concentration of compound is required to ensure as high a sample concentration 
of compound as possible. This high stock concentration resulted in a number of 
compounds coming out of solution, looking cloudy or being very viscous, which 
was unavoidable.  
For this first screen, fluorescence was measured in the wells containing CLB01 
worms before the compounds were added and showed fluorescence readings 
within the desired range (results not shown). After addition of the compounds, a 
number of the wells showed a very high level of fluorescence; this was presumed 
to be due to fluorescence from the compounds themselves. Readings were taken 
of the compounds in M9 buffer alone to confirm that some compounds did 
fluoresce. The fluorescent nature of some of the compounds was not ideal, 
however those compounds that did fluoresce could be easily identified both by 
the high fluorescence reading from the EnVision and visually with a GFP 
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microscope (Table 6.2). The level of fluorescence of the compounds in M9 buffer 
without any worms was recorded every hour over a 48 hour period, and found 
not to change over this time. This ensured that any change in fluorescence 
would be specific to the worms rather than the compound. For compounds that 
fluoresce highly, initial readings were taken into consideration when analyzing 
the results.  
Compound Compound 
fluorescence 
alone 
Fluorescence 
observed visually 
Compound & 
worm 
fluorescence 
1/1 78,883 N 300,166 
1/2 84,575 N 289,881 
1/3 146,833 N 224,950 
1/4 261,845 Y 309,226 
1/5 5187,040 Y 6515,069 
1/6  374,127 N 504,552 
1/7 1,090,288 Y 1,005,947 
1/8 82,901 N 220,632 
1/9 170,919 N 357,594 
1/10 519,384 Y 500,586 
1/11 78,256 N 172,914 
1/12 73,873 N 183,003 
1/13 78,458 N 308,301 
1/14 1,003,763 Y 578,885 
1/15 451,747 Y 498,798 
1/16 114,333 N 249,902 
1/17 78,185 N 289,399 
1/18 139,365 N 197,360 
1/19 102,940 N 188,531 
1/20 160,637 Y 474,812 
1/21 90,842 N 226,095 
1/22 68,437 N 245,506 
0.2% DMSO 86,318 N 166,331 
M9 buffer 84,516 N 192,504 
 
Table 6.2 Analysis of the 22 compounds used in the first compound screen  
Values indicated for the compounds alone and with worms at 0 hours (measured by the EnVision), 
compared to visual analysis. Fluorescence levels and visual analysis correlate in all compounds 
except for compound 1/20.  
Initial analysis after 24 hours indicated that for most wells, fluorescence levels 
remained fairly constant, although a few wells showed a slight decrease. 
Compound 1/20 showed a slightly larger decrease over the first 24 hours. This 
was one of the compounds showing visual fluorescence however, the reading 
from the compound alone was quite low (160,637). The first reading for CLB01 
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worms in this compound was 474,812, decreasing to 222,860 at 24 hours. This 
finding may or may not be important, but is worth noting at the 24 hour mark.  
After 48 hours of worm exposure to the compounds, there were a number of 
wells in which the worms showed a decrease in fluorescence by eye. Some 
decrease is to be expected due to the worms not being as healthy as they were 
at the beginning of the screen. To try and identify the potentially active 
compounds, combined analysis of the fluorescence readings and visual analysis 
of the worms microscopically would have to be taken in to consideration. Those 
compounds that showed a decrease in the level of fluorescence using the 
EnVision over the 48 hour screen period were compared to those wells in which 
the level of fluorescence identified using a fluorescence microscope decreased 
and additionally there was a significant level of death. One problem that distorts 
the results provided by the EnVision is the auto-fluorescence that occurs in some 
worms when they die. This auto-fluorescence appears to be restricted to adult 
worms and means that even if a compound does not show a decrease in the level 
of fluorescence recorded by the EnVision or shows a decrease and then an 
increase it may still be active as there may be auto-fluorescence. It is for this 
reason that visual analysis was also carried out. Conversely, during the DMSO 
screen there was no observed auto-fluorescence but worms died and continued 
to produce GFP fluorescence.  
Analysis of the results at the end of the first screen identified a few common 
factors. The 24 hour time point appeared to be important, as it was thought that 
by this point the largest decrease in fluorescence should have occurred. This 
presumption was made from analysis of the RNAi screen and identifying when a 
decrease in fluorescence was first observed (Figure 6.6). For a number of the 
compounds there is either a gradual decrease up until this point or a sharp 
decrease just before it. Post 24 hours the levels either increased, decreased or 
remained constant. Wells showing an increase were thought to be due to an 
increase in auto-fluorescence from the dead worms. Those that decreased were 
most likely due to a continuing drop in GFP expression and those that remained 
constant probably reflect both auto-fluorescence and GFP expression, these 
compounds may still target GFP expression however, GFP effects may be 
masked. A number of the compounds (1/7, 1/10, 1/15, 1/18 and 1/22) appeared 
to have no effect on the level of fluorescence and the early readings from the 
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EnVision remained fairly constant. Even if these compounds kill the worms, they 
are not affecting GFP levels. Compounds that appeared to be most effective at 
killing the worms include 1/7, 1/13, 1/15, 1/20, 1/21 and 1/22. Compounds 1/7, 
1/15 and 1/22 are included in both categories indicating that death does not 
appear to be related to loss of GFP expression. Compounds 1/13, 1/20 and 1/21 
were selected for further analysis as they have been identified as compounds 
that are effective at killing worms. 
Each of the three compounds demonstrated some decrease in fluorescence using 
EnVision over the first 24 hours suggesting an effect on gut GFP expression. 
Compound 1/13 did not show an obvious decrease in fluorescence level by eye. 
Compound 1/21 showed reduced fluorescence but this was not as convincing as 
the effects observed by compound 1/20. Therefore only compound 1/20 was 
examined in more detail. 
6.2.9 Large scale screening of compounds in C. elegans 
From this first screen there was a large volume of data gathered. This was 
manageable due to the small sample number. However, a quicker and more 
efficient method of identifying potentially active compounds was required for 
larger screens. Fluorescence readings for the initial screen were taken every 
hour which proved to be unnecessary and readings were therefore reduced to 
every two hours for subsequent screens. Plates remained stacked in the EnVision 
for the period of the screen and the lids replaced after each 2 hourly read. Only 
readings at 0, 24 and 48 hours were used to identify a decrease and those 
compounds that looked of interest at these three time points were analyzed in 
more detail over the full 48 hour period. Effects of these compounds were 
identified by their fluorescence reading in the EnVision, fluorescence by eye and 
also ability to kill the worms. Any compounds that were of interest in all cases 
could be looked at in more detail.  
The majority of the compounds used for large-scale screening were ordered as 
liquids due to the high number requested. There are a few disadvantages when 
ordering compounds as liquids, one being the significantly lower concentration 
that can be used for screening, due to constraints on the DMSO concentration 
which can be used. The liquids are supplied at a concentration of 4 mM in 100% 
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DMSO. To achieve a workable concentration of DMSO a volume of 0.5 µl of the 
compound in DMSO was added to give a final sample volume of 100 µl. Using the 
calculation  
(IC)(IV) = (FC)(FV) 
(initial concentration)(initial volume) = (final concentration)(final volume) 
results in a final compound concentration of 20 µM in each sample well. This is 
much lower than the 60 µM that can be achieved when using compounds from 
powder form. Secondly, a much lower compound volume is supplied, meaning 
less is available for further screening of compounds of interest. 
Combining the results of the initial screen and the large scale screen, of the 594 
compounds examined, 50% of these showed a decrease in fluorescence at the 24 
hour time point. After this, only 47% of these 50% were lower than the 0 hour 
reading at 48 hours. This was a very large number of compounds that could be 
potentially affecting fluorescence levels and for this reason the other methods 
of analysis (visual GFP observation and percentage death) were taken into 
consideration when selecting compounds for further analysis. Compounds that 
met all three criteria were identified and dose response curves generated. One 
of these, compound 1/20, was identified as potentially affecting gut gene 
expression in C. elegans and was therefore selected to study in more detail.  
6.2.10 Searching for compounds similar to those of interest 
Compound 1/20 that was identified as being of interest in the first screen was 
examined in more detail in RGate. A search was carried out to identify 
compounds with a similar structure, likely to have similar activity. Most drugs 
that work by the same mechanism of action are highly similar in their structural 
composition (McCracken and Lipkowitz, 1990) for this reason if compound 1/20 is 
acting on the desired target, compounds with a similar structure should also 
follow this pattern. A 90% structural similarity was used as the cut-off point. 
Compounds within the criteria were identified using the RGate computer 
programme, using parameters such as the number and position of different 
elements. If the activity observed by the first compound was real then these 
compounds should also have an effect. Ideally a Structure Activity Relationship 
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(SAR) should be observed, as adding or removing groups from the structure 
should have an effect on the potency or even render the compound inactive. 37 
compounds were identified as being structurally similar to compound 1/20 and 
ordered as powders, however only 31 were available for sampling. Compound 
1/20 was also added to this screen, but at an unknown location. 
6.2.11 Creating a dose response curve for compounds of 
interest 
Dose response curves were generated for all compounds of interest to determine 
a linear relationship and threshold level of drug. For those compounds that were 
supplied as powders the concentrations used for the curve were 60 µM, 20 µM, 6 
µM, 2 µM, 0.6 µM and 0.2 µM. When creating the curve, a 50x working 
concentration was made at each dilution, each well contained 97 µl of CLB01 
worms in M9 buffer, 2 µl of compound and 1 µl of OP50. 
For those compounds supplied as liquids, lower concentrations were used (20 
µM, 5 µM, 2 µM, 0.5 µM, 0.2 µM and 0.05 µM) and each well contained 98.5 µl of 
CLB01 worms in M9 buffer, 0.5 µl of compound and 1 µl of OP50. 
Dose response curves were calculated using the fluorescence readings at 24 and 
48 hours and expressing these as a percentage reduction of the 0 hour reading at 
different concentrations of each compound. Ideally a decrease in the percentage 
reduction as the concentration of the compound decreases should be observed. 
Values observed at the 48 hour point should be lower than those observed at 24 
hours. 
6.2.12 Screening and analysis of compounds of interest 
The compounds identified in the similarity search were screened and the results 
analysed. A number of the compounds showed a decrease in fluorescence 
reading over the period of the screen; compounds 2/2, 2/3, 2/4, 2/6, 2/7, 2/9, 
2/10, 2/12, 2/13, 2/15, 2/16, 2/17, 2/18, 2/20, 2/23 and 2/24 all had notable 
decreases in the fluorescence readings from the EnVision. The largest decrease 
was over the first 24 hours; after this point there was an increase in the reading 
in a number of the compounds. A slight increase is not thought to be of interest. 
On visual analysis there appeared to be a number of compounds that resulted in 
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lethality in addition to a decrease in fluorescence. These were; 2/4, 2/6, 2/7, 
2/8, 2/9, 2/10, 2/14, 2/27, 2/31 and 2/32. The fluorescence levels for those 
compounds which appear in both results (2/4, 2/6, 2/7, 2/9 and 2/10) are 
indicated in Figure 6.7. From the fluorescence data, compounds 2/4, 2/8 and 
2/9 closely follow the desired pattern of a decrease in fluorescence at 24 hours 
and also at 48 hours. Compound 2/7, although resulting in a slight increase in 
fluorescence reading at 48 hours, was selected for closer analysis as it looked to 
be effective at killing C. elegans worms. Compound 2/10 was interesting as the 
fluorescence reading throughout the screen period remained almost constant, 
however there was a higher initial reading which is why a decrease in 
fluorescence was identified. Observations by eye identified fluorescence from 
compound 2/10 and also auto-fluorescence in the wells which may have 
interfered with the readings. 
These compounds were used to create curves and determine a dose response. 
Compound 2/7 was identified by both the EnVision and by eye as having activity 
and it was later revealed as being the same compound as number 1/20 from the 
first screen, confirming that the effects observed with this compound in the 
previous screen were repeatable. In addition to the fluorescence reading and 
dose response curves, the percentage death in each of the wells at each 
concentration was recorded. If the effects were real, and a true dose response is 
being observed, the death rate should be higher at higher concentrations (Figure 
6.7).  
Examination of the dose response curves in more detail showed that compounds 
2/4, 2/6 and 2/9 look to be quite similar. As a general trend for compound 2/4, 
the GFP fluorescence level decreases with increasing drug concentration. 
However, this compound shows auto-fluorescence, which is greater at higher 
concentrations. This could account for a lower percentage decrease of 
fluorescence at higher drug concentrations. The only compound to follow the 
desired visual pattern of a linear relationship between fluorescence level and 
drug concentration was compound 2/7 at 24 hours. Additionally, observations by 
eye support the readings observed by the EnVision and relationship between 
drug concentration and fluorescence. 
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All of the compounds exhibited a high percentage of death at the highest 
screening concentration, suggesting non-specific toxicity. Only for compound 2/4 
was a high level of death observed, even at low concentrations (Figure 6.7). 
Visual analysis identified this compound as being effective at killing worms of all 
stages.
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Figure 6.7 Graphic analysis of the compounds of interest  
Graphs indicate the decrease in fluorescence readings for each compound throughout the 48 hour screen period when screened at 60 µM. Dose 
response curves for the compounds of interest indicate the % reduction in GFP fluorescence at 24 and 48 hours, relative to the 0 hour value for each 
compound. Percentage of death of the worms in each compound after 48 hours are shown, with values being the average of visual counting of 2 wells 
at each concentration. Although the compounds shown resulted in a decrease in fluorescence over time, only compound 2/7 showed a desired dose-
response curve (at 24 h). 
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6.2.13 Screening of compounds using H. contortus L3 larvae 
All of the compounds screened in C. elegans were additionally screened in H. 
contortus. The H. contortus larvae were recovered from American sheep fed on 
pasture and thus parasite resistance status reflects that of the natural endemic 
population (Section 2.2.2). Compounds were added to produce a final 
concentration of 80 µM per well, with each compound being examined only 
once. The exsheathed larvae were observed by eye at 24 hours and after 4 days, 
and positive results were recorded. The method of H. contortus larval 
preparation was the standard procedure developed at and followed by Pfizer 
employees. 
Only three compounds showed any activity in H. contortus; these were termed 
compounds X, Y and Z. ‘Active’ compounds were identified by the visual 
observation of wells and recording those in which a large number of H. contortus 
larvae were dead or dying (Figure 6.8). Structurally, compounds X and Y were 
almost identical. In the C. elegans screens, these compounds had not been 
identified as having an effect on GFP levels, however the results of the C. 
elegans screens for these three compounds were subsequently re-examined in 
more detail to confirm observations.  
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Figure 6.8 H. contortus L3 larvae in active and inactive compounds  
These images show the contrast between the larvae that are dead and curled up (A and C) and 
those that are still alive and uncurled (B and D), taken on day 4 of the screen. A and B at x2 
magnification and C and D at x10 magnification. 
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Upon re-examination of the results from the initial C. elegans screens, the 
compounds identified as being active in the H. contortus screen, resulted in 
death of C. elegans worms at the 24 hour time point. Compounds X and Y appear 
to be killing all stages of C. elegans. Compound Z appears to be more effective 
on adults, with a very low rate of larval killing. Visual examination showed 
approximately 50% death at 24 hours in compounds X and Y and approximately 
75% death with compound Z. Although at the 24 hour stage, compound Z appears 
to be most effective at killing the worms, there does not appear to be a visual 
decrease in GFP level. In the presence of compounds X and Y, worms showed a 
slight decrease in level of fluorescence after 24 hours. 
After 48 hours in the compounds, the percentage death of C. elegans are very 
similar to those observed at the 24 hour mark. There was a slight increase in 
killing with compound Y, increasing up to 60%, however this value was still 
relatively low. Compound Z, which appeared to be most effective at killing C. 
elegans, did not appear to have any effect on GFP at 48 hours, while slight 
decreases were observed with X and Y.  
In the first C. elegans screens, a decrease in fluorescence of the compounds 
active in H. contortus screens had not been noted. To re-test this, three sample 
wells were set up for each compound and an average taken of the fluorescence 
readings. For compounds X and Y, after the re-examination screen, the results 
indicated a decrease in fluorescence at both the 24 and 48 hour time points 
(Figure 6.9), in contrast to the initial screen in which an initial decrease was 
followed by an increase. For compound Z however, the readings over the 48h 
screen period were very varied and did not appear to follow any pattern. The 
results from the re-examination screening of compounds X and Y look to be more 
reliable, however for compound Z, the initial results looked to be more 
accurate. 
The 24 and 48 hour readings for compounds X and Y demonstrated a decrease in 
fluorescence at both time periods (Figure 6.9). This differed from the readings in 
the initial screen in which the readings had decreased slightly by 24 hours but 
had increased again by 48 hours. As a number of wells were set up for each 
compound, the significance of the observed results was calculated using the t-
test to determine p value (http://studentsttest.com/). Calculations confirmed 
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that the values for compounds X and Y in the second screen are significant to a 
99% confidence in the results (p<0.001). As the values increased for compound Z 
the results are not significant. Therefore, re-examination screening suggests that 
compounds X and Y share detrimental effects on both H. contortus and C. 
elegans and this is affecting C. elegans cpl-1 GFP levels. 
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Figure 6.9 Fluorescence readings of the compounds identified by the H. contortus screen  
Original graphs from the first C. elegans screen are in blue and the average values of the re-
examination screen in red. Original graphs did not show a significant decrease in fluorescence 
throughout the screen period. However in the repeat screen fluorescence levels for compounds X 
and Y decreased throughout the time period.   
 
6.2.14 Further analysis of two of the Pfizer compounds 
Two of the compounds (1/20 and 2/4) identified from the larger scale screen at 
Pfizer as being of interest in C. elegans, were analysed to examine their effects 
in more detail. Screening was carried out in 96 well plates with a final compound 
concentration of 60 µM. L2 and L3 stage CLB01 worms were added to the wells 
and those exposed to both compounds displayed a decrease in GFP and 
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developed more slowly compared to DMSO control wells. This is consistent with 
elt-2 RNAi effects, in which if young larvae are put on the plates they are unable 
to develop properly. 
CLB01 larvae exposed to both compounds for two days and control worms in 
DMSO were observed at high power to assess development. The control worms 
were larger and looked as if they had been feeding, with GFP fluorescence 
visible in both gut and hypodermal cells. Worms in the wells containing the 
compounds were visibly smaller but there was still GFP fluorescence (Figure 
6.10).  
Addition of older, L4/young adult, CLB01 worms to the wells resulted in a 
decrease in GFP fluorescence. Moreover, it was obvious that fewer progeny were 
developing from adults exposed to the compound compared to DMSO control 
wells. To confirm that the compound is having a specific effect on gut gene 
fluorescence rather than a generalised reduction of gene expression a SX328 
(myo-2::gfp) worm strain was used as a control. This strain is GFP positive in the 
pharynx and after exposure to the compounds there was no observed decrease in 
GFP, however the worms appeared less healthy compared to the control wells 
and showed the same embryonic effect as the CLB01 strain (results not shown). 
To examine the embryonic effect the compounds were having on progeny 
production, eight L4 CLB01 worms were picked into compound or DMSO control 
wells and left to develop for three days. This was carried out in triplicate and on 
day three the L1 progeny in the wells were counted. The results of this are 
indicated in Table 6.3; it was observed that over three times as many progeny 
are produced from worms in control wells.  
 Control Compound 1/20 Compound 2/4 
Sample 1 214 108 26 
Sample 2 214 24 46 
Sample 3 251 68 74 
Average 226 67 49 
STDEV + 21.36 + 42.01 + 24.11 
Table 6.3 Number of progeny in compound and control wells after three days  
8 L4 larvae added per sample well and the progeny counted after 3 days. The statistical 
significance of compound 1/20 and compound 2/4 was determined by Student’s t-test which was 
p<0.005 and p<0.001 respectively.     
 
Chapter 6                                                                                                                                        181   
 
      
      
Figure 6.10 Slower development of CLB01 larvae following exposure to compound 
(A and B) CLB01 worms 3 days after the addition of L3 larvae to wells containing DMSO. Normal 
development to adult and GFP fluorescence in gut and hypodermal cells observed. (C and D) 
CLB01 worms 3 days after the addition of L3 larvae to wells containing compound 1/20. Slower 
development and reduced GFP fluorescence compared to control worms. All images at x10 
magnification. 
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It was of interest to determine at what point embryonic development is being 
interrupted and therefore adult CLB01 worms from both the control and 
compound wells were observed at high power. As the worms were being grown in 
liquid culture it is normal for embryos to develop further within the worms and 
thus in some worms fully elongated embryos could be observed. Egg 
development in the compound wells did not look normal, with a pitted or 
vacuolar appearance in some of the embryos. Development appeared to be most 
affected in younger embryos that started developing when the adult worms had 
been exposed to the compounds for a longer time. Figure 6.11 indicates the 
difference in development of the embryos, with those in the control wells 
developing further than those exposed to compound. GFP fluorescence is clearly 
visible in the control embryos however this is decreased and hardly visible in 
compound wells. A few embryos in the compound wells, particularly those 
produced first, showed normal, full development (Figure 6.11 palette D) but GFP 
fluorescence was barely visible. 
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Figure 6.11 GFP fluorescence in CLB01 embryos 
(A and B) CLB01 worms 3 days after the addition of L4 larvae to wells containing DMSO. 
Embryonic development is observed and also GFP fluorescence visible within the embryos. (C and 
D) CLB01 worms 3 days after the addition of L4 larvae to wells containing compound 1/20. 
Embryonic development is slower and GFP fluorescence minimal in embryos. Red circles indicate 
corresponding regions. All images at x40 magnification. 
 
 
A B 
C D 
Chapter 6                                                                                                                                        184   
In an attempt to determine whether the compounds were effecting yolk 
production leading to embryonic effects, C. elegans strain BIS1 (vit-2::gfp) was 
examined. After exposure to the compounds, GFP fluorescence was no different 
from the control wells, suggesting that there is no direct effect on the 
production or uptake of yolk proteins. However, examination of the vit-2::gfp 
embryos indicated abnormal cell division, resulting in what appeared to be 
multinucleated cells and a number of abnormal small circular regions of 
cytoplasm (Figure 6.12). 
It was suspected that the abnormal embryos would not develop properly, 
explaining the observed decrease in progeny. As the main aim of the drug 
screening work was to identify a compound that was having an effect on the 
ELT-2 GATA TF, an elt-2 specific line (JR1838, wIs84pJM66 elt-2::gfp::lac-Z, 
kindly supplied by Joel Rothman, University of California, Santa Barbara, CA) 
was also used to ensure that this was happening. This worm strain has strong 
GFP fluorescence in the gut nuclei and after exposure to compound, but not 
DMSO, in addition to the observed embryonic effects, there was a decrease in 
fluorescence suggesting that the compounds are also reducing elt-2 (results not 
shown). 
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Figure 6.12 C. elegans BIS1 (vit-2::gfp) worms indicating embryonic GFP fluorescence  
(A) BIS1 worms in control well, indicating normal division and distribution of yolk protein. (B, C and 
D) BIS1 worms exposed to compound 1/20 with arrows indicating pitted appearance and uneven 
yolk patterning. All at x40 magnification. 
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6.3 Discussion 
The aim of this chapter was to identify compounds that potentially target the 
ELT-2 GATA transcription factor in C. elegans worms as indicated by a decrease 
in GFP expression from the C. elegans cpl-1 promoter. Ideally compounds that 
inhibited the target would have a negative effect on growth and survival, with 
lethality being the eventual outcome. Work carried out by Couthier et al. (2004) 
identified an elt-2 homologue in H. contortus capable of directing gut cell 
expression when ectopically expressed in C. elegans. It was speculated that 
compounds hitting the target may have a detrimental effect on C. elegans gut 
function and that the same may be observed in H. contortus. 
The transgenic CLB01 worms exhibit GFP fluorescence in their gut and 
hypodermal cells, and elt-2 RNAi results from this work (Chapter 5) suggest gut 
expression is under the control of the ELT-2 GATA TF. This ELT-2-directed GFP 
can be measured and used as a marker for ELT-2 activity, the key factor 
controlling gene transcription in the C. elegans intestine (McGhee et al., 2007). 
Screening was carried out in vitro, testing fluorescence levels of transgenic 
CLB01 worms in M9 buffer, in the presence of a number of compounds. It was 
presumed that the level of fluorescence from the CLB01 worms would decrease 
during screening due to interference with gut gene expression and intestinal 
development in embryos and early larvae. It was anticipated that some decrease 
in fluorescence may occur as during maintenance of the CLB01 strain, GFP levels 
are reduced with extended culture and starvation. Compounds capable of 
interfering with ELT-2 activity may increase the speed of this effect. However, 
the level of fluorescence recorded in the first control readings taken by the 
EnVision did not show a significant decrease over the test period, but instead 
remained relatively constant over the 4 days. One explanation for the lack of 
decrease in fluorescence reading throughout the period of the screen was the 
presence of auto-fluorescence. Auto-fluorescence in C. elegans is a natural 
phenomenon and is associated with lipids, oxidative stress and related to the 
lifespan of the worm (Le et al., 2010). As GFP and auto-fluorescence are 
observed at different locations in the C. elegans worm it is possible to 
distinguish between the two visually. However as they are very similar in their 
wavelength emissions it was difficult to use the EnVision to differentiate 
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between GFP and auto-fluorescence. Therefore it was imperative that all sample 
wells were observed microscopically in addition to the readings recorded by the 
EnVision. This was vitally important in those wells in which no measurable 
decrease in fluorescence was recorded by the EnVision, to ensure that any 
decrease in fluorescence was not being masked by the presence of auto-
fluorescence.  
Screens were carried out to determine the concentration of DMSO that could be 
tolerated by the transgenic CLB01 worm strain. In contrast to worms that 
became naturally starved or aged, in which auto-fluorescence was observed, no 
auto-fluorescence was observed in worms that had been killed by DMSO. 
Additionally GFP expression in worms killed by DMSO was at an equally high level 
at the start and end of the screen, i.e. worms still produced GFP fluorescence 
when dead. Thus it was assumed that because the worms had been killed rapidly 
by DMSO and had not become sick, the level of GFP fluorescence was not 
affected. Although a similar effect could not be assumed for other compounds, 
this observation suggested that where GFP levels decreased this may be a 
specific effect on gene expression and not a non-specific consequence of 
lethality.    
The fluorescence that was observed from the OP50 bacteria presented an initial 
difficulty that had to be overcome. The fluorescence produced by bacteria has 
previously been identified as a problem when carrying out C. elegans screening, 
specifically if the results rely on a measure of fluorescence level (Gill et al., 
2003). The approach taken to combat this in the current study was to reduce the 
concentration of OP50 to a level that would not interfere with the fluorescence 
reading. This however often resulted in worms that were not as healthy as they 
would have been if grown on OP50 seeded plates or in OP50 culture rich media. 
As OP50 is the standard bacteria used for maintenance of C. elegans worms, 
finding a suitable alternative proved to be problematic. Work has been carried 
out in C. elegans using an anexic medium, which is nutrient rich but contains no 
bacterial food source. When fed on this medium the worms had a slower rate of 
development and a reduced fecundity but an increase in lifespan was observed 
(Lenaerts et al., 2008). This method of C. elegans feeding is not ideal as worms 
may not be at their most healthy, experiencing a degree of starvation, as 
suggested by the aforementioned phenotypes. However if the worms could be 
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maintained at a reasonable degree of health and for a longer period of time then 
this method of maintenance may be a solution to the interference fluorescence 
caused by OP50 bacteria when screening and could be tested for future screens.  
As identified by the initial screen, the level of fluorescence recorded using the 
EnVision remained fairly constant for a period of up to 4 days. For this reason a 
control was required to confirm that if fluorescence in the worms decreased, 
this could be identified by the EnVision. There are no available compounds 
known to directly target the ELT-2 GATA TF to cause a decrease and for this 
reason C. elegans elt-2 RNAi was used as an alternative. Feeding the worms on 
liquid bacteria expressing C. elegans elt-2 dsRNA had not been tested before and 
it was possible that it would not be successful as worms do not feed as well 
when they are in the sample wells (comparable to liquid culture) as they do 
when maintained on plates (Muschiol et al., 2009). Additionally, the low 
concentration of bacteria that was required so as to not interfere with 
fluorescence readings may not have provided the worms with enough bacteria to 
have a measurable RNAi effect on fluorescence.  
RNAi results when worms were fed in the sample wells did not show a decrease 
in fluorescence, most likely for reasons discussed above. Therefore, no direct 
comparison between worms maintained in the sample wells on OP50 bacteria 
and on the C. elegans elt-2 RNAi clone was possible. However a control was 
required to ensure that a decrease in fluorescence was measurable by the 
EnVision. The most commonly used RNAi method, feeding C. elegans worms on 
agar plates seeded with the RNAi clone, was therefore used. This method was 
successful and a decrease in fluorescence was observed.  
One alternative that could have been attempted was soaking the C. elegans 
worms in dsRNA. The standard method involves soaking L4 larvae in dsRNA 
solution for a period of 24 hours, washing and then allowing them to feed on 
bacterial seeded plates to wait for the RNAi to have an effect (Maeda et al., 
2001). These conditions would not have been ideal for the type of fluorescence 
screening used here and modifications to this technique may have been more 
suited, for example soaking worms in dsRNA while in the sample wells would 
enable all stages of the worms to be targeted and for them to remain in the 
dsRNA for the entirety of the screen. This method however may have resulted in 
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decreased growth of young larvae as the ELT-2 GATA TF is essential for gut 
development and growth (Fukushige et al., 1998). Although this would prove 
that RNAi was having the desired effect, it would not confirm that a decrease in 
fluorescence was measurable, as very young and unhealthy worms do not 
fluoresce. An alternative to combat this would be synchronisation of the worm 
population to silence C. elegans elt-2 at the L4 stage. 
The results of the C. elegans screen identified a number of compounds that 
could potentially be having an effect on the ELT-2 GATA TF target. These effects 
were determined by a decrease in the level of GFP fluorescence in the worms as 
recorded by the EnVision and also by a visual GFP decrease and worm death. All 
of the compounds that were screened in C. elegans were additionally screened 
in H. contortus. This enabled any compounds of interest from C. elegans studies 
to be examined in H. contortus. Ideally, based on functional conservation of the 
ELT-2 GATA TF in H. contortus (Couthier et al., 2004), a similar effect may be 
observed in both nematodes. On analysis of these compounds in H. contortus 
none of them were found to be active. This was a disappointing finding, however 
each compound was only tested in one sample well and the recording of the 
results was subjective as it was carried out by eye. Repeating the screens with a 
higher number of sample wells may help identify if there is any activity that was 
missed in the initial screen. In addition compounds were tested only on the H. 
contortus L3 stage, which is not particularly active and may not take up a 
significant amount of compound. Other stages of H. contortus could therefore be 
examined. In the C. elegans screen, GFP was used as the predominant marker 
for identifying potential inhibition of the target and percent death was a second 
measure. ‘Active’ compounds in the H. contortus screen were those in which 
there was a high level of death only. For this reason the activity of compounds 
may be missed if they are inhibiting the target but having a slightly different 
effect e.g. starvation or reduced growth. If this is happening, these worms may 
not be easily identified when carrying out visual analysis of a large number of 
wells.  
The method employed to confirm if an effect shown by a compound is real, 
rather than due to non-specific toxicity, is to generate a dose response curve for 
that compound, plotting drug concentration against percentage reduction in 
fluorescence and death, and looking for a correlation. It is reasonable to 
Chapter 6                                                                                                                                        190   
presume that if a reduction is observed after 24 hours then this level of 
reduction would remain or be further reduced at the 48 hour time point. Of the 
compounds analysed in this way the graphs did not always follow this pattern 
and those which looked to be promising still had anomalies at different 
concentrations. Compound 2/10 was one example in which the graph did not 
follow the predicted pattern, with the fluorescent values at both time points 
remaining almost constant over the different concentrations. There are a 
number of reasons why the dose response curves did not always give the desired 
pattern. Only two wells were sampled at each concentration, therefore including 
more samples may have reduced the standard error. Additionally, at the lower 
concentrations even the smallest variation in the compound volume added to the 
well could have a dramatic effect on the results, due to the sensitivity of the 
assay. One compound, 2/7, did show a good correlation between drug 
concentration and effect.  
There were three compounds that were identified as being active in H. contortus 
however none of these compounds were highlighted in the initial C. elegans 
screen. These compounds were re-screened in C. elegans for closer examination 
to determine if any effect may have been missed originally. Two of the 
compounds, X and Y, looked to cause a decrease in fluorescence in C. elegans. 
Statistical examination was carried out on the results, giving a 95% confidence in 
this decrease. Additionally, examination of the percentage death of C. elegans 
when exposed to these compounds showed a 50-60% death. In H. contortus, no 
effect was recorded at 24 hours and no observations are routinely made between 
this point and the final day 4 observation. For this reason it was unknown at 
exactly which point the compounds had produced an effect. C. elegans screens 
are relatively short in comparison to those carried out in H. contortus (2 days 
compared to 4 days). The main reason for this was that the screening conditions 
were not favourable for the maintenance of the C. elegans worms over an 
extended period. This problem could be addressed by using a different feeding 
media (as previously mentioned) in an attempt to maintain the health of the 
worms for a longer period of time. With longer exposure to the compound it may 
be possible to determine if a greater decrease in fluorescence and higher death 
rate could be observed, similar to that in H. contortus. Ideally, compounds that 
are inhibiting the ELT-2 GATA TF target are desired. Similar effects in both 
Chapter 6                                                                                                                                        191   
species would allow full analysis of the mechanism of action using the C. elegans 
system.  
C. elegans has traditionally been used as a model for H. contortus work due to 
ease of culture and genetic manipulation. For this reason it was presumed that 
using C. elegans for compound screening would be easier to work with than 
screening in H. contortus. However, establishing C. elegans-based screening 
presented several challenges. This type of screening required worms to be at 
optimum health to obtain maximum GFP expression. Worms require a constant 
food source (OP50 bacteria) and due to fluorescence from OP50, worms had to 
be extremely clean. This required ensuring that the worms and sample wells had 
minimal OP50 contamination, to ensure no interference with the results. This is 
in contrast to H. contortus larvae which can be easily prepared for screening and 
remain healthy for a number of days in the absence of bacteria. The ease with 
which H. contortus larvae can be maintained means that screening in H. 
contortus can be carried out for a much larger number of compounds as worm 
preparation is minimal and significantly higher numbers of worms are easily 
attainable. There are great differences in lifestyle between these two 
organisms. Inconsistencies in the reaction and potency to known anthelmintics 
has resulted in C. elegans not being widely used for whole parasite screening, 
however once a target of interest has been selected C. elegans is a very useful 
tool for mechanism-based screening to confirm its effects (Geary et al., 1999). 
The advantage of using C. elegans worms over H. contortus is the ability to 
produce transgenic C. elegans worms. These worms can be used to confirm if 
compounds are selective for specific targets, whereas in H. contortus 
confirmation of mechanism of action is very difficult. 
Use of Ce-elt-2::gfp strain JR1838 helped show compounds also reduced activity 
of ELT-2, supporting their action as possible TF inhibitors. In addition, more 
detailed analysis using C. elegans showed that compounds have a major effect 
on embryogenesis, with far fewer progeny being observed following exposure to 
compound. 
In conclusion, the transgenic CLB01 worm strain proved to be a very useful tool 
in identification of compounds that potentially target the ELT-2 GATA TF. The 
developed screening method and conditions could easily be transferred and used 
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for the analysis of a number of GFP linked targets in the intestine or other cell 
types. Although compounds that appeared to have an effect on the desired 
target in C. elegans did not significantly affect H. contortus a possible reason for 
this may be lower drug uptake by H. contortus. Two compounds found to be 
effective at killing H. contortus were subsequently found to affect C. elegans 
cpl-1 GFP expression and viability, therefore further examination of these in 
both species is warranted.  
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Information about genes and genomes is continually increasing and with this 
comes invaluable advances in many fields. H. contortus is a worldwide 
economically important parasite, and due to the increasing resistance to 
anthelmintics much effort has been spent understanding the mechanisms of drug 
resistance and development of novel approaches to interfere with parasite 
development and survival (Knox et al., 1999;Munn et al., 1997). This is aided by 
advances in genome sequencing. The H. contortus genome sequencing project is 
currently ongoing and is anticipated to be completed in 2012/2013. The most 
recent assembly became available June 2012 and has an N50 of 83,238 bp 
(James Cotton, personal communication). Previous data had shown an N50 of 
6,447 bp in May 2011 (Laing et al., 2011), indicating the advances within this 
project and that the number and size of contiguous regions is rapidly increasing.  
Multigene families have been found in a number of species. One study carried 
out by Demuth et al., (2006) examined the evolution of mammalian gene 
families. When compared to the closely related chimpanzee genome, 6.4% of 
genes in the human genome were found to have no orthologs in the chimpanzee. 
This is also similar between the rat and mouse, with 10% of genes having no 
orthologs. A high rate of genetic turnover is accountable for these changes, with 
emphasis on gene duplication and deletion. It is therefore likely that gene 
families have undergone selective pressure and have altered to fill the 
requirements. Due to the ongoing sequencing of the H. contortus genome, there 
is no full comparative genomics with C. elegans or other nematodes. However, 
Yin et al., (2008) carried out comparative analysis of intestinal transcriptomes of 
A. suum, H. contortus and C. elegans. There are over 5,000 known C. elegans 
intestinal genes which were compared to the 3,121 and 1,755 identified for A. 
suum and H. contortus, respectively. This was an extensive study that 
discovered 241 intestinal protein families having members within all three 
species. It is of interest to determine why some genes form expanded families 
and others are present in the genome as single copies. The expansion of CBL 
cysteine protease genes appears to occur more frequently than for other types 
of enzyme in H. contortus; for example the cathepsin L protease, Hc-CPL-1 
(Britton and Murray, 2002), the metalloproteases MEP-1 and MEP-2 (Redmond et 
al., 1997) and SOD (Liddell and Knox, 1998) are present as single copies. 
Additionally, Yin et al., (Yin et al., 2008) described 39% of A. suum and 19% of 
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H. contortus genes as being novel when compared to previously published 
databases, suggesting a significant degree of species-specific evolution. 
In this thesis a number of multigene families in a number of species have been 
discussed. Ranjit et al., (2008) described a family of cathepsin B cysteine 
proteases in the gut of the human hookworm N. americanus and in the dog 
hookworm A. caninum. Figure 7.1 is a phylogenetic tree indicating the 
relationship between all aforementioned proteases and families. From this figure 
it is evident that the cathepsin B-like gene family members in H. contortus are 
more similar to each other than to cathepsin Bs from other species, with the 
exception of Hc-CPR-6. Interestingly, CP proteases identified so far from 
hookworm species group more closely to C. elegans CPRs than to any of the H. 
contortus cathepsin B families. As hookworms also blood feed this suggests that 
the H. contortus CBLs have not diverged and duplicated specifically for blood-
feeding, although further information on the full set of proteases in hookworms 
is needed to confirm this. In H. contortus, analysis to date has shown that the 
families are all located at different regions of the genome and it is likely that 
they have evolved to have different functions. One interesting point to note is 
the location of Hc-scaffold161-12 (HmCP genes) which appears to be more 
similar to the BAC 18f22 family than other genes on scaffold161.  
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Figure 7.1 Phylogenetic tree showing the relationship of CBL-like proteases in H. contortus 
(Hc), N. americanus (Na), A. caninum (Ac) and C. elegans (Ce) 
Neighbour joining tree, with 500 replicates. 
A greater knowledge of members of gene families and their relationship to 
related families will help direct the development of novel anthelmintics or 
vaccines. In addition to CBLs, many studies have been carried out examining the 
importance of H. contortus H11 aminopeptidases, encoded by a family of 
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targets (Bakker et al., 2004;Cachate et al., 2010;De Vries et al., 2009;Knox et 
al., 1999;Munn et al., 1997;Ruiz et al., 2004a).  
Cysteine protease genes are abundantly expressed in the H. contortus intestine 
and are thought to have a role in blood digestion, thus making them of interest 
as potential protective antigens. Work by Ruiz et al., (2004b) examining five H. 
contortus cysteine proteases in two different strains identified 20 alleles. It is 
unknown what the implications of this genetic variation are, however changes 
may result in antigenic variation which may have an impact on the efficacy of 
potential novel vaccines. A recent study carried out by Molina et al., (2012) 
reported a protective effect of cysteine protease-enriched fractions (CPFs) 
during a vaccine trial using two different H. contortus strains (North American 
and Spanish). This study reported a similar level of protection observed across 
the two strains, despite one strain being adapted to sheep and one to goats. It 
could be speculated that certain components within the CPFs with low genetic 
diversity e.g. AC-5 (Ruiz et al., 2004b) may be maintaining a similar level of 
protection. It would be of interest to determine if there are specific cysteine 
protease genes that have low genetic diversity over a range of H. contortus 
strains, as these may be effective targets for a wide-scale novel vaccine. CPR-6 
may be an obvious candidate; this protease is present only as a single copy and 
is highly conserved across species. No information is yet available on cpr-6 
sequences in different H. contortus strains, but this could be examined.  
Bakker et al., (2004) examined H. contortus protection using fractions from the 
adult stage excretory/secretory (ES) products. Analysis of the ES products 
identified a number of proteins that were un-characterised and it was thought 
that these may represent cysteine proteases. Interestingly, of the two ES 
fractions used in trials, the one containing the most cysteine protease activity 
gave the highest protection. Yatsuda et al., (2006) also carried out a study 
examining the proteases in H. contortus ES products. Six different cysteine 
proteases were obtained; AC-4, GCP-7, Hm-CP1, Hm-CP1-like, Hm-CP2, and Hm-
CP2-like. There were also three additional proteases identified, and as these did 
not show high DNA similarity to any known CBL were designated Hm-CP7 
(CA869450, 181AA), Hm-CP8 (CB019057, ~53AA), Hm-CP9 (CA034108, 173AA). 
From the newly identified CBL sequences discussed in this thesis I have 
discovered that Hm-CP7 has 99% AA identity to Hc-scaffold161-1 and Hm-CP9 
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shows a 90% AA identity to Hc-scaffold306-10. Hm-CP8 only has a small amount 
of available sequence and therefore it is still unknown to which protein (if any) 
it is most similar. The work contained in this thesis has helped characterize and 
group many different cathepsin B proteases and supports the need for 
annotation and characterization of the complete H. contortus genome. This 
information would help in the identification of cysteine proteases within 
fractions such as the ES products (Bakker et al., 2004) and subsequently help 
with protection studies, as targeting a number of proteins in a family may 
provide significant protection and be of benefit. 
In addition to the work carried out characterising H. contortus gut cysteine 
proteases, in this thesis an assay was generated to test inhibition of a major gut 
TF, ELT-2. To date, screening potential anthelmintics in H. contortus is more 
frequently carried out than in the model organism C. elegans, as screening in the 
target organism is generally favoured. However, once a target of interest has 
been selected, C. elegans is a useful tool for mechanism-based screening to 
confirm compound effects (Geary et al., 1999). C. elegans screening has 
recently been applied to human medicine, with screens being carried out for 
diseases such as Huntington’s Disease (Voisine et al., 2007) and Alzheimer’s 
Disease (Lublin and Link, 2012). Gosai et al., (2010) developed an assay 
examining the use of C. elegans in high-throughput screening. This work 
focussed on human liver disease caused by α1-antitrypsin deficiency and aimed 
to identify compounds that prevented misfolded protein accumulation, typical of 
the disease. The same difficulties identified in the generation of the screening 
assay in Chapter 6, such as DMSO tolerance and OP50 fluorescence, were also 
mentioned by Gosai et al., (2010) but despite these factors an effective assay 
was produced.  
This work provides an alternative to the generation of vaccines against gut 
proteases and protease families by targeting specific TFs involved in controlling 
their expression. TFs are essential for the control of specific genes and the roles 
of many nematode TFs, such as CEH-22 in pharyngeal muscles (Okkema and Fire, 
1994) have been identified in C. elegans and the work of Reece-Hoys et al., 
(2005), with 934 potential TFs identified in the C. elegans genome has provided 
much data for future work. 
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In conclusion, cathepsin B proteases in a number of parasitic species have been 
identified as having a place in the development of novel approaches to parasite 
control. In this thesis over 30 novel CBL genes have been identified and 
characterised. Two compounds were identified which can potentially target the 
ELT-2 TF in C. elegans, causing embryonic and larval effects. Further work 
testing these in H. contortus and other parasitic nematodes would therefore be 
of great interest. 
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Appendix 1: Common buffers and reagents 
1x Phosphate Buffered 
Saline (PBS) 
137 mM NaCl, 8.1 mM Na2HPO4, 2.7 mM KCl, 1.47 
mM KH2PO4 in sterile distilled H20. pH 7.2. 
Sterilise by autoclaving, store at room 
temperature. 
1x Phosphate Buffered 
Saline Tween-20 (PBST) 
Prepare 1 x PBS as above add 1 ml/L Tween-20. 
1x Tris-acetate-EDTA (TAE) 10 mM Tris-HCl pH 8, 1.2 ml acetic acid, 1 mM 
EDTA pH 8 in distilled H2O. Sterilise by 
autoclaving. 
1x TE 10 mM Tris-HCl pH 8, 1 mM EDTA pH 8 in distilled 
H2O. Sterilise by autoclaving. 
2% X-gal 5-bromo-4-chloro-3-indoyl-β-D-galactosidase 
(Promega) in N’-dimethly-formamide. Store at -
20OC out of light. 
2x SDS-PAGE buffer 0.09 M Tris-HCl (pH 6.8), 20% Glycerol, 2% SDS, 
0.02% bromophenol blue. Store at room 
temperature. 
5% block solution 10 g skimmed milk powder in 200 ml 1x PBST. 
Ampicillin plates L. agar + 1/1,000 dilution 1 M Ampicillin. 
Basal media 100 g bacto-tryptone, 5 g yeast extract, 25 g 
glucose, 4 g HK2PO4, 4 g KH2PO4 , 50 ml 250 µg/ml 
Amphotericin B up to 5 L ddH20. Add 6.5 mg/100 
ml Penicillin G, 6.5 mg/100 ml Streptomycin, 25 
µl/100 ml Gentamicin, 200 µl 1 M Hepes and 5.2 g 
Glucose. 
Blotting buffer 80 ml 10x Tris-glycine solution (BioRad), 160 ml 
100% Methanol, 0.8 ml 10% SDS made up to 800 ml 
H2O. 
DNA ladder 100 bp and 1 kb 100 µl DNA loading buffer, 50 µl ladder and 350 µl 
1x TE. 
DNA loading buffer 4 ml 0.5 M EDTA, 25 g FICOL (type 400) and 0.2 g 
bromophenol blue, made in to 100 ml with H20. 
Freezing solution 2.34 g NaCl, 2.72 g KH2PO4, 120 ml  30% glucose, 
2.24 ml 1 M NaOH up to 400 ml ddH2O. Sterilise by 
autoclaving add 1.2 ml 0.1 M MgSO4 before use. 
Glucose Tyrodes balanced 
salt solution 
9.6 g Glucose Tyrodes, 1 g NaHCO3, 1.2 g 
Penicillin G, 2 g Steptomycin Sulphate, 0.01 g 5-
fluorocytosine in 1 L ddH20. 
IPTG Isopropyl-β-D-thiogalactoside (Promega) in ddH2O. 
1 M stock concentration, filter sterilise. Store at -
20OC. 
L. agar L. broth + 15 g/L bacto-agar (Oxoid). Sterilise by 
autoclaving, store at room temperature.  
L. broth 10 g NaCl, 10 g bacto tryptone (Oxoid) and 5 g 
yeast extract (Oxoid) up to 1 L ddH2O. Sterilise by 
autoclaving, store at room temperature. 
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M9 buffer 3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl in 1 L of ddH2O. 
Sterilise by autoclaving add 1 ml MgSO4 before 
use. 
M9/0.001% Triton solution 5 µl of 10% Triton X-100 in to 50 ml M9 buffer. 
NGM agar plates 3 g NaCl, 17 g agar, 2.5 g Peptone in 975 ml of 
ddH2O. Sterilise by autoclaving then add 1 ml of 1 
M CaCl2, 1 ml of 5 mg/ml cholesterol in ethanol, 1 
ml of 1 M MgSO4 and 25 ml of 1 M KH2PO4. Store at 
4OC. 
NGM agar plates + IPTG Prepare NGM agar plates as above add 1 ml 1 M 
IPTG and 1 ml 100 mg/ml Ampicillin. Store at 4OC 
Running buffer 70 ml 10x Tris-glycine-SDS solution (BioRad) made 
up to 700 ml H2O. 
SOC medium L. broth + 20 µl/ml glucose. 
SWLB 20 mM Tris pH 7, 50 mM EDTA, 200 mM NaCl and 
0.5% SDS. Store at -20OC. 
X-gal stain 40 µl 1M NaH2PO4, 210 µl Na2HPO4, 10 µl 1 M 
MgCl2, 10 µl 0.5 M K4FeCN6, 10 µl 0.5 M K3FeCN6, 1 
µl 1x SDS and 18 µl 2% X-gal, made up to 1 ml with 
H20. Made fresh as required. 
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Appendix 2: Primer sequences 
Chapter 3 
Table 3.1 5’ RACE primer sequences for BAC 18f22 genes 
Name 5’  3’ Sequence 
SJ03_1 TCTGATAGGCAATCCTCCATCGCACCCGTA 
SJ03_2 AATAAGATCTTGATTCTGATATTTGAACCT 
SJ04_1 TTCGATAGGCCATCCTCCTTCACACCCGTC 
SJ04_2 GAACGTTGTGCAGTTTTTCCAGACGTC 
SJ05_1 TTTGATAGACCAGCCTCCGTCACACCCGAA 
SJ05_2 GAACGAGGTGCAGTTGCTCCAGATTTT 
SJ06_1 TTTGTAGGCCCAGCCCCCATTACACCCGCT 
SJ06_2 GAGAACAGGGTTTGGAACCTGTTTCTCGAA 
SJ07_out AGTCCAGCCTCCTAGACAGTACCCAAGGCCGCA 
SJ07_in AATAGGGTTTATATTGCGGCTTGCGAACTT 
 
Table 3.2 sj02 expression primers giving a fragment of 378 bp on cDNA 
Name 5’  3’ Sequence 
SJ02_forward1 CGTCCCTCTGAAGGCTCGAACC 
SJ02_exon7 GGAGAGCAGCATGACAATATGTCTG 
 
Table 3.3 sj02 primers for start methionine, 465 bp on cDNA. sj02 primers in Table 3.2 used as a 
control. 
Name 5’  3’ Sequence 
SJ02start GTGACCATGAAGTTCTTGGTGTTTACG 
SJ02_exon7 GGAGAGCAGCATGACAATATGTCTG 
 
Table 3.4 RT-PCR primer sequences for BAC 18f22 genes 
Name 5’  3’ Sequence 
SJ02_forward1 CGTCCCTCTGAAGGCTCGAACC 
SJ02_exon7 GGAGAGCAGCATGACAATATGTCTG 
SJ03_forward1 CAAGGATGATTCCGAACCTGTC 
SJ03_1 TCTGATAGGCAATCCTCCATCGCACCCGTA 
SJ04_exon4 GCTACGATCCTCGAGACGTCTGG 
SJ04_exon8 GCACGGTGGGGTTGGCGCTGTTCC 
SJ05_forward1 CATAAAGTTCAGAAATCGGAATC 
SJ05_1 TTTGATAGACCAGCCTCCGTCACACCCGAA 
SJ06_forward1 CGCCTGGTTTTGAGCTCAAATTG 
SJ06_1 TTTGTAGGCCCAGCCCCCATTACACCCGCT 
SJ07_forward1 GCCGCAATATAAACCCTATTGTA 
SJ07_out AGTCCAGCCTCCTAGACAGTACCCAAGGCCGCA 
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Chapter 4 
Table 4.1 RT-PCR primer sequences for H. contortus cpr-6 and Hc-sod-1 expression 
Name 5’  3’ Sequence 
cpr-6_2 CACACTCAGGCGCACATTATTCACACCCATCAGACC 
Hccpr6_exon2 CGTACTGGCCGATCGCCGTATTGAACTCG 
Hcsod-1F1 CAAAGGCGAAATCAAGGGTTTG 
Hcsod-1R1 AATAACTCCGCAAGCGACAC 
 
Table 4.2 Primer sequences for amplification of 1.2 kb of H. contortus cpr-6 promoter 
Name 5’  3’ Sequence 
Hccpr6promF3 GCGCATGCGTGTCGCGCACAAGATCATACGGCACTATTTACCC 
Hccpr6promR GCTCTAGACGTGTCCAACTGAAGACCACTTTGTTGTCGGC 
 
Table 4.3 Primer sequences for amplification of C. elegans cpr-6 
Name 5’  3’ Sequence 
cpr-6GFPFOR2 TATCTGCAGAGTACCATTAACATGCGACAAAC 
cpr-6GFPREV    TGACCCGGGAGTAGTTGTCATCGTAGACGTG 
 
 
Chapter 5 
Table 5.1 primer sequences for amplification of a 1 kb H. contortus sj04 promoter region 
Name 5’  3’ Sequence 
SJ04forward2 TGCTGCAGCCCACGATCAAAACACTGATGTGGG 
SJ04reverse1 CGGGATCCATATCTTCAATCTGCCGTTCAATCC 
 
Table 5.2 Ce-cpl-1 gene specific primers. Reverse vector primer used with forward gene specific 
primer as a control 
Name 5’  3’ Sequence 
T03E6F1 ACAGCATGCTCCCGAAAAAAACTTCAATATTCAG 
T03E6R1 CGGTCTAGACTGGAATTTTATAACATTTAAAAT 
Vector96.04rev TCTGAGCTCGGTACCCTCCAAGGG 
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Appendix 3: Additional figures 
Table 1 Additional information for the HmCP genes on scaffold161 
Gene Nembase cluster 
number 
Percentage DNA 
identity 
Sequence 
conservation (bp) 
Number of ESTs Published sequences 
with high identity 
hc-scaffold161-1 HCC06366_1 99 702/1017 15 EMBL:BF060207 
hc-scaffold161-2 - - - - - 
hc-scaffold161-3 HCC03301_1 
HCC01418_2 
98                      
98 
752/932      
639/932 
3                        
23 
EMBL:BU665613 
hc-scaffold161-4 HCC00202_2 98 1006/1011 38 EMBL:Z69345 (HmCP4) 
hc-scaffold161-5 HCC00328_1 98 993/1023 28 EMBL:Z69344 (HmCP3) 
hc-scaffold161-6 HCC00473_2 99 908/951 53 EMBL:CA959067 
hc-scaffold161-7 HCC01418_2 99 667/1017 23 EMBL:CA956449  
hc-scaffold161-8 HCC00021_1 98 956/984 3 EMBL:Z69346 (HmCP5) 
hc-scaffold161-9 - - - - - 
hc-scaffold161-10 HCC02966_2 96 890/990 136 EMBL:CA958802 
hc-scaffold161-11 HCC01573_1 97 592/855 11 EMBL:CA869542 
hc-scaffold161-12 - - - - - 
 
Tables 1 and 2 indicate the information obtained from Nembase BLAST searches using the maximum sequence information available for each gene. In addition to EST 
data, the Washington University BLAST server (http://www.ebi.ac.uk/Tools/sss/wublast/parasites.html) was used to identify previously published partial sequences for 
the genes. 
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Table 2 Additional information for the gcp-7-like genes on scaffold306 
Gene Nembase cluster 
number 
Percentage DNA 
identity 
Sequence 
conservation (bp) 
Number of ESTs Published sequences with 
high identity 
hc-scaffold306-1 HCC00358_1 96 404/750 5 EMBL:CB020616 
hc-scaffold306-2 - - - - EMBL:CA958613 
hc-scaffold306-3 HCC00018_2 99 1029/1035 96 EMBL:Z69342 (HmCP1) 
hc-scaffold306-4 HCC00019_1 97 1013/1035 10 EMBL:69343 (HmCP2) 
hc-scaffold306-5 HCC00230_1 97 1018/1041 14 EMBL:BE496731 
hc-scaffold306-6 HCC01556_1 99 1039/1044 9 EMBL:BG734185 
hc-scaffold306-7 - - - - - 
hc-scaffold306-8 HCC00316_1 98 532/1044 17 EMBL:CB099492 
hc-scaffold306-9 HCC00166_1 96 1003/1038 6 EMBL:AF046229 (gcp-7) 
hc-scaffold306-10 HCC03318_1 97 572/1050 3 EMBL:CA869627 
hc-scaffold306-11 - - - - - 
hc-scaffold306-12 HCC04186_1 98 646/1044 3 EMBL:CA958735 
hc-scaffold306-13 HCC00310_1 98 293/690 9 EMBL:CB015574 
hc-scaffold306-14 HCC00310_2 98 742/1035 9 EMBL:CB015446 
hc-scaffold306-15 - - - - - 
hc-scaffold306-16 HCC01012_1 97 1018/1041 6 EMBL:CA956400 
hc-scaffold306-17 - - - - - 
hc-scaffold306-18 - - - - EMBL:CA958026 
hc-scaffold306-19 - - - - - 
hc-scaffold306-20 HCC01173_2 95 655/1047 10 EMBL:CA868860 
hc-scaffold306-21 HCC01124_1 95 565/852 3 EMBL:CB192118 
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